| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.921 | 0.001 | 0.921 | Tyrosine 3 hydroxylase inhibitor | 0.65 0.003 DB00988 0.886 0.001 DBMET02439 0.331 0.021 DBMET02448 0.331 0.021 DBMET02449 0.204 0.129 DBMET02451 0.204 0.129 DBMET02450 0.531 0.004 DBMET02440 0.441 0.005 DBMET02443 0.49 0.004 DBMET02445 0.411 0.007 DBMET02441 0.357 0.014 DBMET02444 0.571 0.003 DBMET02447 0.739 0.002 DBMET02446 0.618 0.003 DBMET02442 | ||
| 0.858 | 0.001 | 0.877 | Glutamate decarboxylase inhibitor | 0.634 0.002 DB00988 0.509 0.002 DBMET02439 0.266 0.004 DBMET02448 0.266 0.004 DBMET02449 0.151 0.013 DBMET02451 0.151 0.013 DBMET02450 0.325 0.003 DBMET02440 0.877 0.001 DBMET02443 0.39 0.003 DBMET02445 0.232 0.005 DBMET02441 0.247 0.004 DBMET02444 0.291 0.004 DBMET02447 0.796 0.002 DBMET02446 0.429 0.003 DBMET02442 | DBMET02443 | |
| 0.82 | 0.001 | 0.82 | Phenylalanine 4-hydroxylase inhibitor | 0.691 0.001 DB00988 0.669 0.002 DBMET02439 0.453 0.003 DBMET02448 0.453 0.003 DBMET02449 0.213 0.006 DBMET02451 0.213 0.006 DBMET02450 0.431 0.003 DBMET02440 0.789 0.001 DBMET02443 0.29 0.004 DBMET02445 0.119 0.019 DBMET02441 0.72 0.001 DBMET02444 0.539 0.002 DBMET02447 0.579 0.002 DBMET02446 0.29 0.004 DBMET02442 | ||
| 0.763 | 0.003 | 0.791 | Superoxide dismutase inhibitor | 0.696 0.004 DB00988 0.791 0.003 DBMET02439 0.768 0.003 DBMET02448 0.768 0.003 DBMET02449 0.22 0.097 DBMET02451 0.22 0.097 DBMET02450 0.738 0.004 DBMET02440 0.574 0.008 DBMET02443 0.685 0.004 DBMET02445 0.73 0.004 DBMET02441 0.282 0.058 DBMET02444 0.603 0.007 DBMET02447 0.634 0.005 DBMET02446 0.694 0.004 DBMET02442 | DBMET02439 | |
| 0.72 | 0.003 | 0.72 | Peroxidase inhibitor | 0.611 0.004 DB00988 0.654 0.004 DBMET02439 0.407 0.02 DBMET02448 0.407 0.02 DBMET02449 0.523 0.008 DBMET02440 0.699 0.003 DBMET02443 0.504 0.009 DBMET02445 0.401 0.02 DBMET02441 0.555 0.006 DBMET02444 0.628 0.004 DBMET02447 0.644 0.004 DBMET02446 0.561 0.005 DBMET02442 | ||
| 0.691 | 0.008 | 0.814 | 5 Hydroxytryptamine release stimulant | 0.806 0.004 DB00988 0.707 0.007 DBMET02439 0.402 0.045 DBMET02448 0.402 0.045 DBMET02449 0.731 0.005 DBMET02451 0.731 0.005 DBMET02450 0.814 0.003 DBMET02440 0.496 0.028 DBMET02443 0.409 0.044 DBMET02445 0.435 0.039 DBMET02441 0.407 0.044 DBMET02444 0.533 0.022 DBMET02447 0.494 0.028 DBMET02446 0.516 0.025 DBMET02442 | DBMET02440 | |
| 0.671 | 0.002 | 0.671 | 5 Hydroxytryptamine uptake stimulant | 0.57 0.003 DB00988 0.66 0.002 DBMET02439 0.314 0.038 DBMET02448 0.314 0.038 DBMET02449 0.236 0.095 DBMET02451 0.236 0.095 DBMET02450 0.56 0.003 DBMET02440 0.461 0.006 DBMET02443 0.472 0.005 DBMET02445 0.46 0.006 DBMET02441 0.368 0.021 DBMET02444 0.48 0.005 DBMET02447 0.555 0.003 DBMET02446 0.545 0.004 DBMET02442 | ||
| 0.66 | 0.001 | 0.66 | Histidine decarboxylase inhibitor | 0.458 0.003 DB00988 0.618 0.002 DBMET02439 0.097 0.033 DBMET02448 0.097 0.033 DBMET02449 0.113 0.028 DBMET02451 0.113 0.028 DBMET02450 0.408 0.004 DBMET02440 0.318 0.005 DBMET02443 0.265 0.008 DBMET02445 0.204 0.013 DBMET02441 0.101 0.031 DBMET02444 0.296 0.006 DBMET02447 0.548 0.002 DBMET02446 0.498 0.003 DBMET02442 | ||
| 0.656 | 0.005 | 0.656 | Psychostimulant | 0.496 0.011 DB00988 0.619 0.005 DBMET02439 0.493 0.011 DBMET02451 0.493 0.011 DBMET02450 0.472 0.014 DBMET02440 0.421 0.019 DBMET02443 0.181 0.092 DBMET02445 0.162 0.106 DBMET02441 0.58 0.007 DBMET02444 0.232 0.065 DBMET02447 0.316 0.039 DBMET02446 0.287 0.046 DBMET02442 | ||
| 0.652 | 0.013 | 0.806 | Aldehyde oxidase inhibitor | 0.662 0.012 DB00988 0.669 0.011 DBMET02439 0.153 0.136 DBMET02448 0.153 0.136 DBMET02449 0.678 0.01 DBMET02440 0.645 0.013 DBMET02443 0.658 0.012 DBMET02445 0.675 0.01 DBMET02441 0.575 0.022 DBMET02444 0.806 0.004 DBMET02447 0.761 0.005 DBMET02446 0.779 0.005 DBMET02442 | DBMET02447 | |
| 0.64 | 0.014 | 0.64 | Cholesterol antagonist | 0.392 0.051 DB00988 0.619 0.016 DBMET02439 0.549 0.025 DBMET02448 0.549 0.025 DBMET02449 0.638 0.014 DBMET02451 0.638 0.014 DBMET02450 0.36 0.06 DBMET02440 0.463 0.039 DBMET02443 0.391 0.051 DBMET02445 0.359 0.061 DBMET02441 0.392 0.051 DBMET02444 0.633 0.014 DBMET02447 0.613 0.017 DBMET02446 0.588 0.02 DBMET02442 | ||
| 0.61 | 0.01 | 0.61 | 5 Hydroxytryptamine release inhibitor | 0.481 0.039 DB00988 0.591 0.012 DBMET02439 0.56 0.017 DBMET02451 0.56 0.017 DBMET02450 0.46 0.047 DBMET02440 0.483 0.038 DBMET02443 0.412 0.071 DBMET02445 0.392 0.083 DBMET02441 0.362 0.105 DBMET02444 0.552 0.019 DBMET02447 0.548 0.02 DBMET02446 0.528 0.024 DBMET02442 | ||
| 0.574 | 0.003 | 0.574 | Cystathionine beta-synthase inhibitor | 0.297 0.01 DB00988 0.517 0.004 DBMET02439 0.265 0.013 DBMET02451 0.265 0.013 DBMET02450 0.269 0.013 DBMET02440 0.235 0.017 DBMET02443 0.313 0.009 DBMET02445 0.283 0.011 DBMET02441 0.157 0.038 DBMET02444 0.369 0.005 DBMET02447 0.524 0.003 DBMET02446 0.468 0.004 DBMET02442 | ||
| 0.556 | 0.037 | 0.849 | Transcription factor NF kappa B inhibitor | 0.492 0.045 DB00988 0.605 0.031 DBMET02439 0.351 0.077 DBMET02448 0.351 0.077 DBMET02449 0.849 0.01 DBMET02451 0.849 0.01 DBMET02450 0.548 0.038 DBMET02440 0.571 0.035 DBMET02443 0.459 0.051 DBMET02445 0.511 0.043 DBMET02441 0.55 0.038 DBMET02444 0.468 0.049 DBMET02447 0.547 0.038 DBMET02446 0.596 0.032 DBMET02442 | DBMET02450 | |
| 0.506 | 0.004 | 0.616 | GABA C receptor agonist | 0.557 0.003 DB00988 0.255 0.013 DBMET02439 0.175 0.026 DBMET02448 0.175 0.026 DBMET02449 0.128 0.045 DBMET02451 0.128 0.045 DBMET02450 0.3 0.009 DBMET02440 0.437 0.004 DBMET02443 0.269 0.012 DBMET02445 0.121 0.049 DBMET02441 0.166 0.028 DBMET02444 0.285 0.01 DBMET02447 0.616 0.003 DBMET02446 0.361 0.006 DBMET02442 | DBMET02446 | |
| 0.507 | 0.006 | 0.558 | Phospholipase C inhibitor | 0.468 0.007 DB00988 0.385 0.011 DBMET02439 0.558 0.005 DBMET02448 0.558 0.005 DBMET02449 0.341 0.015 DBMET02451 0.341 0.015 DBMET02450 0.349 0.014 DBMET02440 0.289 0.019 DBMET02443 0.213 0.036 DBMET02445 0.172 0.07 DBMET02441 0.178 0.063 DBMET02444 0.347 0.014 DBMET02447 0.413 0.009 DBMET02446 0.285 0.02 DBMET02442 | DBMET02449 | |
| 0.5 | 0.009 | 0.505 | Interleukin agonist | 0.374 0.023 DB00988 0.452 0.013 DBMET02439 0.499 0.009 DBMET02451 0.499 0.009 DBMET02450 0.33 0.035 DBMET02440 0.505 0.009 DBMET02443 0.258 0.073 DBMET02445 0.216 0.106 DBMET02441 0.496 0.009 DBMET02444 0.355 0.028 DBMET02447 0.496 0.009 DBMET02446 0.448 0.013 DBMET02442 | DBMET02443 | |
| 0.487 | 0.001 | 0.487 | DOPA decarboxylase inhibitor | 0.264 0.003 DB00988 0.403 0.001 DBMET02439 0.135 0.031 DBMET02448 0.135 0.031 DBMET02449 0.104 0.069 DBMET02451 0.104 0.069 DBMET02450 0.211 0.005 DBMET02440 0.189 0.008 DBMET02443 0.267 0.003 DBMET02445 0.213 0.005 DBMET02441 0.128 0.036 DBMET02444 0.287 0.003 DBMET02447 0.415 0.001 DBMET02446 0.343 0.002 DBMET02442 | ||
| 0.523 | 0.044 | 0.759 | Cyclophilin D inhibitor | 0.246 0.217 DB00988 0.403 0.089 DBMET02439 0.332 0.136 DBMET02448 0.332 0.136 DBMET02449 0.759 0.009 DBMET02451 0.759 0.009 DBMET02450 0.626 0.023 DBMET02443 0.626 0.023 DBMET02444 0.525 0.043 DBMET02447 0.692 0.015 DBMET02446 0.547 0.038 DBMET02442 | DBMET02450 | |
| 0.505 | 0.027 | 0.627 | Histamine release inhibitor | 0.44 0.055 DB00988 0.477 0.037 DBMET02439 0.382 0.085 DBMET02448 0.382 0.085 DBMET02449 0.613 0.009 DBMET02451 0.613 0.009 DBMET02450 0.406 0.073 DBMET02440 0.493 0.031 DBMET02443 0.404 0.074 DBMET02445 0.359 0.096 DBMET02441 0.477 0.038 DBMET02444 0.51 0.025 DBMET02447 0.627 0.008 DBMET02446 0.585 0.011 DBMET02442 | DBMET02446 | |
| 0.492 | 0.03 | 0.764 | Antithrombotic | 0.345 0.066 DB00988 0.464 0.035 DBMET02439 0.52 0.026 DBMET02448 0.52 0.026 DBMET02449 0.764 0.005 DBMET02451 0.764 0.005 DBMET02450 0.318 0.078 DBMET02440 0.399 0.049 DBMET02443 0.346 0.066 DBMET02445 0.319 0.077 DBMET02441 0.344 0.067 DBMET02444 0.347 0.065 DBMET02447 0.541 0.024 DBMET02446 0.512 0.027 DBMET02442 | DBMET02450 | |
| 0.478 | 0.018 | 0.683 | Free radical scavenger | 0.489 0.017 DB00988 0.474 0.019 DBMET02439 0.376 0.033 DBMET02448 0.376 0.033 DBMET02449 0.683 0.005 DBMET02451 0.683 0.005 DBMET02450 0.482 0.018 DBMET02440 0.409 0.027 DBMET02443 0.461 0.02 DBMET02445 0.459 0.02 DBMET02441 0.376 0.033 DBMET02444 0.552 0.012 DBMET02447 0.542 0.012 DBMET02446 0.525 0.014 DBMET02442 | DBMET02450 | |
| 0.468 | 0.009 | 0.649 | Monophenol monooxygenase inhibitor | 0.277 0.021 DB00988 0.501 0.008 DBMET02439 0.199 0.033 DBMET02448 0.199 0.033 DBMET02449 0.649 0.004 DBMET02451 0.649 0.004 DBMET02450 0.297 0.018 DBMET02440 0.291 0.019 DBMET02443 0.216 0.029 DBMET02445 0.236 0.026 DBMET02441 0.207 0.032 DBMET02444 0.378 0.012 DBMET02447 0.362 0.013 DBMET02446 0.399 0.011 DBMET02442 | DBMET02450 | |
| 0.464 | 0.013 | 0.483 | Interleukin 2 agonist | 0.373 0.036 DB00988 0.405 0.026 DBMET02439 0.233 0.139 DBMET02448 0.233 0.139 DBMET02449 0.474 0.011 DBMET02451 0.474 0.011 DBMET02450 0.303 0.072 DBMET02440 0.405 0.026 DBMET02443 0.231 0.141 DBMET02445 0.296 0.076 DBMET02444 0.328 0.056 DBMET02447 0.483 0.01 DBMET02446 0.408 0.025 DBMET02442 | DBMET02446 | |
| 0.443 | 0.004 | 0.443 | Glutamate dehydrogenase inhibitor | 0.155 0.015 DB00988 0.215 0.009 DBMET02439 0.083 0.042 DBMET02448 0.083 0.042 DBMET02449 0.094 0.034 DBMET02451 0.094 0.034 DBMET02450 0.082 0.043 DBMET02440 0.15 0.016 DBMET02443 0.104 0.029 DBMET02445 0.099 0.031 DBMET02444 0.113 0.025 DBMET02447 0.194 0.01 DBMET02446 0.102 0.03 DBMET02442 | ||
| 0.444 | 0.012 | 0.589 | Anesthetic general | 0.384 0.019 DB00988 0.433 0.013 DBMET02439 0.407 0.015 DBMET02451 0.407 0.015 DBMET02450 0.374 0.02 DBMET02440 0.348 0.024 DBMET02443 0.261 0.046 DBMET02445 0.253 0.049 DBMET02441 0.279 0.039 DBMET02444 0.589 0.005 DBMET02447 0.537 0.006 DBMET02446 0.527 0.006 DBMET02442 | DBMET02447 | |
| 0.438 | 0.022 | 0.671 | Hypoglycemic | 0.301 0.052 DB00988 0.382 0.031 DBMET02439 0.671 0.005 DBMET02451 0.671 0.005 DBMET02450 0.265 0.068 DBMET02440 0.316 0.048 DBMET02443 0.246 0.079 DBMET02445 0.218 0.097 DBMET02441 0.255 0.074 DBMET02444 0.443 0.021 DBMET02447 0.523 0.013 DBMET02446 0.446 0.021 DBMET02442 | DBMET02450 | |
| 0.446 | 0.038 | 0.583 | Immunostimulant | 0.331 0.07 DB00988 0.411 0.046 DBMET02439 0.406 0.048 DBMET02448 0.406 0.048 DBMET02449 0.583 0.019 DBMET02451 0.583 0.019 DBMET02450 0.271 0.088 DBMET02440 0.327 0.071 DBMET02443 0.292 0.081 DBMET02445 0.234 0.103 DBMET02441 0.234 0.103 DBMET02444 0.293 0.08 DBMET02447 0.343 0.066 DBMET02446 0.284 0.084 DBMET02442 | DBMET02450 | |
| 0.437 | 0.029 | 0.706 | Antioxidant | 0.441 0.028 DB00988 0.432 0.03 DBMET02439 0.554 0.015 DBMET02448 0.554 0.015 DBMET02449 0.706 0.005 DBMET02451 0.706 0.005 DBMET02450 0.434 0.029 DBMET02440 0.39 0.037 DBMET02443 0.435 0.029 DBMET02445 0.429 0.03 DBMET02441 0.365 0.043 DBMET02444 0.578 0.013 DBMET02447 0.528 0.017 DBMET02446 0.503 0.02 DBMET02442 | DBMET02450 | |
| 0.415 | 0.008 | 0.547 | Alpha-N-acetylglucosaminidase inhibitor | 0.23 0.026 DB00988 0.22 0.029 DBMET02439 0.327 0.014 DBMET02451 0.327 0.014 DBMET02450 0.116 0.082 DBMET02440 0.258 0.022 DBMET02443 0.533 0.005 DBMET02445 0.3 0.016 DBMET02441 0.24 0.025 DBMET02444 0.487 0.005 DBMET02447 0.547 0.004 DBMET02446 0.311 0.015 DBMET02442 | DBMET02446 | |
| 0.423 | 0.019 | 0.423 | Insulysin inhibitor | 0.386 0.024 DB00988 0.403 0.022 DBMET02439 0.26 0.087 DBMET02448 0.26 0.087 DBMET02449 0.363 0.03 DBMET02440 0.293 0.063 DBMET02443 0.309 0.053 DBMET02445 0.277 0.074 DBMET02441 0.261 0.086 DBMET02444 0.324 0.045 DBMET02447 0.389 0.024 DBMET02446 0.366 0.029 DBMET02442 | ||
| 0.407 | 0.005 | 0.407 | Cell adhesion inhibitor | 0.357 0.007 DBMET02439 0.231 0.018 DBMET02451 0.231 0.018 DBMET02450 0.098 0.094 DBMET02447 0.259 0.014 DBMET02446 0.229 0.018 DBMET02442 | ||
| 0.399 | 0.006 | 0.409 | Insulin sensitizer | 0.268 0.025 DB00988 0.351 0.009 DBMET02439 0.175 0.101 DBMET02448 0.175 0.101 DBMET02449 0.241 0.04 DBMET02451 0.241 0.04 DBMET02450 0.248 0.035 DBMET02440 0.291 0.018 DBMET02443 0.208 0.065 DBMET02445 0.188 0.087 DBMET02441 0.292 0.017 DBMET02444 0.305 0.015 DBMET02447 0.409 0.006 DBMET02446 0.362 0.008 DBMET02442 | DBMET02446 | |
| 0.417 | 0.026 | 0.499 | Antiamyloidogenic | 0.299 0.052 DB00988 0.499 0.016 DBMET02439 0.448 0.022 DBMET02451 0.448 0.022 DBMET02450 0.382 0.032 DBMET02440 0.256 0.068 DBMET02443 0.162 0.131 DBMET02441 0.296 0.053 DBMET02444 0.312 0.048 DBMET02447 0.303 0.051 DBMET02446 0.385 0.031 DBMET02442 | DBMET02439 | |
| 0.4 | 0.016 | 0.4 | Growth hormone agonist | 0.316 0.029 DB00988 0.341 0.025 DBMET02439 0.124 0.115 DBMET02448 0.124 0.115 DBMET02449 0.237 0.047 DBMET02440 0.193 0.062 DBMET02443 0.184 0.066 DBMET02447 0.261 0.041 DBMET02446 0.187 0.064 DBMET02442 | ||
| 0.419 | 0.036 | 0.779 | Spasmolytic | 0.476 0.027 DB00988 0.439 0.033 DBMET02439 0.352 0.052 DBMET02448 0.352 0.052 DBMET02449 0.651 0.009 DBMET02451 0.651 0.009 DBMET02450 0.494 0.024 DBMET02440 0.581 0.015 DBMET02443 0.259 0.087 DBMET02445 0.276 0.08 DBMET02441 0.779 0.004 DBMET02444 0.43 0.035 DBMET02447 0.355 0.051 DBMET02446 0.373 0.046 DBMET02442 | DBMET02444 | |
| 0.427 | 0.047 | 0.605 | Vasodilator, peripheral | 0.32 0.087 DB00988 0.465 0.036 DBMET02439 0.342 0.077 DBMET02451 0.342 0.077 DBMET02450 0.361 0.069 DBMET02440 0.444 0.042 DBMET02443 0.231 0.143 DBMET02445 0.264 0.117 DBMET02441 0.605 0.015 DBMET02444 0.501 0.027 DBMET02447 0.479 0.032 DBMET02446 0.516 0.025 DBMET02442 | DBMET02444 | |
| 0.399 | 0.022 | 0.779 | Angiogenesis stimulant | 0.297 0.05 DB00988 0.37 0.028 DBMET02439 0.564 0.008 DBMET02448 0.564 0.008 DBMET02449 0.779 0.004 DBMET02451 0.779 0.004 DBMET02450 0.276 0.059 DBMET02440 0.26 0.065 DBMET02443 0.17 0.111 DBMET02445 0.169 0.111 DBMET02441 0.344 0.034 DBMET02447 0.32 0.042 DBMET02446 0.296 0.051 DBMET02442 | DBMET02450 | |
| 0.395 | 0.028 | 0.496 | Platelet antagonist | 0.19 0.109 DB00988 0.326 0.045 DBMET02439 0.213 0.092 DBMET02448 0.213 0.092 DBMET02449 0.38 0.031 DBMET02451 0.38 0.031 DBMET02450 0.2 0.1 DBMET02447 0.496 0.014 DBMET02446 0.391 0.029 DBMET02442 | DBMET02446 | |
| 0.447 | 0.084 | 0.793 | Caspase 9 stimulant | 0.569 0.041 DB00988 0.529 0.05 DBMET02439 0.57 0.041 DBMET02451 0.57 0.041 DBMET02450 0.709 0.023 DBMET02440 0.489 0.064 DBMET02443 0.504 0.058 DBMET02445 0.622 0.033 DBMET02441 0.474 0.071 DBMET02444 0.75 0.018 DBMET02447 0.715 0.022 DBMET02446 0.793 0.012 DBMET02442 | DBMET02442 | |
| 0.367 | 0.005 | 0.367 | Aminopeptidase B inhibitor | 0.214 0.018 DB00988 0.269 0.011 DBMET02439 0.249 0.013 DBMET02448 0.249 0.013 DBMET02449 0.146 0.039 DBMET02440 0.167 0.031 DBMET02443 0.193 0.023 DBMET02445 0.123 0.051 DBMET02441 0.088 0.075 DBMET02444 0.187 0.024 DBMET02447 0.22 0.017 DBMET02446 0.152 0.037 DBMET02442 | ||
| 0.398 | 0.036 | 0.639 | Vasodilator, coronary | 0.425 0.028 DB00988 0.455 0.022 DBMET02439 0.195 0.187 DBMET02448 0.195 0.187 DBMET02449 0.639 0.006 DBMET02451 0.639 0.006 DBMET02450 0.485 0.018 DBMET02440 0.466 0.02 DBMET02443 0.303 0.085 DBMET02445 0.35 0.055 DBMET02441 0.548 0.01 DBMET02444 0.435 0.026 DBMET02447 0.368 0.047 DBMET02446 0.42 0.029 DBMET02442 | DBMET02450 | |
| 0.366 | 0.004 | 0.366 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.154 0.025 DB00988 0.247 0.01 DBMET02439 0.177 0.02 DBMET02451 0.177 0.02 DBMET02450 0.093 0.061 DBMET02440 0.114 0.043 DBMET02443 0.147 0.027 DBMET02445 0.09 0.066 DBMET02441 0.214 0.014 DBMET02447 0.311 0.005 DBMET02446 0.201 0.015 DBMET02442 | ||
| 0.385 | 0.024 | 0.388 | Pyruvate kinase inhibitor | 0.163 0.105 DB00988 0.388 0.023 DBMET02439 0.166 0.102 DBMET02440 0.146 0.118 DBMET02443 0.292 0.05 DBMET02445 0.297 0.048 DBMET02441 0.194 0.084 DBMET02447 0.281 0.053 DBMET02446 0.287 0.051 DBMET02442 | DBMET02439 | |
| 0.353 | 0.004 | 0.353 | Catalase inhibitor | 0.081 0.047 DB00988 0.313 0.005 DBMET02439 0.12 0.033 DBMET02448 0.12 0.033 DBMET02449 0.064 0.06 DBMET02440 0.111 0.035 DBMET02443 0.174 0.021 DBMET02445 0.148 0.027 DBMET02441 0.167 0.022 DBMET02447 0.253 0.008 DBMET02446 0.229 0.011 DBMET02442 | ||
| 0.358 | 0.016 | 0.399 | Thrombolytic | 0.204 0.05 DB00988 0.298 0.024 DBMET02439 0.275 0.028 DBMET02448 0.275 0.028 DBMET02449 0.399 0.011 DBMET02451 0.399 0.011 DBMET02450 0.162 0.073 DBMET02440 0.17 0.068 DBMET02443 0.166 0.07 DBMET02445 0.127 0.102 DBMET02441 0.158 0.076 DBMET02447 0.256 0.032 DBMET02446 0.203 0.051 DBMET02442 | DBMET02450 | |
| 0.381 | 0.044 | 0.551 | Apoptosis antagonist | 0.329 0.067 DB00988 0.365 0.049 DBMET02439 0.551 0.014 DBMET02451 0.551 0.014 DBMET02450 0.323 0.071 DBMET02440 0.254 0.123 DBMET02443 0.397 0.039 DBMET02445 0.373 0.047 DBMET02441 0.193 0.19 DBMET02444 0.402 0.038 DBMET02447 0.392 0.041 DBMET02446 0.37 0.048 DBMET02442 | DBMET02450 | |
| 0.347 | 0.013 | 0.616 | Amylase inhibitor | 0.247 0.029 DB00988 0.372 0.011 DBMET02439 0.616 0.004 DBMET02451 0.616 0.004 DBMET02450 0.265 0.024 DBMET02440 0.305 0.018 DBMET02443 0.391 0.01 DBMET02445 0.419 0.008 DBMET02441 0.191 0.048 DBMET02444 0.377 0.011 DBMET02447 0.432 0.008 DBMET02446 0.467 0.007 DBMET02442 | DBMET02450 | |
| 0.33 | 0.002 | 0.33 | Glutamate (mGluR3) antagonist | 0.053 0.011 DB00988 0.284 0.003 DBMET02439 0.038 0.023 DBMET02440 0.049 0.013 DBMET02447 0.09 0.005 DBMET02446 0.06 0.008 DBMET02442 | ||
| 0.358 | 0.032 | 0.471 | Amyloid beta aggregation inhibitor | 0.436 0.02 DB00988 0.397 0.025 DBMET02439 0.189 0.084 DBMET02448 0.189 0.084 DBMET02449 0.323 0.041 DBMET02451 0.323 0.041 DBMET02450 0.471 0.017 DBMET02440 0.349 0.035 DBMET02443 0.189 0.084 DBMET02445 0.285 0.048 DBMET02441 0.305 0.044 DBMET02444 0.446 0.019 DBMET02447 0.372 0.03 DBMET02446 0.419 0.022 DBMET02442 | DBMET02440 | |
| 0.322 | 0.004 | 0.322 | Argininosuccinate synthase inhibitor | 0.094 0.021 DB00988 0.197 0.008 DBMET02439 0.08 0.025 DBMET02443 0.157 0.011 DBMET02445 0.069 0.031 DBMET02441 0.076 0.027 DBMET02447 0.16 0.01 DBMET02446 0.07 0.03 DBMET02442 | ||
| 0.333 | 0.018 | 0.509 | Melanin inhibitor | 0.304 0.021 DB00988 0.376 0.014 DBMET02439 0.509 0.006 DBMET02451 0.509 0.006 DBMET02450 0.346 0.016 DBMET02440 0.312 0.02 DBMET02443 0.388 0.013 DBMET02445 0.439 0.01 DBMET02441 0.203 0.04 DBMET02444 0.337 0.017 DBMET02447 0.343 0.017 DBMET02446 0.386 0.013 DBMET02442 | DBMET02450 | |
| 0.397 | 0.083 | 0.729 | Calcium channel L-type activator | 0.447 0.052 DB00988 0.38 0.095 DBMET02439 0.24 0.217 DBMET02451 0.24 0.217 DBMET02450 0.422 0.067 DBMET02440 0.648 0.004 DBMET02443 0.383 0.093 DBMET02445 0.358 0.111 DBMET02441 0.729 0.002 DBMET02444 0.463 0.044 DBMET02447 0.459 0.046 DBMET02446 0.431 0.061 DBMET02442 | DBMET02444 | |
| 0.32 | 0.008 | 0.43 | Succinate dehydrogenase inhibitor | 0.273 0.016 DB00988 0.317 0.008 DBMET02439 0.188 0.059 DBMET02448 0.188 0.059 DBMET02449 0.271 0.016 DBMET02440 0.259 0.019 DBMET02443 0.406 0.004 DBMET02445 0.402 0.004 DBMET02441 0.194 0.053 DBMET02444 0.378 0.004 DBMET02447 0.43 0.004 DBMET02446 0.425 0.004 DBMET02442 | DBMET02446 | |
| 0.319 | 0.007 | 0.558 | Expectorant | 0.173 0.027 DB00988 0.406 0.005 DBMET02439 0.558 0.003 DBMET02451 0.558 0.003 DBMET02450 0.226 0.016 DBMET02440 0.29 0.009 DBMET02443 0.128 0.046 DBMET02445 0.173 0.027 DBMET02441 0.27 0.011 DBMET02444 0.293 0.009 DBMET02447 0.307 0.008 DBMET02446 0.386 0.005 DBMET02442 | DBMET02450 | |
| 0.331 | 0.02 | 0.477 | DNA methylase inhibitor | 0.266 0.04 DB00988 0.398 0.011 DBMET02439 0.477 0.006 DBMET02451 0.477 0.006 DBMET02450 0.326 0.021 DBMET02440 0.163 0.107 DBMET02445 0.228 0.061 DBMET02441 0.225 0.063 DBMET02447 0.329 0.02 DBMET02446 0.396 0.011 DBMET02442 | DBMET02450 | |
| 0.346 | 0.042 | 0.384 | DNA damaging | 0.334 0.046 DB00988 0.384 0.032 DBMET02439 0.36 0.038 DBMET02451 0.36 0.038 DBMET02450 0.372 0.035 DBMET02440 0.225 0.097 DBMET02443 0.213 0.105 DBMET02444 0.22 0.1 DBMET02447 0.245 0.083 DBMET02446 0.282 0.065 DBMET02442 | DBMET02439 | |
| 0.304 | 0.003 | 0.306 | GABA aminotransferase inhibitor | 0.306 0.003 DB00988 0.19 0.005 DBMET02439 0.081 0.045 DBMET02448 0.081 0.045 DBMET02449 0.226 0.004 DBMET02451 0.226 0.004 DBMET02450 0.19 0.005 DBMET02440 0.142 0.009 DBMET02443 0.134 0.011 DBMET02445 0.102 0.026 DBMET02441 0.077 0.05 DBMET02444 0.146 0.008 DBMET02447 0.219 0.004 DBMET02446 0.155 0.007 DBMET02442 | DB00988 | |
| 0.304 | 0.003 | 0.304 | Prolactin inhibitor | 0.235 0.005 DB00988 0.247 0.004 DBMET02439 0.084 0.075 DBMET02448 0.084 0.075 DBMET02449 0.183 0.012 DBMET02440 0.136 0.029 DBMET02443 0.21 0.007 DBMET02445 0.16 0.018 DBMET02441 0.127 0.034 DBMET02444 0.194 0.01 DBMET02447 0.22 0.006 DBMET02446 0.169 0.015 DBMET02442 | ||
| 0.318 | 0.022 | 0.337 | Gastrin inhibitor | 0.208 0.137 DB00988 0.288 0.042 DBMET02439 0.193 0.16 DBMET02444 0.236 0.096 DBMET02447 0.337 0.014 DBMET02446 0.309 0.027 DBMET02442 | DBMET02446 | |
| 0.307 | 0.013 | 0.312 | Neurotensin receptor agonist | 0.242 0.022 DB00988 0.312 0.013 DBMET02439 0.152 0.097 DBMET02448 0.152 0.097 DBMET02449 0.249 0.021 DBMET02440 0.168 0.066 DBMET02443 0.164 0.072 DBMET02445 0.168 0.065 DBMET02441 0.144 0.118 DBMET02444 0.182 0.048 DBMET02447 0.229 0.025 DBMET02446 0.235 0.024 DBMET02442 | DBMET02439 | |
| 0.309 | 0.016 | 0.399 | Neurotrophic factor enhancer | 0.316 0.014 DB00988 0.293 0.02 DBMET02439 0.376 0.007 DBMET02451 0.376 0.007 DBMET02450 0.299 0.018 DBMET02440 0.273 0.027 DBMET02443 0.319 0.014 DBMET02445 0.302 0.018 DBMET02441 0.277 0.025 DBMET02444 0.399 0.005 DBMET02447 0.393 0.006 DBMET02446 0.364 0.008 DBMET02442 | DBMET02447 | |
| 0.339 | 0.047 | 0.447 | Sodium/bile acid cotransporter inhibitor | 0.294 0.085 DB00988 0.336 0.049 DBMET02439 0.28 0.098 DBMET02448 0.28 0.098 DBMET02449 0.204 0.183 DBMET02451 0.204 0.183 DBMET02450 0.3 0.079 DBMET02440 0.315 0.066 DBMET02443 0.275 0.103 DBMET02445 0.287 0.091 DBMET02441 0.335 0.05 DBMET02444 0.36 0.034 DBMET02447 0.447 0.008 DBMET02446 0.43 0.01 DBMET02442 | DBMET02446 | |
| 0.296 | 0.006 | 0.324 | NMDA receptor antagonist | 0.258 0.009 DB00988 0.139 0.028 DBMET02439 0.324 0.005 DBMET02448 0.324 0.005 DBMET02449 0.119 0.036 DBMET02440 0.146 0.026 DBMET02443 0.103 0.045 DBMET02444 0.143 0.026 DBMET02447 0.198 0.014 DBMET02446 0.089 0.055 DBMET02442 | DBMET02449 | |
| 0.294 | 0.004 | 0.354 | Mucolytic | 0.185 0.017 DB00988 0.354 0.004 DBMET02439 0.103 0.074 DBMET02448 0.103 0.074 DBMET02449 0.226 0.009 DBMET02451 0.226 0.009 DBMET02450 0.218 0.01 DBMET02440 0.269 0.005 DBMET02443 0.148 0.034 DBMET02445 0.175 0.02 DBMET02441 0.245 0.007 DBMET02444 0.272 0.005 DBMET02447 0.288 0.005 DBMET02446 0.347 0.004 DBMET02442 | DBMET02439 | |
| 0.297 | 0.012 | 0.369 | Nitric-oxide synthase stimulant | 0.358 0.004 DB00988 0.296 0.012 DBMET02439 0.195 0.098 DBMET02448 0.195 0.098 DBMET02449 0.369 0.004 DBMET02451 0.369 0.004 DBMET02450 0.358 0.005 DBMET02440 0.349 0.005 DBMET02443 0.28 0.017 DBMET02445 0.279 0.018 DBMET02441 0.324 0.007 DBMET02444 0.313 0.009 DBMET02447 0.31 0.009 DBMET02446 0.309 0.009 DBMET02442 | DBMET02450 | |
| 0.29 | 0.005 | 0.328 | Toll-Like receptor 2 antagonist | 0.249 0.009 DB00988 0.328 0.004 DBMET02439 0.14 0.06 DBMET02451 0.14 0.06 DBMET02450 0.276 0.006 DBMET02440 0.212 0.019 DBMET02443 0.217 0.017 DBMET02445 0.239 0.011 DBMET02441 0.152 0.051 DBMET02444 0.252 0.009 DBMET02447 0.258 0.008 DBMET02446 0.287 0.005 DBMET02442 | DBMET02439 | |
| 0.307 | 0.024 | 0.394 | DNA methyltransferase I inhibitor | 0.207 0.066 DB00988 0.376 0.011 DBMET02439 0.385 0.01 DBMET02451 0.385 0.01 DBMET02450 0.281 0.034 DBMET02440 0.155 0.098 DBMET02445 0.234 0.054 DBMET02441 0.22 0.059 DBMET02447 0.319 0.02 DBMET02446 0.394 0.009 DBMET02442 | DBMET02442 | |
| 0.292 | 0.012 | 0.292 | Chelator | 0.28 0.013 DB00988 0.237 0.018 DBMET02439 0.126 0.048 DBMET02451 0.126 0.048 DBMET02450 0.214 0.022 DBMET02440 0.159 0.033 DBMET02443 0.105 0.07 DBMET02445 0.092 0.089 DBMET02441 0.162 0.032 DBMET02444 0.24 0.018 DBMET02447 0.282 0.013 DBMET02446 0.214 0.022 DBMET02442 | ||
| 0.285 | 0.006 | 0.343 | Carbonic anhydrase III inhibitor | 0.343 0.005 DB00988 0.267 0.008 DBMET02439 0.295 0.005 DBMET02448 0.295 0.005 DBMET02449 0.235 0.011 DBMET02451 0.235 0.011 DBMET02450 0.313 0.005 DBMET02440 0.267 0.008 DBMET02443 0.168 0.023 DBMET02445 0.153 0.027 DBMET02441 0.172 0.022 DBMET02444 0.264 0.008 DBMET02447 0.28 0.006 DBMET02446 0.262 0.008 DBMET02442 | DB00988 | |
| 0.298 | 0.025 | 0.439 | Peptidyltransferase inhibitor | 0.319 0.019 DB00988 0.271 0.038 DBMET02439 0.216 0.081 DBMET02448 0.216 0.081 DBMET02449 0.439 0.005 DBMET02451 0.439 0.005 DBMET02450 0.285 0.031 DBMET02440 0.418 0.006 DBMET02443 0.199 0.1 DBMET02445 0.173 0.141 DBMET02441 0.411 0.006 DBMET02444 0.295 0.026 DBMET02447 0.266 0.04 DBMET02446 0.233 0.064 DBMET02442 | DBMET02450 | |
| 0.275 | 0.004 | 0.275 | NMDA receptor subunit 3A antagonist | 0.052 0.019 DB00988 0.132 0.006 DBMET02439 0.057 0.017 DBMET02443 0.052 0.019 DBMET02444 0.048 0.021 DBMET02447 0.149 0.005 DBMET02446 0.068 0.015 DBMET02442 | ||
| 0.291 | 0.02 | 0.38 | Lipid peroxidase inhibitor | 0.227 0.032 DB00988 0.27 0.023 DBMET02439 0.206 0.039 DBMET02448 0.206 0.039 DBMET02449 0.367 0.011 DBMET02451 0.367 0.011 DBMET02450 0.217 0.035 DBMET02440 0.17 0.056 DBMET02443 0.185 0.048 DBMET02445 0.183 0.049 DBMET02441 0.146 0.071 DBMET02444 0.38 0.01 DBMET02447 0.313 0.017 DBMET02446 0.283 0.021 DBMET02442 | DBMET02447 | |
| 0.277 | 0.006 | 0.48 | Porphobilinogen synthase inhibitor | 0.364 0.004 DB00988 0.099 0.036 DBMET02439 0.168 0.017 DBMET02448 0.168 0.017 DBMET02449 0.139 0.023 DBMET02440 0.259 0.007 DBMET02443 0.24 0.008 DBMET02445 0.082 0.046 DBMET02441 0.074 0.052 DBMET02444 0.222 0.01 DBMET02447 0.48 0.004 DBMET02446 0.185 0.014 DBMET02442 | DBMET02446 | |
| 0.354 | 0.085 | 0.509 | Immunosuppressant | 0.269 0.135 DB00988 0.326 0.1 DBMET02439 0.509 0.03 DBMET02451 0.509 0.03 DBMET02450 0.245 0.152 DBMET02440 0.22 0.176 DBMET02443 0.223 0.173 DBMET02444 0.4 0.063 DBMET02447 0.345 0.09 DBMET02446 0.31 0.109 DBMET02442 | DBMET02450 | |
| 0.268 | 0.004 | 0.268 | NMDA receptor subunit 3B antagonist | 0.068 0.016 DB00988 0.146 0.006 DBMET02439 0.051 0.024 DBMET02443 0.047 0.027 DBMET02444 0.052 0.024 DBMET02447 0.171 0.005 DBMET02446 0.075 0.014 DBMET02442 | ||
| 0.268 | 0.005 | 0.278 | Keratolytic | 0.175 0.011 DB00988 0.278 0.004 DBMET02439 0.184 0.01 DBMET02440 0.15 0.014 DBMET02443 0.128 0.019 DBMET02445 0.134 0.018 DBMET02441 0.079 0.05 DBMET02444 0.261 0.005 DBMET02447 0.258 0.005 DBMET02446 0.267 0.005 DBMET02442 | DBMET02439 | |
| 0.267 | 0.004 | 0.311 | HIV-1 integrase (Overall Integration) inhibitor | 0.251 0.005 DB00988 0.211 0.009 DBMET02439 0.175 0.018 DBMET02448 0.175 0.018 DBMET02449 0.194 0.013 DBMET02440 0.277 0.004 DBMET02443 0.2 0.011 DBMET02445 0.138 0.03 DBMET02441 0.177 0.017 DBMET02444 0.297 0.004 DBMET02447 0.311 0.003 DBMET02446 0.25 0.005 DBMET02442 | DBMET02446 | |
| 0.305 | 0.042 | 0.379 | DNA synthesis inhibitor | 0.228 0.084 DB00988 0.252 0.065 DBMET02439 0.379 0.025 DBMET02451 0.379 0.025 DBMET02450 0.192 0.135 DBMET02440 0.246 0.069 DBMET02443 0.266 0.057 DBMET02445 0.223 0.091 DBMET02441 0.208 0.112 DBMET02444 0.25 0.067 DBMET02447 0.266 0.057 DBMET02446 0.223 0.091 DBMET02442 | DBMET02450 | |
| 0.308 | 0.046 | 0.4 | Interleukin antagonist | 0.29 0.05 DB00988 0.262 0.057 DBMET02439 0.145 0.121 DBMET02451 0.145 0.121 DBMET02450 0.241 0.065 DBMET02440 0.309 0.046 DBMET02443 0.144 0.123 DBMET02445 0.142 0.124 DBMET02444 0.28 0.052 DBMET02447 0.4 0.031 DBMET02446 0.33 0.042 DBMET02442 | DBMET02446 | |
| 0.263 | 0.004 | 0.263 | NMDA receptor agonist | 0.128 0.011 DB00988 0.156 0.007 DBMET02439 0.154 0.008 DBMET02448 0.154 0.008 DBMET02449 0.069 0.037 DBMET02440 0.091 0.023 DBMET02443 0.077 0.031 DBMET02444 0.062 0.044 DBMET02447 0.159 0.007 DBMET02446 0.09 0.023 DBMET02442 | ||
| 0.275 | 0.018 | 0.313 | Phospholipase A2 inhibitor | 0.227 0.031 DB00988 0.24 0.026 DBMET02439 0.179 0.054 DBMET02448 0.179 0.054 DBMET02449 0.19 0.048 DBMET02451 0.19 0.048 DBMET02450 0.197 0.044 DBMET02440 0.185 0.051 DBMET02443 0.288 0.015 DBMET02445 0.251 0.023 DBMET02441 0.121 0.115 DBMET02444 0.271 0.018 DBMET02447 0.313 0.012 DBMET02446 0.274 0.018 DBMET02442 | DBMET02446 | |
| 0.356 | 0.099 | 0.701 | Antibacterial | 0.396 0.079 DB00988 0.303 0.133 DBMET02439 0.543 0.03 DBMET02448 0.543 0.03 DBMET02449 0.701 0.009 DBMET02451 0.701 0.009 DBMET02450 0.342 0.106 DBMET02440 0.482 0.046 DBMET02443 0.414 0.071 DBMET02445 0.362 0.095 DBMET02441 0.326 0.116 DBMET02444 0.32 0.121 DBMET02447 0.337 0.11 DBMET02446 0.284 0.148 DBMET02442 | DBMET02450 | |
| 0.261 | 0.004 | 0.261 | Aminopeptidase I inhibitor | 0.141 0.014 DB00988 0.167 0.01 DBMET02439 0.083 0.039 DBMET02440 0.109 0.024 DBMET02443 0.1 0.028 DBMET02445 0.073 0.049 DBMET02444 0.142 0.014 DBMET02447 0.166 0.01 DBMET02446 0.101 0.028 DBMET02442 | ||
| 0.26 | 0.004 | 0.358 | Adenylate cyclase stimulant | 0.322 0.002 DB00988 0.236 0.005 DBMET02439 0.308 0.003 DBMET02448 0.308 0.003 DBMET02449 0.239 0.005 DBMET02451 0.239 0.005 DBMET02450 0.294 0.003 DBMET02440 0.355 0.002 DBMET02443 0.203 0.012 DBMET02445 0.184 0.022 DBMET02441 0.358 0.002 DBMET02444 0.24 0.005 DBMET02447 0.251 0.004 DBMET02446 0.228 0.006 DBMET02442 | DBMET02444 | |
| 0.271 | 0.017 | 0.319 | Adenylate cyclase inhibitor | 0.319 0.012 DB00988 0.169 0.034 DBMET02439 0.137 0.054 DBMET02448 0.137 0.054 DBMET02449 0.234 0.021 DBMET02451 0.234 0.021 DBMET02450 0.227 0.022 DBMET02440 0.307 0.013 DBMET02443 0.125 0.064 DBMET02445 0.3 0.014 DBMET02444 0.189 0.028 DBMET02447 0.243 0.02 DBMET02446 0.154 0.042 DBMET02442 | DB00988 | |
| 0.278 | 0.023 | 0.356 | Interferon gamma antagonist | 0.177 0.052 DB00988 0.263 0.026 DBMET02439 0.356 0.014 DBMET02451 0.356 0.014 DBMET02450 0.168 0.058 DBMET02440 0.17 0.057 DBMET02443 0.2 0.04 DBMET02445 0.189 0.045 DBMET02441 0.151 0.076 DBMET02444 0.261 0.026 DBMET02447 0.326 0.016 DBMET02446 0.312 0.018 DBMET02442 | DBMET02450 | |
| 0.287 | 0.033 | 0.497 | Hepatoprotectant | 0.198 0.066 DB00988 0.284 0.034 DBMET02439 0.248 0.044 DBMET02448 0.248 0.044 DBMET02449 0.497 0.007 DBMET02451 0.497 0.007 DBMET02450 0.21 0.059 DBMET02440 0.192 0.07 DBMET02443 0.194 0.069 DBMET02445 0.207 0.061 DBMET02441 0.181 0.079 DBMET02444 0.24 0.046 DBMET02447 0.273 0.037 DBMET02446 0.272 0.038 DBMET02442 | DBMET02450 | |
| 0.266 | 0.013 | 0.266 | Glutamate receptor antagonist | 0.168 0.039 DBMET02439 | ||
| 0.255 | 0.005 | 0.255 | Integrin antagonist | 0.14 0.011 DBMET02439 0.124 0.013 DBMET02446 0.047 0.028 DBMET02442 | ||
| 0.255 | 0.005 | 0.543 | Alcohol oxidase inhibitor | 0.365 0.004 DB00988 0.119 0.014 DBMET02439 0.056 0.039 DBMET02451 0.056 0.039 DBMET02450 0.152 0.01 DBMET02440 0.387 0.004 DBMET02443 0.543 0.003 DBMET02445 0.21 0.006 DBMET02441 0.064 0.032 DBMET02444 0.409 0.004 DBMET02447 0.52 0.004 DBMET02446 0.201 0.006 DBMET02442 | DBMET02445 | |
| 0.273 | 0.025 | 0.382 | Protein-tyrosine phosphatase inhibitor | 0.135 0.095 DB00988 0.227 0.038 DBMET02439 0.382 0.01 DBMET02448 0.382 0.01 DBMET02449 0.15 0.078 DBMET02451 0.15 0.078 DBMET02450 0.141 0.089 DBMET02445 0.25 0.031 DBMET02447 0.302 0.019 DBMET02446 0.243 0.033 DBMET02442 | DBMET02449 | |
| 0.286 | 0.038 | 0.424 | Platelet adhesion inhibitor | 0.144 0.113 DB00988 0.288 0.038 DBMET02439 0.366 0.016 DBMET02448 0.366 0.016 DBMET02449 0.424 0.009 DBMET02451 0.424 0.009 DBMET02450 0.169 0.089 DBMET02440 0.155 0.1 DBMET02445 0.184 0.08 DBMET02441 0.287 0.038 DBMET02447 0.339 0.022 DBMET02446 0.331 0.024 DBMET02442 | DBMET02450 | |
| 0.25 | 0.005 | 0.333 | Creatine kinase inhibitor | 0.268 0.005 DB00988 0.143 0.027 DBMET02439 0.157 0.021 DBMET02448 0.157 0.021 DBMET02449 0.153 0.023 DBMET02440 0.237 0.006 DBMET02443 0.214 0.009 DBMET02445 0.12 0.041 DBMET02441 0.157 0.021 DBMET02444 0.333 0.004 DBMET02447 0.315 0.004 DBMET02446 0.179 0.014 DBMET02442 | DBMET02447 | |
| 0.316 | 0.074 | 0.415 | Immunomodulator | 0.214 0.148 DBMET02439 0.415 0.04 DBMET02451 0.415 0.04 DBMET02450 | DBMET02450 | |
| 0.249 | 0.009 | 0.551 | Cyclooxygenase 3 inhibitor | 0.214 0.014 DB00988 0.263 0.008 DBMET02439 0.551 0.003 DBMET02451 0.551 0.003 DBMET02450 0.223 0.012 DBMET02440 0.208 0.016 DBMET02443 0.168 0.034 DBMET02445 0.176 0.029 DBMET02441 0.159 0.041 DBMET02444 0.222 0.013 DBMET02447 0.361 0.004 DBMET02446 0.388 0.004 DBMET02442 | DBMET02450 | |
| 0.246 | 0.007 | 0.246 | Cell adhesion molecule inhibitor | 0.211 0.009 DBMET02439 0.105 0.031 DBMET02451 0.105 0.031 DBMET02450 0.141 0.017 DBMET02446 0.128 0.021 DBMET02442 | ||
| 0.258 | 0.018 | 0.397 | Insulin secretagoues | 0.152 0.072 DB00988 0.21 0.031 DBMET02439 0.301 0.012 DBMET02451 0.301 0.012 DBMET02450 0.124 0.106 DBMET02440 0.125 0.103 DBMET02443 0.133 0.094 DBMET02444 0.159 0.066 DBMET02447 0.397 0.006 DBMET02446 0.295 0.013 DBMET02442 | DBMET02446 | |
| 0.242 | 0.005 | 0.242 | Inducible nitric-oxide synthase inhibitor | 0.225 0.006 DB00988 0.208 0.007 DBMET02439 0.182 0.01 DBMET02448 0.182 0.01 DBMET02449 0.197 0.009 DBMET02440 0.157 0.014 DBMET02443 0.102 0.035 DBMET02444 0.086 0.053 DBMET02447 0.089 0.049 DBMET02446 0.077 0.067 DBMET02442 | ||
| 0.27 | 0.034 | 0.624 | Anticoagulant | 0.155 0.076 DB00988 0.197 0.054 DBMET02439 0.624 0.005 DBMET02448 0.624 0.005 DBMET02449 0.319 0.025 DBMET02451 0.319 0.025 DBMET02450 0.134 0.096 DBMET02445 0.166 0.068 DBMET02446 | DBMET02449 | |
| 0.248 | 0.013 | 0.336 | Ferrochelatase inhibitor | 0.213 0.02 DB00988 0.096 0.075 DBMET02439 0.271 0.01 DBMET02443 0.163 0.033 DBMET02445 0.147 0.039 DBMET02444 0.169 0.031 DBMET02447 0.336 0.005 DBMET02446 0.156 0.035 DBMET02442 | DBMET02446 | |
| 0.363 | 0.132 | 0.593 | Apoptosis agonist | 0.329 0.153 DB00988 0.426 0.102 DBMET02439 0.593 0.051 DBMET02451 0.593 0.051 DBMET02450 0.413 0.107 DBMET02440 0.311 0.165 DBMET02445 0.407 0.11 DBMET02441 0.3 0.172 DBMET02444 0.454 0.09 DBMET02447 0.392 0.118 DBMET02446 0.457 0.089 DBMET02442 | DBMET02450 | |
| 0.237 | 0.006 | 0.388 | Vanilloid 1 agonist | 0.228 0.007 DB00988 0.32 0.004 DBMET02439 0.192 0.014 DBMET02448 0.192 0.014 DBMET02449 0.211 0.009 DBMET02451 0.211 0.009 DBMET02450 0.299 0.004 DBMET02440 0.161 0.029 DBMET02443 0.173 0.022 DBMET02445 0.203 0.011 DBMET02441 0.17 0.023 DBMET02444 0.215 0.009 DBMET02447 0.29 0.004 DBMET02446 0.388 0.003 DBMET02442 | DBMET02442 | |
| 0.234 | 0.004 | 0.234 | Kainate receptor antagonist | 0.112 0.006 DBMET02439 0.086 0.009 DBMET02446 0.038 0.031 DBMET02442 | ||
| 0.239 | 0.009 | 0.239 | Aminoacyl-tRNA synthetase inhibitor | 0.135 0.024 DB00988 0.178 0.013 DBMET02439 0.09 0.058 DBMET02448 0.09 0.058 DBMET02449 0.094 0.052 DBMET02451 0.094 0.052 DBMET02450 0.105 0.04 DBMET02440 0.202 0.01 DBMET02443 0.212 0.01 DBMET02444 | ||
| 0.24 | 0.011 | 0.305 | Adenylate kinase inhibitor | 0.154 0.025 DB00988 0.144 0.029 DBMET02439 0.097 0.072 DBMET02448 0.097 0.072 DBMET02449 0.105 0.059 DBMET02451 0.105 0.059 DBMET02450 0.1 0.067 DBMET02440 0.176 0.019 DBMET02443 0.205 0.014 DBMET02445 0.126 0.039 DBMET02441 0.117 0.047 DBMET02444 0.153 0.025 DBMET02447 0.305 0.007 DBMET02446 0.191 0.016 DBMET02442 | DBMET02446 | |
| 0.23 | 0.004 | 0.23 | NMDA 2A receptor antagonist | 0.155 0.007 DB00988 0.108 0.011 DBMET02439 0.104 0.012 DBMET02448 0.104 0.012 DBMET02449 0.073 0.023 DBMET02440 0.091 0.016 DBMET02443 0.09 0.016 DBMET02444 0.079 0.02 DBMET02447 0.079 0.02 DBMET02446 | ||
| 0.234 | 0.008 | 0.234 | Phosphofructokinase-1 inhibitor | 0.134 0.021 DB00988 0.147 0.019 DBMET02439 0.062 0.054 DBMET02448 0.062 0.054 DBMET02449 0.226 0.009 DBMET02451 0.226 0.009 DBMET02450 0.068 0.049 DBMET02440 0.121 0.025 DBMET02443 0.215 0.01 DBMET02445 0.132 0.022 DBMET02441 0.067 0.05 DBMET02444 0.208 0.01 DBMET02447 0.232 0.009 DBMET02446 0.145 0.019 DBMET02442 | ||
| 0.228 | 0.006 | 0.228 | Carbamoyl phosphate synthetase inhibitor | 0.098 0.021 DB00988 0.132 0.014 DBMET02439 0.099 0.021 DBMET02443 0.078 0.03 DBMET02445 0.135 0.013 DBMET02447 0.153 0.011 DBMET02446 0.086 0.026 DBMET02442 | ||
| 0.225 | 0.004 | 0.225 | Ornithine decarboxylase inhibitor | 0.169 0.007 DB00988 0.194 0.005 DBMET02439 0.081 0.066 DBMET02448 0.081 0.066 DBMET02449 0.13 0.019 DBMET02451 0.13 0.019 DBMET02450 0.152 0.01 DBMET02440 0.154 0.01 DBMET02443 0.133 0.018 DBMET02445 0.121 0.025 DBMET02441 0.128 0.021 DBMET02444 0.144 0.013 DBMET02447 0.146 0.012 DBMET02446 0.133 0.018 DBMET02442 | ||
| 0.234 | 0.014 | 0.234 | Farnesoid X receptor antagonist | 0.127 0.089 DB00988 0.199 0.022 DBMET02439 0.116 0.113 DBMET02440 0.122 0.1 DBMET02443 0.125 0.094 DBMET02445 0.171 0.034 DBMET02447 0.228 0.015 DBMET02446 0.188 0.026 DBMET02442 | ||
| 0.22 | 0.001 | 0.22 | Kainate receptor agonist | 0.054 0.01 DB00988 0.151 0.002 DBMET02439 0.044 0.023 DBMET02440 0.046 0.019 DBMET02443 0.045 0.021 DBMET02445 0.048 0.017 DBMET02447 0.089 0.003 DBMET02446 0.069 0.005 DBMET02442 | ||
| 0.222 | 0.003 | 0.222 | AMPA 2 receptor antagonist | 0.149 0.004 DBMET02439 0.049 0.011 DBMET02446 | ||
| 0.228 | 0.009 | 0.297 | Alcohol dehydrogenase inhibitor | 0.147 0.021 DB00988 0.137 0.025 DBMET02439 0.131 0.028 DBMET02451 0.131 0.028 DBMET02450 0.102 0.051 DBMET02440 0.105 0.047 DBMET02443 0.199 0.012 DBMET02445 0.125 0.032 DBMET02441 0.297 0.005 DBMET02447 0.252 0.008 DBMET02446 0.151 0.02 DBMET02442 | DBMET02447 | |
| 0.281 | 0.063 | 0.299 | Transcription factor STAT3 inhibitor | 0.299 0.054 DB00988 0.274 0.067 DBMET02439 0.292 0.057 DBMET02440 0.199 0.135 DBMET02443 0.258 0.077 DBMET02445 0.252 0.081 DBMET02441 0.286 0.06 DBMET02447 0.238 0.094 DBMET02446 0.232 0.099 DBMET02442 | DB00988 | |
| 0.255 | 0.04 | 0.379 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.374 0.01 DB00988 0.261 0.038 DBMET02439 0.154 0.14 DBMET02448 0.154 0.14 DBMET02449 0.331 0.016 DBMET02451 0.331 0.016 DBMET02450 0.379 0.009 DBMET02440 0.34 0.014 DBMET02443 0.248 0.044 DBMET02445 0.254 0.041 DBMET02441 0.28 0.03 DBMET02444 0.312 0.02 DBMET02447 0.35 0.013 DBMET02446 0.355 0.012 DBMET02442 | DBMET02440 | |
| 0.266 | 0.051 | 0.278 | Calpain inhibitor | 0.236 0.079 DB00988 0.243 0.071 DBMET02439 0.203 0.111 DBMET02440 0.213 0.101 DBMET02443 0.278 0.043 DBMET02445 0.256 0.059 DBMET02441 0.231 0.084 DBMET02444 0.197 0.117 DBMET02447 0.225 0.09 DBMET02446 0.188 0.126 DBMET02442 | DBMET02445 | |
| 0.22 | 0.006 | 0.22 | Carbonic anhydrase stimulant | 0.137 0.012 DB00988 0.17 0.009 DBMET02439 0.055 0.047 DBMET02448 0.055 0.047 DBMET02449 0.103 0.018 DBMET02440 0.164 0.01 DBMET02443 0.211 0.007 DBMET02444 0.054 0.048 DBMET02447 0.091 0.021 DBMET02446 0.069 0.032 DBMET02442 | ||
| 0.279 | 0.068 | 0.334 | Transcription factor STAT inhibitor | 0.334 0.04 DB00988 0.247 0.089 DBMET02439 0.304 0.053 DBMET02440 0.255 0.083 DBMET02443 0.232 0.1 DBMET02445 0.208 0.127 DBMET02441 0.304 0.053 DBMET02447 0.219 0.113 DBMET02446 0.197 0.142 DBMET02442 | DB00988 | |
| 0.21 | 0.004 | 0.21 | Glutamate (mGluR group III) agonist | 0.171 0.004 DBMET02439 0.045 0.027 DBMET02446 | ||
| 0.206 | 0.003 | 0.206 | Glutamate (mGluR6) antagonist | 0.079 0.025 DB00988 0.141 0.004 DBMET02439 0.063 0.058 DBMET02440 0.081 0.023 DBMET02443 0.069 0.041 DBMET02445 0.085 0.02 DBMET02447 0.107 0.008 DBMET02446 0.083 0.021 DBMET02442 | ||
| 0.206 | 0.003 | 0.206 | AMPA 4 receptor antagonist | 0.046 0.018 DB00988 0.058 0.011 DBMET02439 0.041 0.025 DBMET02447 0.09 0.005 DBMET02446 | ||
| 0.21 | 0.008 | 0.227 | Nitric-oxide synthase inhibitor | 0.227 0.006 DB00988 0.176 0.015 DBMET02439 0.159 0.019 DBMET02448 0.159 0.019 DBMET02449 0.187 0.012 DBMET02440 0.152 0.021 DBMET02443 0.116 0.04 DBMET02444 0.098 0.063 DBMET02447 | DB00988 | |
| 0.207 | 0.007 | 0.207 | Ornithine carbamoyltransferase inhibitor | 0.083 0.021 DB00988 0.102 0.016 DBMET02439 0.078 0.022 DBMET02443 0.073 0.024 DBMET02445 0.068 0.027 DBMET02447 0.082 0.021 DBMET02446 | ||
| 0.209 | 0.011 | 0.28 | Interleukin 8 antagonist | 0.17 0.023 DB00988 0.174 0.021 DBMET02439 0.136 0.044 DBMET02440 0.106 0.083 DBMET02445 0.104 0.087 DBMET02444 0.148 0.035 DBMET02447 0.28 0.005 DBMET02446 0.227 0.008 DBMET02442 | DBMET02446 | |
| 0.207 | 0.009 | 0.354 | NMDA 2 receptor antagonist | 0.196 0.01 DB00988 0.098 0.033 DBMET02439 0.354 0.004 DBMET02448 0.354 0.004 DBMET02449 0.092 0.036 DBMET02440 0.133 0.02 DBMET02443 0.085 0.04 DBMET02444 0.111 0.027 DBMET02447 0.093 0.035 DBMET02446 | DBMET02449 | |
| 0.206 | 0.009 | 0.234 | Sphingosine 1-phosphate receptor 5 antagonist | 0.188 0.018 DB00988 0.174 0.029 DBMET02439 0.155 0.053 DBMET02440 0.133 0.094 DBMET02443 0.16 0.046 DBMET02445 0.123 0.117 DBMET02441 0.226 0.005 DBMET02447 0.234 0.004 DBMET02446 0.201 0.011 DBMET02442 | DBMET02446 | |
| 0.221 | 0.026 | 0.591 | Hemostatic | 0.25 0.022 DB00988 0.19 0.037 DBMET02439 0.591 0.004 DBMET02448 0.591 0.004 DBMET02449 0.564 0.004 DBMET02451 0.564 0.004 DBMET02450 0.205 0.03 DBMET02440 0.181 0.042 DBMET02443 0.151 0.066 DBMET02444 0.156 0.061 DBMET02447 0.196 0.034 DBMET02446 0.17 0.049 DBMET02442 | DBMET02449 | |
| 0.213 | 0.019 | 0.213 | Cathepsin H inhibitor | 0.151 0.045 DB00988 0.177 0.031 DBMET02439 0.116 0.08 DBMET02440 0.103 0.101 DBMET02443 0.176 0.031 DBMET02445 0.141 0.054 DBMET02441 0.124 0.07 DBMET02447 0.145 0.05 DBMET02446 0.11 0.089 DBMET02442 | ||
| 0.315 | 0.122 | 0.531 | 15-Lipoxygenase inhibitor | 0.503 0.04 DB00988 0.334 0.109 DBMET02439 0.443 0.056 DBMET02448 0.443 0.056 DBMET02449 0.531 0.034 DBMET02440 0.242 0.171 DBMET02443 0.302 0.131 DBMET02445 0.321 0.117 DBMET02441 0.254 0.162 DBMET02444 0.435 0.06 DBMET02447 0.434 0.06 DBMET02446 0.454 0.053 DBMET02442 | DBMET02440 | |
| 0.199 | 0.006 | 0.199 | Heat shock protein 70 antagonist | 0.186 0.009 DB00988 0.198 0.007 DBMET02439 0.196 0.007 DBMET02451 0.196 0.007 DBMET02450 0.185 0.01 DBMET02440 0.156 0.033 DBMET02443 0.154 0.037 DBMET02445 0.153 0.039 DBMET02441 0.138 0.082 DBMET02444 0.174 0.015 DBMET02447 0.183 0.011 DBMET02446 0.182 0.011 DBMET02442 | ||
| 0.195 | 0.005 | 0.195 | Glycine transporter 2 inhibitor | 0.089 0.015 DB00988 0.163 0.007 DBMET02439 0.077 0.018 DBMET02440 0.058 0.026 DBMET02446 0.049 0.031 DBMET02442 | ||
| 0.22 | 0.031 | 0.229 | Bone formation stimulant | 0.111 0.094 DB00988 0.191 0.038 DBMET02439 0.107 0.098 DBMET02440 0.129 0.078 DBMET02445 0.121 0.085 DBMET02441 0.157 0.053 DBMET02447 0.229 0.029 DBMET02446 0.19 0.038 DBMET02442 | DBMET02446 | |
| 0.195 | 0.005 | 0.195 | Glutathione S-transferase inhibitor | 0.101 0.036 DB00988 0.156 0.011 DBMET02439 0.082 0.058 DBMET02440 0.099 0.039 DBMET02443 0.096 0.042 DBMET02445 0.078 0.065 DBMET02441 0.077 0.066 DBMET02444 0.124 0.021 DBMET02447 0.189 0.006 DBMET02446 0.151 0.012 DBMET02442 | ||
| 0.223 | 0.034 | 0.491 | Protein kinase stimulant | 0.294 0.017 DB00988 0.233 0.031 DBMET02439 0.115 0.098 DBMET02448 0.115 0.098 DBMET02449 0.491 0.004 DBMET02451 0.491 0.004 DBMET02450 0.307 0.016 DBMET02440 0.267 0.022 DBMET02443 0.161 0.061 DBMET02445 0.169 0.056 DBMET02441 0.233 0.031 DBMET02444 0.302 0.016 DBMET02447 0.274 0.021 DBMET02446 0.285 0.019 DBMET02442 | DBMET02450 | |
| 0.192 | 0.003 | 0.192 | Glutamate (mGluR4) antagonist | 0.048 0.023 DB00988 0.095 0.006 DBMET02439 0.068 0.011 DBMET02446 | ||
| 0.191 | 0.003 | 0.191 | Glutamate (mGluR1) agonist | 0.064 0.004 DBMET02439 0.026 0.015 DBMET02448 0.026 0.015 DBMET02449 0.037 0.006 DBMET02446 | ||
| 0.213 | 0.026 | 0.234 | Protein-tyrosine phosphatase 1B inhibitor | 0.173 0.037 DBMET02439 0.223 0.023 DBMET02448 0.223 0.023 DBMET02449 0.126 0.059 DBMET02451 0.126 0.059 DBMET02450 0.096 0.082 DBMET02445 0.207 0.027 DBMET02447 0.234 0.02 DBMET02446 0.186 0.033 DBMET02442 | DBMET02446 | |
| 0.207 | 0.024 | 0.263 | Alkylator | 0.134 0.056 DB00988 0.214 0.023 DBMET02439 0.109 0.079 DBMET02448 0.109 0.079 DBMET02449 0.263 0.015 DBMET02451 0.263 0.015 DBMET02450 0.141 0.051 DBMET02440 0.172 0.036 DBMET02443 0.115 0.073 DBMET02445 0.121 0.067 DBMET02441 0.193 0.028 DBMET02444 0.135 0.055 DBMET02447 0.149 0.047 DBMET02446 0.157 0.043 DBMET02442 | DBMET02450 | |
| 0.187 | 0.004 | 0.187 | Integrin alpha4 antagonist | 0.125 0.005 DBMET02439 0.065 0.009 DBMET02446 0.03 0.016 DBMET02442 | ||
| 0.208 | 0.027 | 0.208 | Histone deacetylase SIRT1 inhibitor | 0.201 0.03 DB00988 0.17 0.047 DBMET02439 0.156 0.057 DBMET02440 0.131 0.079 DBMET02446 | ||
| 0.25 | 0.069 | 0.481 | Vasodilator | 0.326 0.04 DB00988 0.26 0.064 DBMET02439 0.457 0.015 DBMET02451 0.457 0.015 DBMET02450 0.323 0.041 DBMET02440 0.481 0.013 DBMET02443 0.173 0.129 DBMET02441 0.419 0.02 DBMET02444 0.373 0.028 DBMET02447 0.277 0.056 DBMET02446 0.285 0.054 DBMET02442 | DBMET02443 | |
| 0.183 | 0.003 | 0.183 | Glutamate (mGluR group III) antagonist | 0.043 0.032 DB00988 0.127 0.004 DBMET02439 0.064 0.011 DBMET02446 0.044 0.029 DBMET02442 | ||
| 0.194 | 0.014 | 0.434 | Carbonic anhydrase VI inhibitor | 0.433 0.004 DB00988 0.193 0.014 DBMET02439 0.381 0.004 DBMET02448 0.381 0.004 DBMET02449 0.267 0.008 DBMET02451 0.267 0.008 DBMET02450 0.431 0.004 DBMET02440 0.204 0.013 DBMET02443 0.144 0.022 DBMET02445 0.144 0.022 DBMET02441 0.094 0.043 DBMET02444 0.434 0.004 DBMET02447 0.266 0.008 DBMET02446 0.264 0.008 DBMET02442 | DBMET02447 | |
| 0.181 | 0.001 | 0.181 | Tryptophan hydroxylase 1 inhibitor | 0.109 0.002 DBMET02439 0.017 0.012 DBMET02446 | ||
| 0.209 | 0.03 | 0.269 | Alkaline phosphatase inhibitor | 0.158 0.054 DB00988 0.22 0.027 DBMET02439 0.222 0.026 DBMET02448 0.222 0.026 DBMET02449 0.172 0.047 DBMET02451 0.172 0.047 DBMET02450 0.167 0.049 DBMET02440 0.137 0.069 DBMET02445 0.145 0.063 DBMET02441 0.269 0.016 DBMET02447 0.207 0.031 DBMET02446 0.217 0.027 DBMET02442 | DBMET02447 | |
| 0.205 | 0.028 | 0.39 | Cell wall synthesis inhibitor | 0.204 0.028 DB00988 0.144 0.071 DBMET02439 0.39 0.006 DBMET02448 0.39 0.006 DBMET02449 0.383 0.007 DBMET02451 0.383 0.007 DBMET02450 0.143 0.072 DBMET02440 0.244 0.017 DBMET02443 0.218 0.024 DBMET02444 0.167 0.05 DBMET02447 0.178 0.041 DBMET02446 0.118 0.102 DBMET02442 | DBMET02449 | |
| 0.202 | 0.031 | 0.264 | Arachidonic acid antagonist | 0.198 0.035 DB00988 0.184 0.049 DBMET02439 0.179 0.055 DBMET02440 0.183 0.051 DBMET02443 0.214 0.021 DBMET02445 0.199 0.034 DBMET02441 0.169 0.067 DBMET02444 0.24 0.008 DBMET02447 0.264 0.004 DBMET02446 0.251 0.005 DBMET02442 | DBMET02446 | |
| 0.183 | 0.014 | 0.183 | Opioid delta receptor antagonist | 0.123 0.025 DB00988 0.127 0.024 DBMET02439 0.065 0.043 DBMET02440 0.055 0.05 DBMET02446 | ||
| 0.182 | 0.014 | 0.21 | Sphingosine 1-phosphate receptor 2 antagonist | 0.189 0.011 DB00988 0.163 0.027 DBMET02439 0.17 0.021 DBMET02440 0.148 0.043 DBMET02443 0.146 0.046 DBMET02445 0.127 0.08 DBMET02441 0.132 0.069 DBMET02444 0.188 0.011 DBMET02447 0.21 0.006 DBMET02446 0.187 0.011 DBMET02442 | DBMET02446 | |
| 0.189 | 0.02 | 0.473 | Carbonic anhydrase XV inhibitor | 0.473 0.003 DB00988 0.181 0.022 DBMET02439 0.351 0.005 DBMET02448 0.351 0.005 DBMET02449 0.123 0.045 DBMET02451 0.123 0.045 DBMET02450 0.459 0.004 DBMET02440 0.305 0.008 DBMET02443 0.169 0.025 DBMET02445 0.163 0.026 DBMET02441 0.153 0.03 DBMET02444 0.398 0.004 DBMET02447 0.223 0.015 DBMET02446 0.215 0.016 DBMET02442 | DB00988 | |
| 0.171 | 0.004 | 0.257 | GABA B receptor agonist | 0.216 0.003 DB00988 0.167 0.004 DBMET02439 0.11 0.011 DBMET02448 0.11 0.011 DBMET02449 0.21 0.003 DBMET02440 0.246 0.003 DBMET02443 0.114 0.009 DBMET02445 0.112 0.01 DBMET02441 0.134 0.005 DBMET02444 0.149 0.004 DBMET02447 0.257 0.003 DBMET02446 0.252 0.003 DBMET02442 | DBMET02446 | |
| 0.168 | 0.001 | 0.168 | Glutamate (mGluR6) agonist | 0.016 0.005 DB00988 0.072 0.002 DBMET02439 0.013 0.007 DBMET02443 0.012 0.008 DBMET02445 0.015 0.005 DBMET02447 0.032 0.003 DBMET02446 0.019 0.004 DBMET02442 | ||
| 0.184 | 0.017 | 0.216 | Photosensitizer | 0.154 0.029 DB00988 0.176 0.019 DBMET02439 0.21 0.011 DBMET02451 0.21 0.011 DBMET02450 0.148 0.032 DBMET02440 0.15 0.031 DBMET02443 0.132 0.044 DBMET02445 0.127 0.049 DBMET02441 0.114 0.065 DBMET02444 0.186 0.016 DBMET02447 0.216 0.01 DBMET02446 0.208 0.011 DBMET02442 | DBMET02446 | |
| 0.168 | 0.002 | 0.168 | Glutamate (mGluR8) agonist | 0.062 0.006 DB00988 0.132 0.002 DBMET02439 0.049 0.012 DBMET02440 0.049 0.013 DBMET02443 0.052 0.011 DBMET02445 0.041 0.02 DBMET02441 0.055 0.009 DBMET02447 0.086 0.004 DBMET02446 0.067 0.005 DBMET02442 | ||
| 0.203 | 0.038 | 0.203 | Thiol protease inhibitor | 0.17 0.054 DB00988 0.161 0.06 DBMET02439 0.133 0.091 DBMET02440 0.182 0.047 DBMET02445 0.142 0.078 DBMET02441 0.171 0.054 DBMET02447 0.137 0.084 DBMET02446 | ||
| 0.235 | 0.071 | 0.417 | Cyclic AMP phosphodiesterase inhibitor | 0.199 0.095 DB00988 0.272 0.054 DBMET02439 0.417 0.014 DBMET02451 0.417 0.014 DBMET02450 0.233 0.072 DBMET02440 0.304 0.04 DBMET02443 0.157 0.141 DBMET02445 0.179 0.112 DBMET02441 0.343 0.027 DBMET02444 0.316 0.036 DBMET02447 0.375 0.02 DBMET02446 0.415 0.014 DBMET02442 | DBMET02450 | |
| 0.287 | 0.125 | 0.471 | GABA C receptor rho-3 antagonist | 0.471 0.034 DB00988 0.287 0.125 DBMET02440 0.374 0.073 DBMET02443 0.416 0.055 DBMET02445 0.232 0.171 DBMET02441 0.34 0.091 DBMET02444 0.43 0.049 DBMET02447 0.461 0.038 DBMET02446 0.276 0.133 DBMET02442 | DB00988 | |
| 0.176 | 0.014 | 0.314 | Triose-phosphate isomerase inhibitor | 0.142 0.023 DB00988 0.096 0.052 DBMET02439 0.314 0.004 DBMET02448 0.314 0.004 DBMET02449 0.235 0.008 DBMET02451 0.235 0.008 DBMET02450 0.08 0.077 DBMET02440 0.164 0.016 DBMET02443 0.277 0.005 DBMET02445 0.141 0.023 DBMET02441 0.102 0.045 DBMET02444 0.262 0.006 DBMET02447 0.291 0.005 DBMET02446 0.147 0.021 DBMET02442 | DBMET02449 | |
| 0.175 | 0.014 | 0.175 | Glutamate receptor agonist | 0.091 0.044 DBMET02439 | ||
| 0.277 | 0.116 | 0.505 | Calcium channel activator | 0.391 0.028 DB00988 0.326 0.068 DBMET02439 0.229 0.173 DBMET02448 0.229 0.173 DBMET02449 0.437 0.014 DBMET02440 0.454 0.01 DBMET02443 0.307 0.085 DBMET02445 0.354 0.047 DBMET02441 0.505 0.005 DBMET02444 0.351 0.049 DBMET02447 0.409 0.021 DBMET02446 0.453 0.01 DBMET02442 | DBMET02444 | |
| 0.256 | 0.096 | 0.508 | Lipoxygenase inhibitor | 0.322 0.061 DB00988 0.288 0.077 DBMET02439 0.362 0.047 DBMET02440 0.226 0.117 DBMET02443 0.258 0.095 DBMET02445 0.291 0.076 DBMET02441 0.2 0.141 DBMET02444 0.42 0.033 DBMET02447 0.465 0.024 DBMET02446 0.508 0.018 DBMET02442 | DBMET02442 | |
| 0.163 | 0.006 | 0.163 | NMDA 2C receptor antagonist | 0.127 0.009 DB00988 0.099 0.016 DBMET02439 0.13 0.009 DBMET02448 0.13 0.009 DBMET02449 0.081 0.025 DBMET02440 0.111 0.012 DBMET02443 0.06 0.046 DBMET02444 0.105 0.014 DBMET02446 0.067 0.036 DBMET02442 | ||
| 0.162 | 0.005 | 0.162 | Glycine receptor agonist | 0.126 0.011 DB00988 0.138 0.009 DBMET02439 0.069 0.056 DBMET02448 0.069 0.056 DBMET02449 0.104 0.019 DBMET02451 0.104 0.019 DBMET02450 0.108 0.017 DBMET02440 0.112 0.015 DBMET02443 0.084 0.034 DBMET02445 0.073 0.049 DBMET02441 0.145 0.008 DBMET02447 0.13 0.01 DBMET02446 0.112 0.015 DBMET02442 | ||
| 0.16 | 0.003 | 0.16 | Kainate receptor 2 antagonist | 0.031 0.029 DB00988 0.083 0.006 DBMET02439 0.073 0.008 DBMET02446 | ||
| 0.188 | 0.032 | 0.233 | DNA polymerase I inhibitor | 0.216 0.024 DB00988 0.168 0.04 DBMET02439 0.128 0.063 DBMET02448 0.128 0.063 DBMET02449 0.214 0.024 DBMET02451 0.214 0.024 DBMET02450 0.188 0.032 DBMET02440 0.166 0.041 DBMET02443 0.151 0.049 DBMET02445 0.132 0.06 DBMET02441 0.13 0.061 DBMET02444 0.216 0.024 DBMET02447 0.233 0.02 DBMET02446 0.199 0.028 DBMET02442 | DBMET02446 | |
| 0.185 | 0.032 | 0.54 | Aldehyde dehydrogenase inhibitor | 0.204 0.027 DB00988 0.131 0.061 DBMET02439 0.196 0.029 DBMET02451 0.196 0.029 DBMET02450 0.142 0.052 DBMET02440 0.129 0.062 DBMET02443 0.54 0.004 DBMET02445 0.377 0.006 DBMET02441 0.228 0.022 DBMET02447 0.229 0.022 DBMET02446 0.157 0.043 DBMET02442 | DBMET02445 | |
| 0.214 | 0.061 | 0.506 | Non-steroidal antiinflammatory agent | 0.201 0.07 DB00988 0.244 0.045 DBMET02439 0.485 0.007 DBMET02451 0.485 0.007 DBMET02450 0.228 0.053 DBMET02440 0.144 0.124 DBMET02443 0.227 0.054 DBMET02445 0.257 0.04 DBMET02441 0.137 0.136 DBMET02444 0.248 0.044 DBMET02447 0.458 0.009 DBMET02446 0.506 0.006 DBMET02442 | DBMET02442 | |
| 0.23 | 0.077 | 0.233 | Neuropeptide Y2 antagonist | 0.233 0.073 DB00988 0.193 0.133 DBMET02439 0.195 0.128 DBMET02440 0.204 0.113 DBMET02443 0.188 0.143 DBMET02447 0.179 0.163 DBMET02446 | DB00988 | |
| 0.169 | 0.016 | 0.169 | Folate antagonist | 0.147 0.023 DBMET02439 0.106 0.055 DBMET02446 0.096 0.073 DBMET02442 | ||
| 0.17 | 0.018 | 0.198 | Cathepsin G inhibitor | 0.085 0.04 DB00988 0.141 0.023 DBMET02439 0.198 0.016 DBMET02448 0.198 0.016 DBMET02449 0.07 0.053 DBMET02440 0.078 0.045 DBMET02443 0.118 0.028 DBMET02445 0.094 0.036 DBMET02441 0.069 0.055 DBMET02447 0.192 0.016 DBMET02446 0.157 0.02 DBMET02442 | DBMET02449 | |
| 0.17 | 0.02 | 0.17 | Opioid antagonist | 0.138 0.03 DB00988 0.122 0.035 DBMET02439 0.092 0.055 DBMET02440 0.08 0.069 DBMET02447 0.076 0.075 DBMET02446 | ||
| 0.159 | 0.01 | 0.159 | Ribonucleoside-diphosphate reductase inhibitor | 0.06 0.034 DB00988 0.099 0.019 DBMET02439 0.057 0.036 DBMET02445 0.059 0.035 DBMET02447 0.074 0.027 DBMET02446 | ||
| 0.221 | 0.073 | 0.345 | RNA-directed DNA polymerase inhibitor | 0.244 0.053 DB00988 0.204 0.094 DBMET02439 0.345 0.025 DBMET02448 0.345 0.025 DBMET02449 0.21 0.086 DBMET02451 0.21 0.086 DBMET02450 0.225 0.068 DBMET02440 0.222 0.072 DBMET02443 0.244 0.053 DBMET02445 0.225 0.069 DBMET02441 0.176 0.141 DBMET02444 0.279 0.037 DBMET02447 0.269 0.04 DBMET02446 0.247 0.051 DBMET02442 | DBMET02449 | |
| 0.185 | 0.038 | 0.406 | M18 aspartyl aminopeptidase inhibitor | 0.399 0.005 DB00988 0.162 0.047 DBMET02439 0.179 0.04 DBMET02448 0.179 0.04 DBMET02449 0.14 0.057 DBMET02451 0.14 0.057 DBMET02450 0.35 0.008 DBMET02440 0.372 0.006 DBMET02443 0.279 0.015 DBMET02445 0.237 0.024 DBMET02441 0.406 0.005 DBMET02444 0.287 0.014 DBMET02447 0.299 0.013 DBMET02446 0.255 0.02 DBMET02442 | DBMET02444 | |
| 0.185 | 0.039 | 0.274 | Mannose-6-phosphate isomerase inhibitor | 0.157 0.059 DB00988 0.172 0.047 DBMET02439 0.154 0.061 DBMET02451 0.154 0.061 DBMET02450 0.144 0.069 DBMET02440 0.142 0.071 DBMET02443 0.274 0.008 DBMET02445 0.26 0.01 DBMET02441 0.232 0.017 DBMET02447 0.232 0.017 DBMET02446 0.221 0.021 DBMET02442 | DBMET02445 | |
| 0.261 | 0.116 | 0.465 | Thyroid hormone antagonist | 0.278 0.105 DBMET02439 0.442 0.045 DBMET02446 0.465 0.04 DBMET02442 | DBMET02442 | |
| 0.156 | 0.011 | 0.156 | Ribonucleotide reductase inhibitor | 0.065 0.034 DB00988 0.098 0.021 DBMET02439 0.058 0.037 DBMET02445 0.06 0.036 DBMET02447 0.075 0.029 DBMET02446 | ||
| 0.187 | 0.044 | 0.236 | Catenin beta inhibitor | 0.147 0.113 DB00988 0.177 0.056 DBMET02439 0.143 0.123 DBMET02440 0.225 0.018 DBMET02447 0.236 0.014 DBMET02446 0.213 0.023 DBMET02442 | DBMET02446 | |
| 0.149 | 0.008 | 0.214 | Bile acid receptor antagonist | 0.111 0.03 DB00988 0.134 0.011 DBMET02439 0.115 0.025 DBMET02448 0.115 0.025 DBMET02449 0.102 0.046 DBMET02440 0.101 0.048 DBMET02443 0.102 0.045 DBMET02445 0.093 0.067 DBMET02441 0.089 0.075 DBMET02444 0.124 0.017 DBMET02447 0.214 0.004 DBMET02446 0.178 0.005 DBMET02442 | DBMET02446 | |
| 0.144 | 0.004 | 0.144 | VLA-4 antagonist | 0.12 0.005 DBMET02439 0.068 0.009 DBMET02446 0.044 0.014 DBMET02442 | ||
| 0.147 | 0.009 | 0.18 | Sphingosine 1-phosphate receptor 4 agonist | 0.089 0.031 DB00988 0.102 0.024 DBMET02439 0.065 0.049 DBMET02443 0.142 0.01 DBMET02447 0.18 0.005 DBMET02446 0.132 0.013 DBMET02442 | DBMET02446 | |
| 0.165 | 0.03 | 0.195 | Falcipain 3 inhibitor | 0.166 0.029 DB00988 0.155 0.034 DBMET02439 0.155 0.034 DBMET02440 0.195 0.019 DBMET02445 0.186 0.022 DBMET02441 0.151 0.036 DBMET02447 0.132 0.046 DBMET02446 0.12 0.053 DBMET02442 | DBMET02445 | |
| 0.139 | 0.003 | 0.139 | Kainate receptor 1 antagonist | 0.04 0.007 DBMET02439 0.039 0.007 DBMET02446 | ||
| 0.139 | 0.004 | 0.14 | Glutamate (mGluR7) antagonist | 0.075 0.034 DB00988 0.14 0.003 DBMET02439 0.076 0.032 DBMET02440 0.062 0.059 DBMET02443 0.079 0.029 DBMET02445 0.08 0.027 DBMET02441 0.073 0.037 DBMET02447 0.106 0.008 DBMET02446 0.107 0.007 DBMET02442 | DBMET02439 | |
| 0.149 | 0.017 | 0.149 | Opioid mu receptor antagonist | 0.113 0.027 DB00988 0.102 0.031 DBMET02439 0.065 0.05 DBMET02440 | ||
| 0.16 | 0.03 | 0.18 | Nav1.4 sodium channel blocker | 0.13 0.044 DB00988 0.129 0.045 DBMET02439 0.18 0.024 DBMET02448 0.18 0.024 DBMET02449 0.1 0.076 DBMET02440 0.162 0.029 DBMET02443 0.105 0.069 DBMET02444 0.143 0.037 DBMET02446 0.109 0.064 DBMET02442 | DBMET02449 | |
| 0.182 | 0.053 | 0.275 | Interleukin 6 antagonist | 0.155 0.082 DB00988 0.178 0.057 DBMET02439 0.214 0.034 DBMET02451 0.214 0.034 DBMET02450 0.155 0.082 DBMET02440 0.139 0.107 DBMET02443 0.217 0.032 DBMET02445 0.203 0.039 DBMET02441 0.275 0.019 DBMET02447 0.236 0.026 DBMET02446 0.216 0.033 DBMET02442 | DBMET02447 | |
| 0.131 | 0.002 | 0.132 | Thyroid hormone agonist | 0.041 0.006 DB00988 0.077 0.003 DBMET02439 0.056 0.004 DBMET02448 0.056 0.004 DBMET02449 0.026 0.017 DBMET02440 0.029 0.013 DBMET02443 0.033 0.01 DBMET02445 0.045 0.005 DBMET02447 0.132 0.002 DBMET02446 0.078 0.003 DBMET02442 | DBMET02446 | |
| 0.181 | 0.053 | 0.498 | Diuretic | 0.174 0.058 DB00988 0.498 0.008 DBMET02448 0.498 0.008 DBMET02449 0.343 0.017 DBMET02451 0.343 0.017 DBMET02450 0.229 0.035 DBMET02447 0.215 0.039 DBMET02446 0.138 0.087 DBMET02442 | DBMET02449 | |
| 0.153 | 0.028 | 0.255 | GABA C receptor antagonist | 0.255 0.006 DB00988 0.103 0.073 DBMET02439 0.174 0.019 DBMET02448 0.174 0.019 DBMET02449 0.174 0.02 DBMET02440 0.197 0.013 DBMET02443 0.122 0.05 DBMET02445 0.134 0.04 DBMET02444 0.151 0.029 DBMET02447 0.217 0.01 DBMET02446 0.148 0.031 DBMET02442 | DB00988 | |
| 0.137 | 0.013 | 0.267 | Vanilloid agonist | 0.183 0.008 DB00988 0.149 0.011 DBMET02439 0.128 0.015 DBMET02448 0.128 0.015 DBMET02449 0.099 0.034 DBMET02451 0.099 0.034 DBMET02450 0.194 0.007 DBMET02440 0.113 0.022 DBMET02443 0.111 0.024 DBMET02445 0.125 0.016 DBMET02441 0.109 0.025 DBMET02444 0.163 0.009 DBMET02447 0.267 0.005 DBMET02446 0.26 0.005 DBMET02442 | DBMET02446 | |
| 0.128 | 0.004 | 0.128 | AMPA 3 receptor antagonist | 0.025 0.024 DB00988 0.043 0.012 DBMET02439 0.055 0.007 DBMET02446 | ||
| 0.14 | 0.017 | 0.418 | Adrenaline agonist | 0.235 0.005 DB00988 0.111 0.03 DBMET02439 0.087 0.049 DBMET02448 0.087 0.049 DBMET02449 0.194 0.007 DBMET02440 0.364 0.003 DBMET02443 0.086 0.05 DBMET02445 0.418 0.003 DBMET02444 0.209 0.006 DBMET02447 0.162 0.012 DBMET02446 0.13 0.021 DBMET02442 | DBMET02444 | |
| 0.126 | 0.003 | 0.4 | Dopamine D5 agonist | 0.4 0.001 DB00988 0.08 0.006 DBMET02439 0.139 0.003 DBMET02448 0.139 0.003 DBMET02449 0.046 0.021 DBMET02451 0.046 0.021 DBMET02450 0.27 0.001 DBMET02440 0.14 0.003 DBMET02443 0.138 0.003 DBMET02445 0.088 0.005 DBMET02441 0.065 0.01 DBMET02444 0.135 0.003 DBMET02447 0.149 0.003 DBMET02446 0.095 0.004 DBMET02442 | DB00988 | |
| 0.124 | 0.002 | 0.124 | Glutamate (mGluR3) agonist | 0.04 0.01 DB00988 0.104 0.002 DBMET02439 0.036 0.015 DBMET02440 0.035 0.016 DBMET02443 0.036 0.015 DBMET02445 0.032 0.023 DBMET02441 0.045 0.006 DBMET02447 0.056 0.004 DBMET02446 0.049 0.005 DBMET02442 | ||
| 0.125 | 0.004 | 0.125 | Fumarate hydratase inhibitor | 0.046 0.015 DB00988 0.07 0.008 DBMET02439 0.039 0.019 DBMET02443 0.039 0.019 DBMET02445 0.045 0.015 DBMET02447 0.099 0.005 DBMET02446 0.058 0.011 DBMET02442 | ||
| 0.122 | 0.002 | 0.122 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.009 DB00988 0.107 0.002 DBMET02439 0.038 0.018 DBMET02440 0.043 0.011 DBMET02443 0.037 0.022 DBMET02447 0.056 0.004 DBMET02446 0.048 0.006 DBMET02442 | ||
| 0.174 | 0.056 | 0.366 | Acetylcholine M1 receptor antagonist | 0.238 0.028 DB00988 0.134 0.091 DBMET02439 0.186 0.049 DBMET02440 0.352 0.008 DBMET02443 0.366 0.007 DBMET02444 0.156 0.069 DBMET02447 0.136 0.089 DBMET02446 | DBMET02444 | |
| 0.153 | 0.035 | 0.179 | Ca2+-transporting ATPase inhibitor | 0.155 0.033 DB00988 0.14 0.072 DBMET02439 0.146 0.052 DBMET02451 0.146 0.052 DBMET02450 0.142 0.068 DBMET02440 0.161 0.023 DBMET02443 0.162 0.021 DBMET02445 0.149 0.046 DBMET02441 0.149 0.044 DBMET02444 0.179 0.007 DBMET02447 0.178 0.008 DBMET02446 0.164 0.019 DBMET02442 | DBMET02447 | |
| 0.157 | 0.039 | 0.157 | Histone deacetylase class III inhibitor | 0.15 0.043 DB00988 0.12 0.07 DBMET02439 0.103 0.087 DBMET02440 0.126 0.064 DBMET02447 | ||
| 0.139 | 0.021 | 0.238 | NADH dehydrogenase inhibitor | 0.142 0.02 DB00988 0.101 0.042 DBMET02439 0.088 0.059 DBMET02448 0.088 0.059 DBMET02449 0.238 0.008 DBMET02451 0.238 0.008 DBMET02450 0.104 0.04 DBMET02440 0.153 0.017 DBMET02443 0.125 0.026 DBMET02445 0.092 0.054 DBMET02441 0.107 0.037 DBMET02444 0.184 0.012 DBMET02447 0.199 0.01 DBMET02446 0.141 0.02 DBMET02442 | DBMET02450 | |
| 0.127 | 0.009 | 0.127 | Phosphorylase inhibitor | 0.073 0.019 DBMET02439 0.064 0.023 DBMET02451 0.064 0.023 DBMET02450 0.041 0.036 DBMET02445 0.04 0.037 DBMET02444 0.073 0.019 DBMET02447 0.072 0.019 DBMET02446 | ||
| 0.121 | 0.005 | 0.121 | AMPA 1 receptor antagonist | 0.029 0.021 DBMET02439 0.049 0.011 DBMET02446 | ||
| 0.118 | 0.003 | 0.118 | AMPA receptor agonist | 0.081 0.004 DBMET02439 | ||
| 0.149 | 0.034 | 0.179 | Sphingosine 1-phosphate receptor 4 antagonist | 0.135 0.049 DB00988 0.127 0.06 DBMET02439 0.115 0.082 DBMET02440 0.117 0.079 DBMET02445 0.179 0.015 DBMET02447 0.175 0.017 DBMET02446 0.153 0.031 DBMET02442 | DBMET02447 | |
| 0.139 | 0.025 | 0.162 | Anabolic | 0.133 0.029 DB00988 0.106 0.055 DBMET02439 0.15 0.018 DBMET02448 0.15 0.018 DBMET02449 0.1 0.063 DBMET02440 0.161 0.013 DBMET02443 0.139 0.024 DBMET02445 0.106 0.054 DBMET02441 0.162 0.012 DBMET02444 0.144 0.021 DBMET02447 0.154 0.016 DBMET02446 0.125 0.035 DBMET02442 | DBMET02444 | |
| 0.117 | 0.003 | 0.125 | Arginase inhibitor | 0.077 0.006 DB00988 0.074 0.007 DBMET02439 0.125 0.003 DBMET02451 0.125 0.003 DBMET02450 0.045 0.019 DBMET02440 0.044 0.019 DBMET02443 0.052 0.014 DBMET02447 0.061 0.01 DBMET02446 0.031 0.03 DBMET02442 | DBMET02450 | |
| 0.148 | 0.035 | 0.227 | Xanthine oxidase inhibitor | 0.101 0.059 DB00988 0.14 0.038 DBMET02439 0.227 0.015 DBMET02451 0.227 0.015 DBMET02450 0.097 0.063 DBMET02440 0.096 0.063 DBMET02443 0.141 0.038 DBMET02445 0.134 0.041 DBMET02441 0.194 0.021 DBMET02447 0.203 0.019 DBMET02446 0.196 0.02 DBMET02442 | DBMET02450 | |
| 0.125 | 0.013 | 0.166 | Granulocyte macrophage colony stimulating factor agonist | 0.119 0.016 DB00988 0.15 0.005 DBMET02439 0.143 0.006 DBMET02440 0.101 0.034 DBMET02443 0.127 0.012 DBMET02445 0.152 0.005 DBMET02441 0.082 0.069 DBMET02444 0.136 0.009 DBMET02447 0.139 0.008 DBMET02446 0.166 0.004 DBMET02442 | DBMET02442 | |
| 0.132 | 0.02 | 0.171 | Glutamate (mGluR7) agonist | 0.1 0.059 DB00988 0.149 0.012 DBMET02439 0.113 0.038 DBMET02440 0.115 0.036 DBMET02443 0.089 0.086 DBMET02441 0.171 0.007 DBMET02444 0.092 0.078 DBMET02447 0.106 0.049 DBMET02446 0.119 0.031 DBMET02442 | DBMET02444 | |
| 0.155 | 0.044 | 0.19 | Proteasome inhibitor | 0.113 0.072 DB00988 0.138 0.053 DBMET02439 0.098 0.09 DBMET02440 0.19 0.028 DBMET02445 0.177 0.033 DBMET02441 0.151 0.046 DBMET02447 0.15 0.046 DBMET02446 0.132 0.057 DBMET02442 | DBMET02445 | |
| 0.123 | 0.013 | 0.182 | Biliverdin reductase inhibitor | 0.1 0.019 DB00988 0.054 0.048 DBMET02439 0.092 0.021 DBMET02443 0.081 0.025 DBMET02445 0.109 0.016 DBMET02447 0.182 0.007 DBMET02446 0.084 0.024 DBMET02442 | DBMET02446 | |
| 0.184 | 0.074 | 0.461 | Nitric oxide antagonist | 0.198 0.068 DB00988 0.202 0.066 DBMET02439 0.153 0.092 DBMET02448 0.153 0.092 DBMET02449 0.461 0.019 DBMET02451 0.461 0.019 DBMET02450 0.22 0.061 DBMET02440 0.192 0.07 DBMET02443 0.28 0.044 DBMET02445 0.284 0.044 DBMET02441 0.168 0.083 DBMET02444 0.279 0.045 DBMET02447 0.282 0.044 DBMET02446 0.286 0.043 DBMET02442 | DBMET02450 | |
| 0.129 | 0.02 | 0.129 | Analgesic, opioid | 0.082 0.045 DB00988 0.09 0.037 DBMET02439 | ||
| 0.117 | 0.011 | 0.184 | Estrogen-related receptor beta agonist | 0.166 0.003 DB00988 0.112 0.014 DBMET02439 0.09 0.04 DBMET02448 0.09 0.04 DBMET02449 0.081 0.063 DBMET02451 0.081 0.063 DBMET02450 0.156 0.004 DBMET02440 0.111 0.014 DBMET02443 0.136 0.005 DBMET02445 0.129 0.007 DBMET02441 0.124 0.008 DBMET02444 0.184 0.003 DBMET02447 0.164 0.004 DBMET02446 0.155 0.004 DBMET02442 | DBMET02447 | |
| 0.109 | 0.004 | 0.109 | Glutamate (mGluR1a) agonist | 0.02 0.019 DB00988 0.031 0.008 DBMET02439 0.037 0.006 DBMET02448 0.037 0.006 DBMET02449 0.021 0.018 DBMET02447 0.034 0.007 DBMET02446 | ||
| 0.149 | 0.045 | 0.361 | Cholesterol synthesis inhibitor | 0.163 0.039 DB00988 0.159 0.04 DBMET02439 0.222 0.022 DBMET02448 0.222 0.022 DBMET02449 0.113 0.072 DBMET02451 0.113 0.072 DBMET02450 0.174 0.034 DBMET02440 0.209 0.025 DBMET02443 0.26 0.016 DBMET02445 0.275 0.014 DBMET02441 0.187 0.03 DBMET02444 0.263 0.016 DBMET02447 0.35 0.007 DBMET02446 0.361 0.006 DBMET02442 | DBMET02442 | |
| 0.108 | 0.004 | 0.108 | Glutamate (mGluR4) agonist | 0.073 0.006 DBMET02439 | ||
| 0.157 | 0.053 | 0.34 | Neurotrophic factor | 0.181 0.037 DB00988 0.149 0.06 DBMET02439 0.138 0.071 DBMET02451 0.138 0.071 DBMET02450 0.167 0.046 DBMET02440 0.14 0.069 DBMET02443 0.192 0.031 DBMET02445 0.175 0.041 DBMET02441 0.143 0.066 DBMET02444 0.34 0.006 DBMET02447 0.143 0.065 DBMET02446 0.137 0.072 DBMET02442 | DBMET02447 | |
| 0.122 | 0.019 | 0.407 | HIV-1 integrase (3'-Processing) inhibitor | 0.114 0.021 DB00988 0.106 0.024 DBMET02439 0.407 0.004 DBMET02448 0.407 0.004 DBMET02449 0.078 0.035 DBMET02451 0.078 0.035 DBMET02450 0.096 0.028 DBMET02440 0.081 0.033 DBMET02443 0.236 0.007 DBMET02445 0.165 0.012 DBMET02441 0.065 0.042 DBMET02444 0.212 0.009 DBMET02447 0.251 0.006 DBMET02446 0.183 0.011 DBMET02442 | DBMET02449 | |
| 0.131 | 0.027 | 0.153 | Interleukin 1 beta converting enzyme inhibitor | 0.086 0.079 DB00988 0.108 0.047 DBMET02439 0.135 0.025 DBMET02445 0.112 0.043 DBMET02441 0.102 0.054 DBMET02447 0.153 0.016 DBMET02446 0.132 0.027 DBMET02442 | DBMET02446 | |
| 0.122 | 0.019 | 0.259 | Myeloperoxidase inhibitor | 0.258 0.004 DB00988 0.122 0.019 DBMET02439 0.259 0.004 DBMET02440 0.113 0.024 DBMET02443 0.079 0.069 DBMET02445 0.079 0.068 DBMET02441 0.099 0.037 DBMET02444 0.143 0.012 DBMET02447 0.093 0.044 DBMET02446 0.094 0.043 DBMET02442 | DBMET02440 | |
| 0.133 | 0.03 | 0.198 | GABA C receptor rho-1 antagonist | 0.198 0.008 DB00988 0.104 0.057 DBMET02439 0.157 0.018 DBMET02440 0.154 0.02 DBMET02443 0.105 0.056 DBMET02445 0.119 0.041 DBMET02444 0.124 0.037 DBMET02447 0.189 0.01 DBMET02446 0.15 0.021 DBMET02442 | DB00988 | |
| 0.127 | 0.027 | 0.847 | Carbonic anhydrase XIII inhibitor | 0.319 0.005 DB00988 0.157 0.02 DBMET02439 0.847 0.002 DBMET02448 0.847 0.002 DBMET02449 0.444 0.004 DBMET02451 0.444 0.004 DBMET02450 0.363 0.004 DBMET02440 0.164 0.019 DBMET02443 0.22 0.012 DBMET02445 0.253 0.008 DBMET02441 0.069 0.059 DBMET02444 0.269 0.007 DBMET02447 0.211 0.013 DBMET02446 0.244 0.009 DBMET02442 | DBMET02449 | |
| 0.139 | 0.04 | 0.242 | TRPA1 agonist | 0.187 0.014 DB00988 0.116 0.064 DBMET02439 0.172 0.019 DBMET02448 0.172 0.019 DBMET02449 0.134 0.044 DBMET02451 0.134 0.044 DBMET02450 0.161 0.024 DBMET02440 0.131 0.047 DBMET02443 0.242 0.006 DBMET02445 0.202 0.01 DBMET02441 0.106 0.078 DBMET02444 0.156 0.027 DBMET02447 0.219 0.008 DBMET02446 0.187 0.014 DBMET02442 | DBMET02445 | |
| 0.132 | 0.033 | 0.181 | Toll-Like receptor 4 antagonist | 0.13 0.035 DB00988 0.136 0.03 DBMET02439 0.181 0.009 DBMET02451 0.181 0.009 DBMET02450 0.135 0.03 DBMET02440 0.101 0.067 DBMET02443 0.097 0.075 DBMET02441 0.12 0.044 DBMET02447 0.138 0.029 DBMET02446 0.141 0.026 DBMET02442 | DBMET02450 | |
| 0.141 | 0.043 | 0.178 | Microtubule formation inhibitor | 0.113 0.069 DB00988 0.155 0.035 DBMET02439 0.136 0.046 DBMET02451 0.136 0.046 DBMET02450 0.124 0.056 DBMET02440 0.125 0.055 DBMET02443 0.15 0.038 DBMET02445 0.165 0.031 DBMET02441 0.144 0.041 DBMET02444 0.161 0.032 DBMET02447 0.161 0.032 DBMET02446 0.178 0.026 DBMET02442 | DBMET02442 | |
| 0.11 | 0.012 | 0.112 | NMDA receptor glycine site agonist | 0.078 0.03 DB00988 0.074 0.033 DBMET02439 0.068 0.038 DBMET02447 0.112 0.011 DBMET02446 0.076 0.031 DBMET02442 | DBMET02446 | |
| 0.12 | 0.022 | 0.371 | Selectin antagonist | 0.062 0.048 DB00988 0.084 0.035 DBMET02439 0.271 0.007 DBMET02448 0.271 0.007 DBMET02449 0.371 0.004 DBMET02451 0.371 0.004 DBMET02450 0.073 0.041 DBMET02443 0.064 0.047 DBMET02444 0.078 0.038 DBMET02447 0.172 0.014 DBMET02446 0.102 0.027 DBMET02442 | DBMET02450 | |
| 0.148 | 0.051 | 0.367 | Interleukin 4 antagonist | 0.175 0.032 DB00988 0.148 0.052 DBMET02439 0.17 0.035 DBMET02451 0.17 0.035 DBMET02450 0.169 0.036 DBMET02440 0.213 0.019 DBMET02443 0.367 0.005 DBMET02445 0.311 0.008 DBMET02441 0.17 0.035 DBMET02444 0.212 0.019 DBMET02447 0.335 0.007 DBMET02446 0.289 0.009 DBMET02442 | DBMET02445 | |
| 0.229 | 0.133 | 0.48 | Caspase 3 stimulant | 0.235 0.126 DB00988 0.312 0.073 DBMET02439 0.305 0.076 DBMET02451 0.305 0.076 DBMET02450 0.339 0.063 DBMET02440 0.196 0.175 DBMET02443 0.429 0.036 DBMET02445 0.48 0.023 DBMET02441 0.33 0.066 DBMET02447 0.303 0.077 DBMET02446 0.408 0.042 DBMET02442 | DBMET02441 | |
| 0.11 | 0.015 | 0.122 | Aminopeptidase microsomal inhibitor | 0.057 0.041 DB00988 0.081 0.024 DBMET02439 0.122 0.013 DBMET02445 0.081 0.025 DBMET02441 0.076 0.027 DBMET02446 0.056 0.043 DBMET02442 | DBMET02445 | |
| 0.119 | 0.024 | 0.153 | Somatostatin 1 agonist | 0.133 0.019 DB00988 0.086 0.045 DBMET02439 0.071 0.063 DBMET02448 0.071 0.063 DBMET02449 0.069 0.066 DBMET02451 0.069 0.066 DBMET02450 0.091 0.04 DBMET02440 0.153 0.013 DBMET02443 0.101 0.033 DBMET02444 | DBMET02443 | |
| 0.122 | 0.029 | 0.122 | Metalloproteinase-2 inhibitor | 0.107 0.035 DBMET02439 0.083 0.049 DBMET02447 0.109 0.034 DBMET02446 0.093 0.042 DBMET02442 | ||
| 0.132 | 0.039 | 0.132 | Protease inhibitor | 0.115 0.051 DBMET02439 0.097 0.068 DBMET02445 | ||
| 0.221 | 0.128 | 0.524 | Hypoxia-inducible factor 1 alpha inhibitor | 0.26 0.092 DB00988 0.259 0.092 DBMET02439 0.282 0.075 DBMET02451 0.282 0.075 DBMET02450 0.303 0.064 DBMET02440 0.471 0.017 DBMET02443 0.299 0.066 DBMET02445 0.349 0.045 DBMET02441 0.524 0.013 DBMET02444 0.269 0.084 DBMET02447 0.328 0.053 DBMET02446 0.379 0.036 DBMET02442 | DBMET02444 | |
| 0.099 | 0.008 | 0.133 | Sphingosine kinase inhibitor | 0.109 0.006 DB00988 0.069 0.026 DBMET02439 0.133 0.004 DBMET02448 0.133 0.004 DBMET02449 0.075 0.019 DBMET02440 0.072 0.023 DBMET02443 0.093 0.01 DBMET02445 0.065 0.032 DBMET02441 0.121 0.005 DBMET02447 0.078 0.017 DBMET02446 0.054 0.052 DBMET02442 | DBMET02449 | |
| 0.106 | 0.015 | 0.106 | Antimetabolite | 0.061 0.025 DBMET02439 0.043 0.037 DBMET02447 0.052 0.03 DBMET02446 | ||
| 0.099 | 0.009 | 0.158 | Aconitate hydratase inhibitor | 0.074 0.016 DB00988 0.057 0.029 DBMET02439 0.073 0.017 DBMET02443 0.072 0.017 DBMET02445 0.088 0.011 DBMET02447 0.158 0.004 DBMET02446 0.085 0.012 DBMET02442 | DBMET02446 | |
| 0.104 | 0.015 | 0.137 | Maillard reaction inhibitor | 0.111 0.013 DB00988 0.085 0.023 DBMET02439 0.064 0.032 DBMET02451 0.064 0.032 DBMET02450 0.088 0.021 DBMET02440 0.137 0.007 DBMET02443 0.125 0.009 DBMET02444 0.103 0.016 DBMET02447 0.121 0.01 DBMET02446 0.099 0.017 DBMET02442 | DBMET02443 | |
| 0.091 | 0.003 | 0.091 | Glutamate (mGluR8) antagonist | 0.035 0.027 DB00988 0.073 0.004 DBMET02439 0.049 0.009 DBMET02446 0.039 0.019 DBMET02442 | ||
| 0.146 | 0.057 | 0.352 | NADPH oxidase inhibitor | 0.304 0.012 DB00988 0.192 0.037 DBMET02439 0.315 0.01 DBMET02451 0.315 0.01 DBMET02450 0.352 0.007 DBMET02440 0.156 0.051 DBMET02443 0.257 0.019 DBMET02445 0.31 0.011 DBMET02441 0.113 0.093 DBMET02444 0.15 0.054 DBMET02447 0.288 0.014 DBMET02446 0.338 0.008 DBMET02442 | DBMET02440 | |
| 0.198 | 0.11 | 0.573 | Tumour necrosis factor alpha release inhibitor | 0.21 0.101 DB00988 0.298 0.054 DBMET02439 0.573 0.009 DBMET02451 0.573 0.009 DBMET02450 0.326 0.045 DBMET02440 0.205 0.104 DBMET02443 0.185 0.123 DBMET02441 0.162 0.142 DBMET02444 0.259 0.071 DBMET02447 0.202 0.108 DBMET02446 0.323 0.046 DBMET02442 | DBMET02450 | |
| 0.1 | 0.013 | 0.1 | Opioid mu receptor agonist | 0.047 0.031 DB00988 0.062 0.023 DBMET02439 | ||
| 0.091 | 0.004 | 0.091 | Lysine carboxypeptidase inhibitor | 0.036 0.012 DB00988 0.038 0.011 DBMET02439 0.026 0.02 DBMET02443 0.027 0.019 DBMET02447 0.036 0.012 DBMET02446 | ||
| 0.101 | 0.014 | 0.187 | 5 Hydroxytryptamine 2A agonist | 0.174 0.004 DB00988 0.107 0.012 DBMET02439 0.187 0.004 DBMET02440 0.071 0.036 DBMET02443 0.06 0.047 DBMET02447 | DBMET02440 | |
| 0.157 | 0.071 | 0.256 | Hexokinase inhibitor | 0.158 0.07 DB00988 0.137 0.095 DBMET02439 0.256 0.016 DBMET02451 0.256 0.016 DBMET02450 0.138 0.093 DBMET02440 0.199 0.036 DBMET02445 0.18 0.049 DBMET02441 0.182 0.048 DBMET02447 0.186 0.044 DBMET02446 0.167 0.06 DBMET02442 | DBMET02450 | |
| 0.125 | 0.04 | 0.176 | Urease inhibitor | 0.144 0.026 DB00988 0.124 0.041 DBMET02439 0.142 0.027 DBMET02440 0.176 0.014 DBMET02443 0.118 0.047 DBMET02445 0.116 0.049 DBMET02441 0.154 0.021 DBMET02444 0.131 0.036 DBMET02447 0.129 0.037 DBMET02446 0.127 0.038 DBMET02442 | DBMET02443 | |
| 0.089 | 0.004 | 0.089 | Integrin beta7 antagonist | 0.077 0.005 DBMET02439 0.031 0.009 DBMET02446 0.025 0.011 DBMET02442 | ||
| 0.094 | 0.009 | 0.136 | Sphingosine kinase 2 inhibitor | 0.129 0.004 DB00988 0.063 0.028 DBMET02439 0.09 0.01 DBMET02440 0.091 0.01 DBMET02443 0.078 0.016 DBMET02445 0.051 0.045 DBMET02441 0.055 0.038 DBMET02444 0.136 0.004 DBMET02447 0.08 0.015 DBMET02446 0.053 0.042 DBMET02442 | DBMET02447 | |
| 0.104 | 0.02 | 0.104 | Sirtuin 1 inhibitor | 0.096 0.025 DB00988 0.083 0.033 DBMET02439 0.071 0.043 DBMET02440 | ||
| 0.087 | 0.004 | 0.087 | Integrin alpha4beta7 antagonist | 0.073 0.004 DBMET02439 0.033 0.008 DBMET02446 0.027 0.01 DBMET02442 | ||
| 0.095 | 0.013 | 0.095 | AMPA receptor antagonist | 0.052 0.029 DBMET02446 | ||
| 0.111 | 0.029 | 0.245 | Macrophage migration inhibitory factor inhibitor | 0.181 0.01 DB00988 0.124 0.024 DBMET02439 0.201 0.008 DBMET02440 0.096 0.037 DBMET02443 0.141 0.018 DBMET02445 0.153 0.014 DBMET02441 0.245 0.005 DBMET02447 0.213 0.007 DBMET02446 0.236 0.005 DBMET02442 | DBMET02447 | |
| 0.105 | 0.024 | 0.13 | D-Ala-D-Ala ligase inhibitor | 0.116 0.016 DB00988 0.093 0.039 DBMET02439 0.103 0.026 DBMET02440 0.111 0.019 DBMET02443 0.106 0.023 DBMET02445 0.094 0.038 DBMET02441 0.091 0.042 DBMET02444 0.107 0.022 DBMET02447 0.13 0.01 DBMET02446 0.114 0.017 DBMET02442 | DBMET02446 | |
| 0.122 | 0.042 | 0.366 | UDP-glucose 4-epimerase inhibitor | 0.152 0.028 DB00988 0.324 0.009 DBMET02451 0.324 0.009 DBMET02450 0.088 0.076 DBMET02440 0.146 0.03 DBMET02443 0.366 0.007 DBMET02445 0.205 0.017 DBMET02441 0.114 0.048 DBMET02444 0.33 0.009 DBMET02447 0.244 0.014 DBMET02446 0.132 0.036 DBMET02442 | DBMET02445 | |
| 0.298 | 0.218 | 0.746 | Antiinflammatory | 0.259 0.257 DBMET02439 0.303 0.213 DBMET02448 0.303 0.213 DBMET02449 0.746 0.023 DBMET02451 0.746 0.023 DBMET02450 0.298 0.217 DBMET02443 0.703 0.03 DBMET02445 0.611 0.05 DBMET02441 0.435 0.118 DBMET02447 0.641 0.043 DBMET02446 0.548 0.069 DBMET02442 | DBMET02450 | |
| 0.103 | 0.023 | 0.173 | HIV-1 integrase inhibitor | 0.088 0.033 DB00988 0.084 0.035 DBMET02439 0.148 0.009 DBMET02448 0.148 0.009 DBMET02449 0.068 0.051 DBMET02440 0.089 0.032 DBMET02443 0.107 0.021 DBMET02445 0.082 0.036 DBMET02441 0.082 0.036 DBMET02444 0.147 0.009 DBMET02447 0.173 0.006 DBMET02446 0.136 0.011 DBMET02442 | DBMET02446 | |
| 0.108 | 0.029 | 0.108 | Hematopoietic | 0.084 0.062 DBMET02439 | ||
| 0.084 | 0.005 | 0.084 | Prostacyclin antagonist | 0.068 0.008 DBMET02439 0.057 0.01 DBMET02447 0.077 0.006 DBMET02446 0.059 0.01 DBMET02442 | ||
| 0.097 | 0.018 | 0.151 | Purinergic P2X1 antagonist | 0.1 0.017 DB00988 0.062 0.04 DBMET02439 0.064 0.038 DBMET02440 0.093 0.019 DBMET02443 0.13 0.01 DBMET02445 0.087 0.021 DBMET02441 0.064 0.038 DBMET02444 0.125 0.01 DBMET02447 0.151 0.007 DBMET02446 0.108 0.014 DBMET02442 | DBMET02446 | |
| 0.1 | 0.022 | 0.1 | Glucagon-like peptide 1 agonist | 0.088 0.029 DBMET02439 0.054 0.053 DBMET02446 | ||
| 0.128 | 0.049 | 0.143 | Caspase 3 inhibitor | 0.111 0.073 DBMET02439 0.143 0.034 DBMET02445 0.126 0.051 DBMET02441 0.131 0.046 DBMET02447 0.143 0.034 DBMET02446 0.126 0.051 DBMET02442 | DBMET02446 | |
| 0.095 | 0.018 | 0.135 | Peroxisome proliferator-activated receptor gamma antagonist | 0.088 0.025 DBMET02439 0.087 0.025 DBMET02447 0.135 0.007 DBMET02446 0.119 0.01 DBMET02442 | DBMET02446 | |
| 0.118 | 0.041 | 0.239 | Factor V inhibitor | 0.096 0.078 DB00988 0.109 0.052 DBMET02439 0.239 0.003 DBMET02445 0.209 0.004 DBMET02441 | DBMET02445 | |
| 0.102 | 0.026 | 0.305 | Peroxisome proliferator-activated receptor gamma agonist | 0.084 0.038 DBMET02439 0.129 0.018 DBMET02447 0.305 0.005 DBMET02446 0.201 0.007 DBMET02442 | DBMET02446 | |
| 0.083 | 0.008 | 0.099 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.033 DB00988 0.074 0.012 DBMET02439 0.054 0.03 DBMET02443 0.051 0.034 DBMET02445 0.046 0.043 DBMET02444 0.08 0.009 DBMET02447 0.099 0.005 DBMET02446 0.088 0.007 DBMET02442 | DBMET02446 | |
| 0.098 | 0.024 | 0.098 | Glutamate (mGluR) agonist | 0.055 0.05 DBMET02439 | ||
| 0.086 | 0.012 | 0.086 | Complement C3a chemotactic receptor antagonist | 0.04 0.033 DB00988 0.065 0.019 DBMET02439 | ||
| 0.089 | 0.016 | 0.089 | Neurotensin receptor antagonist | 0.042 0.034 DB00988 0.061 0.023 DBMET02439 | ||
| 0.106 | 0.033 | 0.106 | Factor XII inhibitor | 0.103 0.035 DBMET02439 0.083 0.061 DBMET02445 0.084 0.058 DBMET02441 | ||
| 0.11 | 0.038 | 0.216 | Histamine N-methyltransferase inhibitor | 0.216 0.005 DB00988 0.105 0.041 DBMET02448 0.105 0.041 DBMET02449 0.154 0.013 DBMET02440 0.1 0.046 DBMET02443 0.1 0.046 DBMET02447 0.092 0.054 DBMET02446 | DB00988 | |
| 0.087 | 0.016 | 0.099 | Aminopeptidase N inhibitor | 0.059 0.025 DBMET02439 0.099 0.013 DBMET02445 0.058 0.025 DBMET02441 0.054 0.028 DBMET02446 | DBMET02445 | |
| 0.091 | 0.02 | 0.091 | Protease 3C (Human rhinovirus) inhibitor | 0.069 0.039 DB00988 0.072 0.034 DBMET02439 0.066 0.042 DBMET02448 0.066 0.042 DBMET02449 0.09 0.02 DBMET02445 0.071 0.035 DBMET02441 0.088 0.021 DBMET02447 0.07 0.037 DBMET02446 | ||
| 0.076 | 0.005 | 0.157 | Catechol O-methyltransferase inhibitor | 0.073 0.005 DB00988 0.047 0.01 DBMET02439 0.045 0.011 DBMET02448 0.045 0.011 DBMET02449 0.044 0.011 DBMET02440 0.157 0.004 DBMET02443 0.095 0.005 DBMET02445 0.046 0.01 DBMET02441 0.05 0.009 DBMET02444 0.121 0.004 DBMET02447 0.139 0.004 DBMET02446 0.064 0.006 DBMET02442 | DBMET02443 | |
| 0.075 | 0.004 | 0.08 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 DB00988 0.058 0.008 DBMET02439 0.047 0.019 DBMET02448 0.047 0.019 DBMET02449 0.056 0.009 DBMET02440 0.063 0.006 DBMET02443 0.064 0.006 DBMET02445 0.05 0.014 DBMET02441 0.049 0.016 DBMET02444 0.071 0.004 DBMET02447 0.08 0.004 DBMET02446 0.062 0.007 DBMET02442 | DBMET02446 | |
| 0.077 | 0.007 | 0.077 | Carbonic anhydrase I stimulant | 0.062 0.011 DB00988 0.053 0.014 DBMET02439 0.038 0.025 DBMET02440 | ||
| 0.074 | 0.005 | 0.074 | VCAM antagonist | 0.058 0.006 DBMET02439 0.044 0.016 DBMET02446 0.041 0.023 DBMET02442 | ||
| 0.094 | 0.025 | 0.385 | HIV-1 integrase (Strand Transfer) inhibitor | 0.084 0.029 DB00988 0.082 0.03 DBMET02439 0.385 0.004 DBMET02448 0.385 0.004 DBMET02449 0.062 0.04 DBMET02451 0.062 0.04 DBMET02450 0.071 0.035 DBMET02440 0.059 0.042 DBMET02443 0.203 0.009 DBMET02445 0.133 0.014 DBMET02441 0.179 0.011 DBMET02447 0.234 0.007 DBMET02446 0.164 0.012 DBMET02442 | DBMET02449 | |
| 0.074 | 0.005 | 0.074 | VCAM-1 antagonist | 0.058 0.006 DBMET02439 0.044 0.016 DBMET02446 0.041 0.023 DBMET02442 | ||
| 0.08 | 0.011 | 0.147 | Alpha-mannosidase inhibitor | 0.072 0.015 DB00988 0.067 0.019 DBMET02439 0.088 0.009 DBMET02448 0.088 0.009 DBMET02449 0.147 0.004 DBMET02451 0.147 0.004 DBMET02450 0.061 0.026 DBMET02440 0.089 0.008 DBMET02443 0.08 0.011 DBMET02445 0.067 0.019 DBMET02441 0.078 0.012 DBMET02444 0.101 0.006 DBMET02447 0.075 0.014 DBMET02446 0.062 0.024 DBMET02442 | DBMET02450 | |
| 0.097 | 0.028 | 0.682 | Carbonic anhydrase V inhibitor | 0.223 0.005 DB00988 0.083 0.034 DBMET02439 0.682 0.002 DBMET02448 0.682 0.002 DBMET02449 0.206 0.006 DBMET02440 0.092 0.03 DBMET02443 0.081 0.035 DBMET02445 0.07 0.042 DBMET02441 0.221 0.005 DBMET02447 0.202 0.007 DBMET02446 0.187 0.008 DBMET02442 | DBMET02449 | |
| 0.078 | 0.01 | 0.099 | Adenine nucleotide translocase inhibitor | 0.058 0.031 DB00988 0.069 0.016 DBMET02439 0.099 0.005 DBMET02448 0.099 0.005 DBMET02449 0.076 0.011 DBMET02451 0.076 0.011 DBMET02450 0.052 0.048 DBMET02440 0.058 0.032 DBMET02443 0.054 0.041 DBMET02445 0.066 0.019 DBMET02447 0.076 0.011 DBMET02446 0.066 0.019 DBMET02442 | DBMET02449 | |
| 0.084 | 0.016 | 0.084 | Toll-Like receptor 2 agonist | 0.041 0.029 DB00988 0.046 0.025 DBMET02439 0.037 0.032 DBMET02443 | ||
| 0.078 | 0.01 | 0.177 | Beta 2 adrenoreceptor agonist | 0.112 0.004 DB00988 0.069 0.021 DBMET02439 0.077 0.011 DBMET02448 0.077 0.011 DBMET02449 0.092 0.005 DBMET02440 0.171 0.003 DBMET02443 0.07 0.02 DBMET02445 0.063 0.039 DBMET02441 0.177 0.002 DBMET02444 0.106 0.004 DBMET02447 0.082 0.008 DBMET02446 0.072 0.016 DBMET02442 | DBMET02444 | |
| 0.092 | 0.025 | 0.092 | Neutrophil collagenase inhibitor | 0.06 0.05 DB00988 0.076 0.035 DBMET02439 0.067 0.043 DBMET02447 0.086 0.028 DBMET02446 0.07 0.039 DBMET02442 | ||
| 0.122 | 0.056 | 0.18 | Transcription factor STAT6 inhibitor | 0.18 0.01 DB00988 0.143 0.029 DBMET02440 0.175 0.011 DBMET02443 0.104 0.096 DBMET02445 0.139 0.033 DBMET02444 0.16 0.017 DBMET02447 0.118 0.064 DBMET02446 | DB00988 | |
| 0.082 | 0.016 | 0.083 | Botulinum neurotoxin type A inhibitor | 0.082 0.016 DB00988 0.061 0.037 DBMET02439 0.061 0.036 DBMET02440 0.066 0.029 DBMET02443 0.054 0.048 DBMET02445 0.061 0.036 DBMET02447 0.083 0.015 DBMET02446 0.062 0.035 DBMET02442 | DBMET02446 | |
| 0.086 | 0.02 | 0.086 | GP IIb/IIIa receptor antagonist | 0.046 0.036 DBMET02439 0.07 0.024 DBMET02446 | ||
| 0.083 | 0.018 | 0.083 | Opioid agonist | 0.053 0.037 DB00988 0.057 0.032 DBMET02439 | ||
| 0.093 | 0.028 | 0.503 | Carbonic anhydrase VA inhibitor | 0.192 0.005 DB00988 0.084 0.034 DBMET02439 0.503 0.002 DBMET02448 0.503 0.002 DBMET02449 0.18 0.006 DBMET02440 0.083 0.034 DBMET02443 0.084 0.034 DBMET02445 0.075 0.041 DBMET02441 0.191 0.005 DBMET02447 0.179 0.006 DBMET02446 0.169 0.008 DBMET02442 | DBMET02449 | |
| 0.074 | 0.01 | 0.074 | Leukotriene A4 hydrolase inhibitor | 0.071 0.011 DB00988 0.041 0.024 DBMET02439 0.032 0.031 DBMET02447 | ||
| 0.086 | 0.023 | 0.293 | Beta adrenoreceptor antagonist | 0.145 0.006 DB00988 0.09 0.021 DBMET02439 0.066 0.045 DBMET02448 0.066 0.045 DBMET02449 0.151 0.006 DBMET02440 0.237 0.003 DBMET02443 0.078 0.029 DBMET02445 0.081 0.026 DBMET02441 0.293 0.003 DBMET02444 0.163 0.005 DBMET02447 0.112 0.012 DBMET02446 0.115 0.011 DBMET02442 | DBMET02444 | |
| 0.08 | 0.017 | 0.087 | Sphingosine 1-phosphate receptor 3 antagonist | 0.066 0.03 DB00988 0.055 0.046 DBMET02439 0.054 0.048 DBMET02443 0.087 0.013 DBMET02447 0.077 0.019 DBMET02446 0.052 0.051 DBMET02442 | DBMET02447 | |
| 0.097 | 0.034 | 0.097 | Metalloproteinase-9 inhibitor | 0.067 0.062 DB00988 0.089 0.038 DBMET02439 0.073 0.051 DBMET02447 0.092 0.037 DBMET02446 0.085 0.041 DBMET02442 | ||
| 0.098 | 0.036 | 0.101 | Opioid kappa receptor antagonist | 0.101 0.034 DB00988 0.079 0.06 DBMET02439 0.077 0.062 DBMET02440 | DB00988 | |
| 0.076 | 0.014 | 0.076 | Prolactin release inhibitor | 0.068 0.026 DBMET02439 | ||
| 0.072 | 0.011 | 0.192 | Mannosidase inhibitor | 0.071 0.011 DB00988 0.054 0.021 DBMET02439 0.093 0.006 DBMET02448 0.093 0.006 DBMET02449 0.192 0.003 DBMET02451 0.192 0.003 DBMET02450 0.054 0.022 DBMET02440 0.097 0.006 DBMET02443 0.071 0.011 DBMET02445 0.054 0.022 DBMET02441 0.068 0.012 DBMET02444 0.098 0.006 DBMET02447 0.066 0.013 DBMET02446 0.05 0.026 DBMET02442 | DBMET02450 | |
| 0.076 | 0.015 | 0.076 | Angiotensin-converting enzyme inhibitor | 0.062 0.027 DBMET02439 0.054 0.04 DBMET02446 | ||
| 0.072 | 0.013 | 0.11 | Vanilloid 2 antagonist | 0.106 0.005 DB00988 0.079 0.009 DBMET02439 0.084 0.008 DBMET02448 0.084 0.008 DBMET02449 0.11 0.005 DBMET02440 0.065 0.018 DBMET02443 0.079 0.01 DBMET02445 0.087 0.007 DBMET02441 0.059 0.023 DBMET02444 0.091 0.007 DBMET02447 0.089 0.007 DBMET02446 0.095 0.006 DBMET02442 | DBMET02440 | |
| 0.073 | 0.014 | 0.092 | CD45 antagonist | 0.05 0.034 DB00988 0.054 0.029 DBMET02439 0.047 0.042 DBMET02445 0.051 0.033 DBMET02447 0.092 0.01 DBMET02446 0.06 0.021 DBMET02442 | DBMET02446 | |
| 0.076 | 0.018 | 0.076 | Bombesin 2 receptor antagonist | 0.057 0.026 DB00988 0.07 0.02 DBMET02439 0.054 0.029 DBMET02440 0.048 0.036 DBMET02447 0.072 0.019 DBMET02446 0.066 0.021 DBMET02442 | ||
| 0.081 | 0.023 | 0.34 | Beta 3 adrenoreceptor antagonist | 0.132 0.008 DB00988 0.077 0.025 DBMET02439 0.069 0.035 DBMET02448 0.069 0.035 DBMET02449 0.127 0.009 DBMET02440 0.252 0.003 DBMET02443 0.075 0.028 DBMET02445 0.072 0.031 DBMET02441 0.34 0.002 DBMET02444 0.154 0.005 DBMET02447 0.104 0.013 DBMET02446 0.099 0.015 DBMET02442 | DBMET02444 | |
| 0.087 | 0.03 | 0.115 | MAP kinase kinase 7 inhibitor | 0.109 0.007 DB00988 0.091 0.023 DBMET02440 0.099 0.014 DBMET02443 0.083 0.038 DBMET02445 0.083 0.037 DBMET02444 0.115 0.005 DBMET02447 0.09 0.025 DBMET02446 0.074 0.067 DBMET02442 | DBMET02447 | |
| 0.067 | 0.011 | 0.067 | AICAR transformylase inhibitor | 0.051 0.021 DB00988 0.045 0.028 DBMET02439 0.059 0.015 DBMET02445 0.061 0.014 DBMET02446 0.041 0.036 DBMET02442 | ||
| 0.187 | 0.131 | 0.466 | Cardiotonic | 0.277 0.066 DB00988 0.19 0.129 DBMET02439 0.176 0.143 DBMET02451 0.176 0.143 DBMET02450 0.262 0.074 DBMET02440 0.466 0.019 DBMET02443 0.371 0.034 DBMET02444 0.179 0.141 DBMET02447 0.163 0.161 DBMET02442 | DBMET02443 | |
| 0.06 | 0.005 | 0.06 | Kainate receptor 5 antagonist | 0.026 0.011 DBMET02439 | ||
| 0.074 | 0.019 | 0.297 | Carbonic anhydrase XIV inhibitor | 0.133 0.005 DB00988 0.087 0.014 DBMET02439 0.104 0.01 DBMET02448 0.104 0.01 DBMET02449 0.297 0.004 DBMET02451 0.297 0.004 DBMET02450 0.16 0.005 DBMET02440 0.054 0.029 DBMET02443 0.045 0.039 DBMET02445 0.051 0.031 DBMET02441 0.129 0.006 DBMET02447 0.092 0.013 DBMET02446 0.103 0.01 DBMET02442 | DBMET02450 | |
| 0.078 | 0.023 | 0.332 | Carbonic anhydrase VB inhibitor | 0.239 0.004 DB00988 0.053 0.042 DBMET02439 0.332 0.003 DBMET02448 0.332 0.003 DBMET02449 0.184 0.006 DBMET02440 0.088 0.019 DBMET02443 0.077 0.024 DBMET02445 0.052 0.043 DBMET02441 0.246 0.004 DBMET02447 0.138 0.01 DBMET02446 0.09 0.019 DBMET02442 | DBMET02449 | |
| 0.071 | 0.016 | 0.284 | Beta 2 adrenoreceptor antagonist | 0.112 0.007 DB00988 0.065 0.02 DBMET02439 0.05 0.037 DBMET02448 0.05 0.037 DBMET02449 0.099 0.008 DBMET02440 0.222 0.003 DBMET02443 0.067 0.018 DBMET02445 0.062 0.022 DBMET02441 0.284 0.003 DBMET02444 0.123 0.006 DBMET02447 0.086 0.01 DBMET02446 0.08 0.012 DBMET02442 | DBMET02444 | |
| 0.059 | 0.005 | 0.059 | Kainate receptor 4 antagonist | 0.029 0.014 DBMET02439 | ||
| 0.113 | 0.059 | 0.165 | Protein kinase C gamma inhibitor | 0.156 0.028 DB00988 0.104 0.07 DBMET02439 0.145 0.034 DBMET02440 0.165 0.024 DBMET02443 0.098 0.081 DBMET02445 0.165 0.024 DBMET02444 0.138 0.039 DBMET02447 | DBMET02444 | |
| 0.094 | 0.04 | 0.094 | Chymotrypsin inhibitor | 0.078 0.057 DBMET02439 0.086 0.047 DBMET02448 0.086 0.047 DBMET02449 0.081 0.053 DBMET02445 0.075 0.061 DBMET02446 | ||
| 0.101 | 0.049 | 0.175 | Protein kinase C zeta inhibitor | 0.11 0.04 DB00988 0.096 0.056 DBMET02439 0.175 0.015 DBMET02448 0.175 0.015 DBMET02449 0.104 0.046 DBMET02440 0.083 0.079 DBMET02443 0.09 0.065 DBMET02447 | DBMET02449 | |
| 0.151 | 0.1 | 0.28 | ATPase inhibitor | 0.162 0.081 DB00988 0.154 0.094 DBMET02439 0.28 0.008 DBMET02451 0.28 0.008 DBMET02450 0.166 0.077 DBMET02440 0.157 0.09 DBMET02443 0.208 0.031 DBMET02445 0.211 0.029 DBMET02441 0.206 0.032 DBMET02444 0.197 0.04 DBMET02447 0.266 0.01 DBMET02446 0.27 0.009 DBMET02442 | DBMET02450 | |
| 0.06 | 0.009 | 0.079 | Sphingosine kinase 1 inhibitor | 0.064 0.008 DB00988 0.039 0.033 DBMET02439 0.041 0.028 DBMET02440 0.042 0.027 DBMET02443 0.042 0.027 DBMET02445 0.079 0.005 DBMET02447 0.046 0.021 DBMET02446 | DBMET02447 | |
| 0.062 | 0.013 | 0.168 | Dopamine beta hydroxylase inhibitor | 0.168 0.003 DB00988 0.049 0.033 DBMET02439 0.053 0.025 DBMET02448 0.053 0.025 DBMET02449 0.118 0.003 DBMET02440 0.084 0.005 DBMET02443 0.073 0.007 DBMET02445 0.058 0.018 DBMET02441 0.063 0.012 DBMET02444 0.072 0.007 DBMET02447 0.089 0.004 DBMET02446 0.068 0.009 DBMET02442 | DB00988 | |
| 0.107 | 0.058 | 0.31 | 5-Lipoxygenase inhibitor | 0.144 0.04 DB00988 0.108 0.057 DBMET02439 0.138 0.042 DBMET02440 0.106 0.059 DBMET02443 0.16 0.034 DBMET02445 0.149 0.038 DBMET02441 0.083 0.078 DBMET02444 0.286 0.012 DBMET02447 0.31 0.01 DBMET02446 0.267 0.014 DBMET02442 | DBMET02446 | |
| 0.084 | 0.035 | 0.084 | Matrix metalloproteinase inhibitor | 0.076 0.039 DBMET02439 0.058 0.056 DBMET02447 0.072 0.042 DBMET02446 0.065 0.048 DBMET02442 | ||
| 0.067 | 0.019 | 0.128 | DNA helicase inhibitor | 0.066 0.02 DBMET02439 0.128 0.004 DBMET02446 0.114 0.004 DBMET02442 | DBMET02446 | |
| 0.064 | 0.016 | 0.064 | Erythropoietin receptor agonist | 0.039 0.03 DBMET02439 0.036 0.032 DBMET02446 | ||
| 0.093 | 0.046 | 0.163 | Transcription factor NF kappa B stimulant | 0.088 0.053 DBMET02439 0.163 0.013 DBMET02451 0.163 0.013 DBMET02450 0.077 0.076 DBMET02444 0.099 0.04 DBMET02447 0.082 0.065 DBMET02446 0.078 0.074 DBMET02442 | DBMET02450 | |
| 0.064 | 0.017 | 0.071 | Immunoglobulin Fc receptor antagonist | 0.071 0.01 DB00988 0.056 0.034 DBMET02439 0.062 0.021 DBMET02440 0.055 0.039 DBMET02445 0.062 0.021 DBMET02447 0.057 0.032 DBMET02446 | DB00988 | |
| 0.12 | 0.073 | 0.198 | DNA repair enzyme inhibitor | 0.119 0.074 DB00988 0.12 0.073 DBMET02439 0.198 0.009 DBMET02451 0.198 0.009 DBMET02450 0.119 0.075 DBMET02440 0.114 0.085 DBMET02443 0.122 0.068 DBMET02444 0.123 0.066 DBMET02447 0.122 0.069 DBMET02446 0.121 0.069 DBMET02442 | DBMET02450 | |
| 0.049 | 0.003 | 0.087 | Thyroid hormone beta agonist | 0.009 0.006 DB00988 0.017 0.004 DBMET02439 0.012 0.005 DBMET02447 0.087 0.002 DBMET02446 0.032 0.003 DBMET02442 | DBMET02446 | |
| 0.058 | 0.012 | 0.058 | Glutamate (mGluR group II) antagonist | 0.045 0.02 DBMET02439 | ||
| 0.089 | 0.044 | 0.125 | Glycine receptor antagonist | 0.081 0.055 DB00988 0.123 0.016 DBMET02448 0.123 0.016 DBMET02449 0.125 0.016 DBMET02451 0.125 0.016 DBMET02450 0.091 0.042 DBMET02446 | DBMET02450 | |
| 0.048 | 0.003 | 0.062 | Thyroid hormone alpha agonist | 0.033 0.004 DBMET02439 0.018 0.009 DBMET02447 0.062 0.003 DBMET02446 0.036 0.004 DBMET02442 | DBMET02446 | |
| 0.072 | 0.029 | 0.134 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.095 0.018 DB00988 0.056 0.045 DBMET02439 0.085 0.022 DBMET02451 0.085 0.022 DBMET02450 0.072 0.029 DBMET02440 0.073 0.029 DBMET02443 0.071 0.03 DBMET02445 0.054 0.046 DBMET02441 0.096 0.018 DBMET02447 0.134 0.009 DBMET02446 0.105 0.015 DBMET02442 | DBMET02446 | |
| 0.069 | 0.027 | 0.259 | Beta 1 adrenoreceptor antagonist | 0.135 0.006 DB00988 0.071 0.025 DBMET02439 0.052 0.044 DBMET02448 0.052 0.044 DBMET02449 0.137 0.005 DBMET02440 0.207 0.003 DBMET02443 0.075 0.021 DBMET02445 0.077 0.02 DBMET02441 0.259 0.003 DBMET02444 0.128 0.006 DBMET02447 0.093 0.012 DBMET02446 0.094 0.012 DBMET02442 | DBMET02444 | |
| 0.054 | 0.011 | 0.054 | Opioid delta receptor agonist | 0.035 0.025 DB00988 0.039 0.02 DBMET02439 | ||
| 0.054 | 0.012 | 0.192 | Beta adrenoreceptor agonist | 0.079 0.004 DB00988 0.047 0.025 DBMET02439 0.047 0.025 DBMET02448 0.047 0.025 DBMET02449 0.061 0.008 DBMET02440 0.163 0.003 DBMET02443 0.045 0.032 DBMET02445 0.192 0.003 DBMET02444 0.078 0.004 DBMET02447 0.065 0.006 DBMET02446 0.054 0.013 DBMET02442 | DBMET02444 | |
| 0.069 | 0.027 | 0.112 | Acyl-CoA dehydrogenase inhibitor | 0.085 0.02 DB00988 0.084 0.021 DBMET02443 0.057 0.035 DBMET02445 0.063 0.031 DBMET02444 0.089 0.019 DBMET02447 0.112 0.014 DBMET02446 0.054 0.038 DBMET02442 | DBMET02446 | |
| 0.046 | 0.004 | 0.046 | Kainate receptor 3 antagonist | 0.021 0.009 DBMET02439 | ||
| 0.061 | 0.02 | 0.07 | Adenosine deaminase inhibitor | 0.057 0.023 DB00988 0.045 0.035 DBMET02451 0.045 0.035 DBMET02450 0.06 0.02 DBMET02445 0.07 0.014 DBMET02447 0.065 0.017 DBMET02446 0.047 0.034 DBMET02442 | DBMET02447 | |
| 0.073 | 0.031 | 0.074 | Trypsin inhibitor | 0.073 0.031 DB00988 0.061 0.046 DBMET02439 0.074 0.03 DBMET02448 0.074 0.03 DBMET02449 0.059 0.049 DBMET02440 0.064 0.04 DBMET02445 | DBMET02449 | |
| 0.082 | 0.041 | 0.197 | CDC25A inhibitor | 0.07 0.057 DB00988 0.069 0.059 DBMET02439 0.197 0.007 DBMET02448 0.197 0.007 DBMET02449 0.066 0.065 DBMET02443 0.083 0.04 DBMET02445 0.067 0.063 DBMET02441 0.147 0.013 DBMET02447 0.181 0.009 DBMET02446 0.131 0.016 DBMET02442 | DBMET02449 | |
| 0.055 | 0.014 | 0.055 | Integrin alpha5beta1 antagonist | 0.044 0.024 DBMET02439 0.043 0.025 DBMET02446 | ||
| 0.053 | 0.013 | 0.053 | Membrane dipeptidase inhibitor | 0.039 0.028 DBMET02443 0.037 0.032 DBMET02447 0.044 0.021 DBMET02446 | ||
| 0.059 | 0.019 | 0.097 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.03 DB00988 0.064 0.015 DBMET02451 0.064 0.015 DBMET02450 0.052 0.027 DBMET02443 0.095 0.005 DBMET02445 0.066 0.015 DBMET02441 0.094 0.005 DBMET02447 0.097 0.005 DBMET02446 0.068 0.014 DBMET02442 | DBMET02446 | |
| 0.098 | 0.058 | 0.157 | Lanosterol 14 alpha demethylase inhibitor | 0.157 0.009 DB00988 0.116 0.034 DBMET02440 0.149 0.012 DBMET02443 0.127 0.024 DBMET02444 0.109 0.043 DBMET02447 0.126 0.025 DBMET02446 | DB00988 | |
| 0.097 | 0.058 | 0.24 | Potassium channel (Ca-activated) activator | 0.091 0.064 DB00988 0.223 0.011 DBMET02447 0.24 0.009 DBMET02446 0.185 0.018 DBMET02442 | DBMET02446 | |
| 0.063 | 0.024 | 0.165 | Leukotriene B4 antagonist | 0.077 0.017 DB00988 0.065 0.023 DBMET02439 0.086 0.014 DBMET02448 0.086 0.014 DBMET02449 0.125 0.007 DBMET02451 0.125 0.007 DBMET02450 0.078 0.016 DBMET02440 0.067 0.021 DBMET02443 0.052 0.041 DBMET02445 0.053 0.039 DBMET02441 0.057 0.032 DBMET02444 0.104 0.01 DBMET02447 0.161 0.005 DBMET02446 0.165 0.004 DBMET02442 | DBMET02442 | |
| 0.071 | 0.032 | 0.071 | Protein kinase C iota inhibitor | 0.059 0.041 DBMET02439 | ||
| 0.046 | 0.008 | 0.111 | NMDA 2D receptor antagonist | 0.032 0.014 DBMET02439 0.111 0.004 DBMET02448 0.111 0.004 DBMET02449 | DBMET02449 | |
| 0.073 | 0.035 | 0.125 | CDC25B inhibitor | 0.058 0.054 DBMET02439 0.114 0.012 DBMET02445 0.083 0.025 DBMET02441 0.125 0.01 DBMET02447 0.098 0.017 DBMET02446 0.074 0.033 DBMET02442 | DBMET02447 | |
| 0.042 | 0.004 | 0.064 | Vanilloid 2 agonist | 0.041 0.004 DB00988 0.029 0.011 DBMET02439 0.038 0.004 DBMET02448 0.038 0.004 DBMET02449 0.064 0.002 DBMET02451 0.064 0.002 DBMET02450 0.028 0.012 DBMET02440 0.029 0.012 DBMET02443 0.036 0.005 DBMET02445 0.025 0.018 DBMET02441 0.03 0.009 DBMET02444 0.039 0.004 DBMET02447 0.045 0.003 DBMET02446 0.031 0.009 DBMET02442 | DBMET02450 | |
| 0.042 | 0.004 | 0.253 | Thyroid hormone alpha antagonist | 0.023 0.006 DBMET02439 0.017 0.01 DBMET02447 0.253 0.003 DBMET02446 0.12 0.003 DBMET02442 | DBMET02446 | |
| 0.061 | 0.024 | 0.061 | Endothelin-converting enzyme inhibitor | 0.044 0.035 DBMET02439 | ||
| 0.195 | 0.158 | 0.431 | 12-Lipoxygenase inhibitor | 0.354 0.055 DB00988 0.223 0.128 DBMET02439 0.39 0.042 DBMET02440 0.216 0.134 DBMET02443 0.322 0.068 DBMET02445 0.361 0.053 DBMET02441 0.198 0.154 DBMET02444 0.411 0.036 DBMET02447 0.387 0.043 DBMET02446 0.431 0.032 DBMET02442 | DBMET02442 | |
| 0.053 | 0.016 | 0.053 | Calcitonin receptor agonist | 0.03 0.027 DB00988 0.03 0.027 DBMET02439 0.031 0.026 DBMET02447 0.031 0.026 DBMET02446 | ||
| 0.103 | 0.066 | 0.211 | Mediator release inhibitor | 0.088 0.084 DB00988 0.098 0.072 DBMET02439 0.211 0.013 DBMET02451 0.211 0.013 DBMET02450 0.122 0.046 DBMET02443 0.144 0.031 DBMET02444 0.201 0.014 DBMET02447 0.187 0.017 DBMET02446 0.178 0.019 DBMET02442 | DBMET02450 | |
| 0.132 | 0.095 | 0.327 | NOS3 expression enhancer | 0.137 0.087 DB00988 0.327 0.014 DBMET02451 0.327 0.014 DBMET02450 0.171 0.055 DBMET02445 0.131 0.097 DBMET02441 0.191 0.045 DBMET02447 0.232 0.031 DBMET02446 0.167 0.058 DBMET02442 | DBMET02450 | |
| 0.056 | 0.021 | 0.056 | Thymidylate synthase inhibitor | 0.055 0.022 DBMET02446 | ||
| 0.06 | 0.024 | 0.112 | Glucose-6-phosphate translocase inhibitor | 0.054 0.032 DB00988 0.07 0.016 DBMET02439 0.112 0.005 DBMET02451 0.112 0.005 DBMET02450 0.068 0.017 DBMET02440 0.064 0.02 DBMET02445 0.078 0.012 DBMET02441 0.066 0.019 DBMET02447 0.075 0.013 DBMET02446 0.087 0.009 DBMET02442 | DBMET02450 | |
| 0.061 | 0.026 | 0.111 | Leukotriene C antagonist | 0.056 0.04 DB00988 0.059 0.032 DBMET02445 0.078 0.009 DBMET02447 0.111 0.004 DBMET02446 0.084 0.006 DBMET02442 | DBMET02446 | |
| 0.092 | 0.057 | 0.115 | Glutamate release inhibitor | 0.102 0.04 DB00988 0.087 0.07 DBMET02439 0.1 0.042 DBMET02451 0.1 0.042 DBMET02450 0.096 0.049 DBMET02440 0.111 0.029 DBMET02443 0.103 0.038 DBMET02444 0.092 0.057 DBMET02447 0.115 0.025 DBMET02446 0.108 0.032 DBMET02442 | DBMET02446 | |
| 0.116 | 0.081 | 0.181 | M17 leucyl aminopeptidase inhibitor | 0.114 0.084 DBMET02439 0.181 0.04 DBMET02446 0.165 0.047 DBMET02442 | DBMET02446 | |
| 0.118 | 0.084 | 0.174 | Antibacterial (Helicobacter pylori) | 0.143 0.053 DB00988 0.122 0.079 DBMET02439 0.113 0.093 DBMET02448 0.113 0.093 DBMET02449 0.146 0.049 DBMET02440 0.174 0.031 DBMET02443 0.171 0.032 DBMET02444 0.131 0.066 DBMET02447 0.164 0.036 DBMET02446 0.169 0.034 DBMET02442 | DBMET02443 | |
| 0.121 | 0.088 | 0.14 | Cytokine production inhibitor | 0.118 0.092 DB00988 0.14 0.07 DBMET02439 0.137 0.073 DBMET02440 | DBMET02439 | |
| 0.045 | 0.012 | 0.045 | Integrin alpha1beta1 antagonist | 0.039 0.024 DBMET02439 0.036 0.033 DBMET02446 | ||
| 0.044 | 0.011 | 0.044 | Endothelial nitric-oxide synthase inhibitor | 0.033 0.019 DB00988 | ||
| 0.058 | 0.026 | 0.071 | Carbonic anhydrase II stimulant | 0.071 0.013 DB00988 0.05 0.04 DBMET02439 0.048 0.045 DBMET02448 0.048 0.045 DBMET02449 0.058 0.025 DBMET02440 | DB00988 | |
| 0.071 | 0.039 | 0.195 | Leukotriene antagonist | 0.069 0.041 DB00988 0.066 0.044 DBMET02439 0.06 0.051 DBMET02451 0.06 0.051 DBMET02450 0.064 0.046 DBMET02440 0.067 0.043 DBMET02443 0.06 0.051 DBMET02444 0.111 0.017 DBMET02447 0.195 0.006 DBMET02446 0.179 0.007 DBMET02442 | DBMET02446 | |
| 0.037 | 0.005 | 0.037 | Aminopeptidase A inhibitor | 0.019 0.011 DBMET02439 0.025 0.008 DBMET02446 | ||
| 0.054 | 0.021 | 0.065 | Oxytocin agonist | 0.065 0.013 DB00988 0.046 0.026 DBMET02440 0.046 0.027 DBMET02443 0.044 0.028 DBMET02445 0.037 0.036 DBMET02444 0.051 0.023 DBMET02447 0.044 0.028 DBMET02446 | DB00988 | |
| 0.045 | 0.015 | 0.046 | Integrin alpha2 antagonist | 0.038 0.024 DBMET02439 0.046 0.014 DBMET02446 0.038 0.023 DBMET02442 | DBMET02446 | |
| 0.053 | 0.022 | 0.063 | Macrophage elastase inhibitor | 0.04 0.033 DBMET02439 0.063 0.017 DBMET02446 0.045 0.028 DBMET02442 | DBMET02446 | |
| 0.061 | 0.031 | 0.061 | Matrix metalloproteinase (membrane-type) inhibitor | 0.056 0.036 DBMET02439 0.057 0.035 DBMET02446 0.053 0.041 DBMET02442 | ||
| 0.081 | 0.05 | 0.166 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.117 0.03 DB00988 0.088 0.045 DBMET02439 0.127 0.026 DBMET02440 0.074 0.057 DBMET02443 0.125 0.027 DBMET02445 0.134 0.024 DBMET02441 0.147 0.02 DBMET02447 0.157 0.017 DBMET02446 0.166 0.015 DBMET02442 | DBMET02442 | |
| 0.034 | 0.005 | 0.034 | ICAM 1 antagonist | 0.023 0.015 DBMET02439 0.026 0.01 DBMET02447 0.027 0.009 DBMET02446 | ||
| 0.044 | 0.015 | 0.064 | Sirtuin 2 inhibitor | 0.064 0.009 DB00988 0.035 0.021 DBMET02440 0.043 0.016 DBMET02447 | DB00988 | |
| 0.067 | 0.039 | 0.132 | Neuraminidase (influenza) inhibitor | 0.071 0.034 DB00988 0.06 0.054 DBMET02439 0.132 0.01 DBMET02448 0.132 0.01 DBMET02449 0.126 0.01 DBMET02451 0.126 0.01 DBMET02450 0.061 0.051 DBMET02440 0.125 0.011 DBMET02443 0.072 0.033 DBMET02444 0.1 0.016 DBMET02447 0.065 0.044 DBMET02446 | DBMET02449 | |
| 0.04 | 0.012 | 0.04 | Carboxypeptidase B inhibitor | 0.033 0.023 DB00988 0.033 0.023 DBMET02448 0.033 0.023 DBMET02449 0.032 0.025 DBMET02446 | ||
| 0.117 | 0.09 | 0.133 | Papain-like protease (SARS coronavirus) inhibitor | 0.13 0.061 DB00988 0.117 0.09 DBMET02439 0.127 0.065 DBMET02440 0.113 0.102 DBMET02443 0.133 0.055 DBMET02445 0.13 0.061 DBMET02441 0.133 0.055 DBMET02444 0.116 0.092 DBMET02447 0.125 0.07 DBMET02446 0.124 0.073 DBMET02442 | DBMET02444 | |
| 0.058 | 0.031 | 0.099 | Epithelial sodium channel blocker | 0.099 0.007 DB00988 0.075 0.015 DBMET02440 0.059 0.03 DBMET02443 0.066 0.021 DBMET02447 0.057 0.034 DBMET02446 | DB00988 | |
| 0.059 | 0.033 | 0.059 | Matrix metalloproteinase 1 inhibitor | 0.055 0.035 DBMET02439 | ||
| 0.142 | 0.117 | 0.202 | Lipocortins synthesis antagonist | 0.134 0.132 DBMET02447 0.202 0.055 DBMET02446 0.169 0.081 DBMET02442 | DBMET02446 | |
| 0.064 | 0.039 | 0.08 | Caspase 9 inhibitor | 0.08 0.023 DBMET02445 0.064 0.04 DBMET02441 0.063 0.041 DBMET02446 | DBMET02445 | |
| 0.078 | 0.053 | 0.13 | Na+ K+ transporting ATPase inhibitor | 0.111 0.022 DB00988 0.117 0.018 DBMET02448 0.117 0.018 DBMET02449 0.13 0.011 DBMET02451 0.13 0.011 DBMET02450 0.099 0.032 DBMET02440 0.119 0.017 DBMET02443 0.107 0.025 DBMET02445 0.094 0.037 DBMET02441 0.088 0.043 DBMET02444 0.11 0.023 DBMET02447 0.097 0.034 DBMET02446 0.079 0.051 DBMET02442 | DBMET02450 | |
| 0.134 | 0.109 | 0.183 | CF transmembrane conductance regulator agonist | 0.183 0.034 DB00988 0.13 0.118 DBMET02439 0.178 0.038 DBMET02440 0.144 0.087 DBMET02443 0.169 0.048 DBMET02445 0.165 0.053 DBMET02441 0.17 0.047 DBMET02447 0.167 0.05 DBMET02446 0.163 0.056 DBMET02442 | DB00988 | |
| 0.056 | 0.032 | 0.111 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.035 DBMET02447 0.111 0.007 DBMET02446 0.071 0.016 DBMET02442 | DBMET02446 | |
| 0.093 | 0.069 | 0.222 | Sphingomyelinase inhibitor | 0.186 0.013 DB00988 0.111 0.048 DBMET02439 0.162 0.02 DBMET02451 0.162 0.02 DBMET02450 0.209 0.008 DBMET02440 0.189 0.012 DBMET02443 0.099 0.06 DBMET02445 0.119 0.042 DBMET02441 0.222 0.006 DBMET02444 0.165 0.019 DBMET02447 0.116 0.044 DBMET02446 0.138 0.03 DBMET02442 | DBMET02444 | |
| 0.028 | 0.005 | 0.028 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DB00988 0.019 0.01 DBMET02445 0.021 0.008 DBMET02447 0.026 0.005 DBMET02446 | ||
| 0.043 | 0.019 | 0.043 | Glutamate (mGluR group II) agonist | |||
| 0.068 | 0.045 | 0.099 | MDM2 inhibitor | 0.071 0.037 DB00988 0.089 0.012 DBMET02447 0.099 0.007 DBMET02446 0.08 0.02 DBMET02442 | DBMET02446 | |
| 0.054 | 0.031 | 0.07 | Prolyl endopeptidase inhibitor | 0.048 0.04 DB00988 0.07 0.015 DBMET02445 0.053 0.032 DBMET02441 0.062 0.022 DBMET02447 0.058 0.027 DBMET02446 | DBMET02445 | |
| 0.029 | 0.006 | 0.029 | Integrin alphaVbeta1 antagonist | 0.019 0.013 DBMET02439 0.02 0.012 DBMET02446 | ||
| 0.029 | 0.006 | 0.03 | Isoleucine-tRNA ligase inhibitor | 0.024 0.013 DB00988 0.025 0.011 DBMET02439 0.03 0.005 DBMET02447 0.024 0.013 DBMET02446 | DBMET02447 | |
| 0.078 | 0.056 | 0.106 | Interferon agonist | 0.085 0.044 DB00988 0.074 0.063 DBMET02448 0.074 0.063 DBMET02449 0.096 0.032 DBMET02451 0.096 0.032 DBMET02450 0.09 0.039 DBMET02443 0.074 0.063 DBMET02445 0.078 0.055 DBMET02444 0.091 0.038 DBMET02447 0.106 0.024 DBMET02446 0.083 0.048 DBMET02442 | DBMET02446 | |
| 0.037 | 0.015 | 0.103 | Lysophosphatidic acid 2 receptor antagonist | 0.033 0.018 DBMET02439 0.032 0.019 DBMET02443 0.028 0.024 DBMET02444 0.046 0.01 DBMET02447 0.103 0.004 DBMET02446 0.088 0.005 DBMET02442 | DBMET02446 | |
| 0.058 | 0.036 | 0.058 | Kallikrein 1 inhibitor | |||
| 0.029 | 0.007 | 0.029 | Integrin alpha4beta1 antagonist | 0.023 0.008 DBMET02439 | ||
| 0.135 | 0.114 | 0.178 | Antipruritic | 0.154 0.09 DB00988 0.178 0.066 DBMET02447 0.135 0.114 DBMET02446 | DBMET02447 | |
| 0.037 | 0.015 | 0.11 | ATP citrate lysase inhibitor | 0.03 0.025 DB00988 0.038 0.015 DBMET02445 0.043 0.011 DBMET02447 0.11 0.003 DBMET02446 0.061 0.005 DBMET02442 | DBMET02446 | |
| 0.056 | 0.034 | 0.297 | Aldose reductase inhibitor | 0.049 0.04 DBMET02439 0.053 0.037 DBMET02448 0.053 0.037 DBMET02449 0.081 0.023 DBMET02451 0.081 0.023 DBMET02450 0.045 0.044 DBMET02445 0.081 0.023 DBMET02447 0.297 0.005 DBMET02446 0.229 0.006 DBMET02442 | DBMET02446 | |
| 0.033 | 0.011 | 0.033 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.017 DB00988 | ||
| 0.062 | 0.041 | 0.11 | Neuraminidase inhibitor | 0.066 0.037 DB00988 0.094 0.018 DBMET02448 0.094 0.018 DBMET02449 0.108 0.013 DBMET02451 0.108 0.013 DBMET02450 0.11 0.012 DBMET02443 0.065 0.037 DBMET02444 0.086 0.022 DBMET02447 0.054 0.052 DBMET02446 | DBMET02443 | |
| 0.073 | 0.052 | 0.1 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.1 0.014 DB00988 0.081 0.036 DBMET02440 0.082 0.034 DBMET02443 | DB00988 | |
| 0.029 | 0.008 | 0.103 | Beta 1 adrenoreceptor agonist | 0.047 0.004 DB00988 0.024 0.013 DBMET02439 0.021 0.019 DBMET02448 0.021 0.019 DBMET02449 0.036 0.005 DBMET02440 0.1 0.003 DBMET02443 0.103 0.003 DBMET02444 0.035 0.006 DBMET02447 0.033 0.007 DBMET02446 0.027 0.01 DBMET02442 | DBMET02444 | |
| 0.087 | 0.067 | 0.119 | Thioredoxin inhibitor | 0.089 0.063 DBMET02439 0.119 0.031 DBMET02451 0.119 0.031 DBMET02450 0.102 0.046 DBMET02446 0.101 0.047 DBMET02442 | DBMET02450 | |
| 0.042 | 0.021 | 0.743 | Cholecystokinin B agonist | 0.743 0.001 DBMET02448 0.743 0.001 DBMET02449 | DBMET02449 | |
| 0.105 | 0.085 | 0.275 | MAO inhibitor | 0.275 0.023 DB00988 0.105 0.086 DBMET02439 0.274 0.024 DBMET02440 0.218 0.036 DBMET02443 0.146 0.062 DBMET02444 0.19 0.044 DBMET02447 | DB00988 | |
| 0.045 | 0.025 | 0.066 | Sphingosine 1-phosphate receptor 1 agonist | 0.045 0.026 DB00988 0.046 0.024 DBMET02443 0.066 0.01 DBMET02447 0.062 0.012 DBMET02446 0.044 0.026 DBMET02442 | DBMET02447 | |
| 0.038 | 0.018 | 0.038 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.029 DBMET02439 | ||
| 0.045 | 0.026 | 0.045 | Cathepsin L2 inhibitor | |||
| 0.031 | 0.012 | 0.031 | Integrin alpha2beta1 antagonist | 0.031 0.012 DBMET02446 | ||
| 0.069 | 0.051 | 0.069 | Secretase beta inhibitor | 0.066 0.058 DBMET02444 | ||
| 0.087 | 0.069 | 0.222 | Uric acid excretion stimulant | 0.123 0.036 DBMET02451 0.123 0.036 DBMET02450 0.096 0.057 DBMET02445 0.143 0.025 DBMET02447 0.222 0.01 DBMET02446 0.153 0.022 DBMET02442 | DBMET02446 | |
| 0.09 | 0.072 | 0.172 | Interleukin 12 antagonist | 0.085 0.083 DB00988 0.093 0.066 DBMET02439 0.132 0.02 DBMET02451 0.132 0.02 DBMET02450 0.09 0.073 DBMET02440 0.172 0.008 DBMET02447 0.11 0.039 DBMET02446 0.11 0.04 DBMET02442 | DBMET02447 | |
| 0.045 | 0.028 | 0.045 | HIV-1 protease inhibitor | |||
| 0.046 | 0.03 | 0.068 | Neuraminidase (Influenza A) inhibitor | 0.053 0.02 DB00988 0.068 0.008 DBMET02451 0.068 0.008 DBMET02450 0.045 0.032 DBMET02440 0.056 0.016 DBMET02443 0.047 0.028 DBMET02447 | DBMET02450 | |
| 0.071 | 0.054 | 0.166 | Thrombin inhibitor | 0.084 0.038 DB00988 0.166 0.009 DBMET02448 0.166 0.009 DBMET02449 0.064 0.063 DBMET02440 0.067 0.06 DBMET02445 | DBMET02449 | |
| 0.055 | 0.039 | 0.061 | Sphingosine 1-phosphate receptor 1 antagonist | 0.061 0.028 DBMET02447 0.061 0.028 DBMET02446 | DBMET02446 | |
| 0.104 | 0.089 | 0.178 | Estrogen antagonist | 0.133 0.035 DB00988 0.117 0.06 DBMET02440 0.109 0.077 DBMET02443 0.159 0.02 DBMET02445 0.129 0.039 DBMET02441 0.111 0.072 DBMET02444 0.178 0.016 DBMET02447 0.153 0.022 DBMET02446 0.128 0.042 DBMET02442 | DBMET02447 | |
| 0.029 | 0.014 | 0.029 | Calcium-sensing receptor agonist | 0.027 0.017 DBMET02439 0.027 0.017 DBMET02446 0.025 0.021 DBMET02442 | ||
| 0.058 | 0.043 | 0.058 | Cathepsin E inhibitor | 0.054 0.05 DBMET02439 | ||
| 0.056 | 0.042 | 0.07 | Plasminogen activator inhibitor | 0.06 0.039 DB00988 0.07 0.032 DBMET02445 | DBMET02445 | |
| 0.048 | 0.034 | 0.135 | Plasminogen activator inhibitor antagonist | 0.046 0.037 DBMET02439 0.046 0.038 DBMET02447 0.135 0.005 DBMET02446 0.109 0.009 DBMET02442 | DBMET02446 | |
| 0.022 | 0.008 | 0.046 | Estrogen-related receptor gamma agonist | 0.042 0.003 DB00988 0.025 0.005 DBMET02440 0.019 0.011 DBMET02443 0.026 0.005 DBMET02445 0.017 0.016 DBMET02441 0.029 0.004 DBMET02444 0.046 0.003 DBMET02447 0.033 0.004 DBMET02446 0.021 0.009 DBMET02442 | DBMET02447 | |
| 0.102 | 0.088 | 0.306 | Acetylcholine muscarinic antagonist | 0.156 0.04 DB00988 0.125 0.062 DBMET02440 0.256 0.014 DBMET02443 0.306 0.009 DBMET02444 0.124 0.063 DBMET02447 | DBMET02444 | |
| 0.098 | 0.085 | 0.41 | Anesthetic local | 0.153 0.048 DB00988 0.092 0.091 DBMET02439 0.145 0.051 DBMET02440 0.254 0.019 DBMET02443 0.113 0.072 DBMET02445 0.106 0.077 DBMET02441 0.41 0.006 DBMET02444 0.174 0.04 DBMET02447 0.105 0.078 DBMET02446 0.099 0.084 DBMET02442 | DBMET02444 | |
| 0.04 | 0.027 | 0.057 | Dihydropteroate synthase inhibitor | 0.057 0.013 DB00988 0.037 0.031 DBMET02439 0.054 0.014 DBMET02440 0.045 0.021 DBMET02447 0.048 0.018 DBMET02446 0.045 0.021 DBMET02442 | DB00988 | |
| 0.025 | 0.012 | 0.025 | Integrin alphaVbeta3 antagonist | 0.022 0.015 DBMET02446 | ||
| 0.048 | 0.035 | 0.049 | Metalloproteinase-3 inhibitor | 0.049 0.034 DBMET02439 | DBMET02439 | |
| 0.026 | 0.013 | 0.026 | Aminopeptidase P inhibitor | |||
| 0.053 | 0.041 | 0.053 | Neuropeptide agonist | |||
| 0.206 | 0.194 | 0.69 | Toll-Like receptor agonist | 0.214 0.185 DBMET02439 0.266 0.134 DBMET02451 0.266 0.134 DBMET02450 0.418 0.053 DBMET02443 0.69 0.009 DBMET02444 0.524 0.027 DBMET02446 0.472 0.038 DBMET02442 | DBMET02444 | |
| 0.02 | 0.008 | 0.021 | Telomerase stimulant | 0.016 0.015 DB00988 0.021 0.006 DBMET02451 0.021 0.006 DBMET02450 0.016 0.015 DBMET02443 0.017 0.012 DBMET02447 0.019 0.009 DBMET02446 | DBMET02450 | |
| 0.025 | 0.013 | 0.025 | Neutral endopeptidase inhibitor | |||
| 0.043 | 0.032 | 0.053 | Dihydrofolate reductase inhibitor | 0.043 0.03 DB00988 0.051 0.018 DBMET02439 0.048 0.022 DBMET02448 0.048 0.022 DBMET02449 0.051 0.017 DBMET02440 0.041 0.037 DBMET02441 0.045 0.028 DBMET02446 0.053 0.016 DBMET02442 | DBMET02442 | |
| 0.023 | 0.012 | 0.024 | Integrin beta5 antagonist | 0.024 0.011 DBMET02446 | DBMET02446 | |
| 0.029 | 0.019 | 0.029 | Bradykinin B2 receptor agonist | |||
| 0.052 | 0.041 | 0.052 | Human rhinovirus A protease inhibitor | |||
| 0.023 | 0.013 | 0.03 | Vitronectin receptor antagonist | 0.03 0.01 DBMET02446 | DBMET02446 | |
| 0.022 | 0.013 | 0.027 | Neuraminidase (Influenza B) inhibitor | 0.027 0.006 DB00988 0.02 0.017 DBMET02440 0.024 0.009 DBMET02443 0.027 0.006 DBMET02447 0.022 0.013 DBMET02446 | DBMET02447 | |
| 0.048 | 0.039 | 0.063 | Factor III inhibitor | 0.053 0.028 DB00988 0.052 0.03 DBMET02439 0.063 0.015 DBMET02451 0.063 0.015 DBMET02450 0.056 0.022 DBMET02440 0.055 0.025 DBMET02443 0.048 0.039 DBMET02441 0.049 0.036 DBMET02447 0.048 0.039 DBMET02446 0.053 0.028 DBMET02442 | DBMET02450 | |
| 0.032 | 0.023 | 0.032 | Trypsin I inhibitor | |||
| 0.126 | 0.117 | 0.237 | Mcl-1 antagonist | 0.191 0.061 DBMET02447 0.237 0.04 DBMET02446 0.185 0.064 DBMET02442 | DBMET02446 | |
| 0.027 | 0.018 | 0.027 | Urotensin II agonist | |||
| 0.072 | 0.064 | 0.086 | Sphingosine 1-phosphate receptor antagonist | 0.086 0.036 DBMET02447 0.084 0.039 DBMET02446 | DBMET02447 | |
| 0.048 | 0.04 | 0.117 | Factor IXa inhibitor | 0.117 0.006 DBMET02448 0.117 0.006 DBMET02449 0.093 0.012 DBMET02451 0.093 0.012 DBMET02450 0.094 0.011 DBMET02443 0.054 0.033 DBMET02444 0.1 0.01 DBMET02447 | DBMET02449 | |
| 0.061 | 0.052 | 0.085 | Interferon inducer | 0.069 0.037 DB00988 0.062 0.049 DBMET02448 0.062 0.049 DBMET02449 0.077 0.026 DBMET02451 0.077 0.026 DBMET02450 0.073 0.031 DBMET02443 0.062 0.049 DBMET02444 0.074 0.03 DBMET02447 0.085 0.02 DBMET02446 0.066 0.042 DBMET02442 | DBMET02446 | |
| 0.038 | 0.03 | 0.08 | Leukotriene C4 antagonist | 0.037 0.033 DBMET02445 0.052 0.009 DBMET02447 0.08 0.004 DBMET02446 0.056 0.007 DBMET02442 | DBMET02446 | |
| 0.051 | 0.043 | 0.104 | Heparanase inhibitor | 0.051 0.044 DBMET02439 0.065 0.016 DBMET02448 0.065 0.016 DBMET02449 0.104 0.004 DBMET02451 0.104 0.004 DBMET02450 0.053 0.037 DBMET02445 0.053 0.038 DBMET02441 0.054 0.035 DBMET02447 0.084 0.005 DBMET02446 0.084 0.005 DBMET02442 | DBMET02450 | |
| 0.091 | 0.083 | 0.34 | AMP-activated protein kinase stimulant | 0.118 0.051 DB00988 0.34 0.004 DBMET02451 0.34 0.004 DBMET02450 0.106 0.062 DBMET02440 0.16 0.022 DBMET02447 0.2 0.011 DBMET02446 0.183 0.014 DBMET02442 | DBMET02450 | |
| 0.038 | 0.03 | 0.038 | Aggrecanase 1 inhibitor | |||
| 0.017 | 0.009 | 0.017 | Purinergic P2Y1 agonist | 0.014 0.013 DBMET02447 0.014 0.013 DBMET02446 | ||
| 0.018 | 0.011 | 0.018 | Angiotensin-converting enzyme 2 inhibitor | |||
| 0.087 | 0.08 | 0.161 | Electrolyte absorption antagonist | 0.098 0.06 DB00988 0.086 0.083 DBMET02443 0.092 0.071 DBMET02445 0.101 0.057 DBMET02447 0.161 0.016 DBMET02446 0.101 0.056 DBMET02442 | DBMET02446 | |
| 0.041 | 0.033 | 0.041 | Opioid kappa receptor agonist | |||
| 0.083 | 0.076 | 0.093 | Polo-like kinase-1 inhibitor | 0.093 0.056 DBMET02439 0.081 0.08 DBMET02440 0.083 0.076 DBMET02444 0.086 0.07 DBMET02447 | DBMET02439 | |
| 0.041 | 0.036 | 0.068 | Sphingosine 1-phosphate receptor agonist | 0.068 0.012 DBMET02447 0.067 0.013 DBMET02446 0.05 0.025 DBMET02442 | DBMET02447 | |
| 0.029 | 0.024 | 0.029 | Caspase 2 inhibitor | |||
| 0.022 | 0.017 | 0.092 | Dopamine D1 agonist | 0.064 0.004 DB00988 0.092 0.003 DBMET02448 0.092 0.003 DBMET02449 0.052 0.004 DBMET02451 0.052 0.004 DBMET02450 0.046 0.005 DBMET02440 0.026 0.012 DBMET02443 0.03 0.009 DBMET02445 0.023 0.016 DBMET02441 0.022 0.018 DBMET02444 0.027 0.011 DBMET02447 0.026 0.012 DBMET02446 0.021 0.02 DBMET02442 | DBMET02449 | |
| 0.032 | 0.027 | 0.044 | RNA-directed RNA polymerase inhibitor | 0.044 0.015 DBMET02446 | DBMET02446 | |
| 0.059 | 0.054 | 0.082 | Histone deacetylase SIRT3 inhibitor | 0.082 0.017 DB00988 0.06 0.049 DBMET02440 | DB00988 | |
| 0.051 | 0.046 | 0.098 | Xanthine dehydrogenase inhibitor | 0.098 0.016 DBMET02445 0.086 0.021 DBMET02441 0.086 0.021 DBMET02447 0.087 0.02 DBMET02446 0.077 0.026 DBMET02442 | DBMET02445 | |
| 0.017 | 0.012 | 0.024 | Ileal bile acid transport inhibitor | 0.019 0.01 DBMET02439 0.024 0.006 DBMET02451 0.024 0.006 DBMET02450 0.017 0.012 DBMET02443 0.023 0.007 DBMET02444 0.017 0.012 DBMET02446 0.019 0.01 DBMET02442 | DBMET02450 | |
| 0.043 | 0.038 | 0.043 | Glutamate (mGluR group I) agonist | |||
| 0.022 | 0.017 | 0.057 | Prostaglandin F2 alpha agonist | 0.027 0.01 DB00988 0.021 0.018 DBMET02443 0.024 0.013 DBMET02445 0.048 0.004 DBMET02447 0.057 0.004 DBMET02446 0.034 0.007 DBMET02442 | DBMET02446 | |
| 0.039 | 0.034 | 0.066 | Carbonic anhydrase IV inhibitor | 0.066 0.016 DB00988 0.038 0.036 DBMET02440 0.054 0.022 DBMET02447 0.039 0.034 DBMET02446 | DB00988 | |
| 0.032 | 0.028 | 0.101 | Phosphoglycerate kinase inhibitor | 0.09 0.008 DB00988 0.036 0.023 DBMET02439 0.096 0.007 DBMET02448 0.096 0.007 DBMET02449 0.038 0.021 DBMET02451 0.038 0.021 DBMET02450 0.101 0.007 DBMET02440 0.093 0.007 DBMET02443 0.035 0.025 DBMET02445 0.039 0.02 DBMET02441 0.046 0.016 DBMET02444 0.086 0.008 DBMET02447 0.049 0.014 DBMET02446 0.056 0.012 DBMET02442 | DBMET02440 | |
| 0.034 | 0.031 | 0.059 | Somatostatin 1 antagonist | 0.045 0.023 DB00988 0.059 0.015 DBMET02443 | DBMET02443 | |
| 0.038 | 0.034 | 0.046 | Growth hormone release inhibitor | 0.042 0.029 DB00988 0.046 0.025 DBMET02443 | DBMET02443 | |
| 0.026 | 0.022 | 0.026 | LFA antagonist | |||
| 0.031 | 0.028 | 0.082 | Free fatty acid receptor 1 antagonist | 0.03 0.029 DBMET02445 0.057 0.006 DBMET02447 0.082 0.004 DBMET02446 0.07 0.004 DBMET02442 | DBMET02446 | |
| 0.03 | 0.027 | 0.033 | Dipeptidyl peptidase II inhibitor | 0.033 0.021 DB00988 | DB00988 | |
| 0.026 | 0.023 | 0.026 | Motilin receptor antagonist | |||
| 0.036 | 0.033 | 0.061 | 5 Hydroxytryptamine 2B agonist | 0.061 0.008 DB00988 0.056 0.01 DBMET02440 | DB00988 | |
| 0.034 | 0.031 | 0.112 | Kinesin antagonist | 0.112 0.006 DB00988 0.065 0.013 DBMET02448 0.065 0.013 DBMET02449 0.043 0.019 DBMET02440 | DB00988 | |
| 0.034 | 0.031 | 0.112 | Kinesin-like protein 1 inhibitor | 0.112 0.006 DB00988 0.065 0.013 DBMET02448 0.065 0.013 DBMET02449 0.043 0.019 DBMET02440 | DB00988 | |
| 0.013 | 0.011 | 0.015 | Integrin alphaVbeta6 antagonist | 0.015 0.009 DBMET02446 | DBMET02446 | |
| 0.122 | 0.119 | 0.147 | Neuropeptide Y1 antagonist | 0.147 0.069 DB00988 0.143 0.077 DBMET02440 | DB00988 | |
| 0.028 | 0.026 | 0.039 | HCV NS5B polymerase inhibitor | 0.039 0.015 DBMET02446 | DBMET02446 | |
| 0.027 | 0.025 | 0.046 | Somatostatin 5 antagonist | 0.038 0.019 DB00988 0.046 0.015 DBMET02443 | DBMET02443 | |
| 0.045 | 0.044 | 0.045 | Collagenase inhibitor | |||
| 0.027 | 0.025 | 0.027 | Glutamate (mGluR2) antagonist | |||
| 0.056 | 0.054 | 0.099 | Prostaglandin F2 alpha antagonist | 0.099 0.012 DBMET02446 0.067 0.035 DBMET02442 | DBMET02446 | |
| 0.039 | 0.038 | 0.067 | Geranyltranstransferase inhibitor | 0.067 0.009 DB00988 0.043 0.032 DBMET02440 0.04 0.037 DBMET02443 0.061 0.013 DBMET02445 0.055 0.018 DBMET02447 0.057 0.016 DBMET02446 | DB00988 | |
| 0.061 | 0.061 | 0.098 | Elastase 1 inhibitor | 0.092 0.025 DBMET02445 0.074 0.042 DBMET02441 0.086 0.03 DBMET02447 0.098 0.021 DBMET02446 0.079 0.036 DBMET02442 | DBMET02446 | |
| 0.017 | 0.018 | 0.034 | Antibiotic Anthracycline-like | 0.021 0.01 DB00988 0.018 0.015 DBMET02439 0.034 0.003 DBMET02451 0.034 0.003 DBMET02450 0.021 0.009 DBMET02440 0.022 0.007 DBMET02443 0.018 0.015 DBMET02441 0.018 0.017 DBMET02444 0.028 0.004 DBMET02447 0.024 0.005 DBMET02446 0.025 0.005 DBMET02442 | DBMET02450 | |
| 0.088 | 0.088 | 0.159 | Estrogen receptor beta antagonist | 0.119 0.033 DB00988 0.103 0.059 DBMET02440 0.098 0.069 DBMET02443 0.159 0.014 DBMET02445 0.123 0.029 DBMET02441 0.095 0.074 DBMET02444 0.148 0.016 DBMET02447 0.132 0.022 DBMET02446 0.112 0.043 DBMET02442 | DBMET02445 | |
| 0.039 | 0.04 | 0.084 | Urokinase inhibitor | 0.078 0.022 DB00988 0.051 0.032 DBMET02440 0.084 0.02 DBMET02443 | DBMET02443 | |
| 0.023 | 0.024 | 0.066 | Uridine phosphorylase inhibitor | 0.043 0.01 DB00988 0.034 0.015 DBMET02451 0.034 0.015 DBMET02450 0.026 0.021 DBMET02440 0.037 0.013 DBMET02443 0.031 0.017 DBMET02445 0.066 0.005 DBMET02447 0.049 0.008 DBMET02446 0.032 0.017 DBMET02442 | DBMET02447 | |
| 0.143 | 0.144 | 0.412 | Hypolipemic | 0.242 0.071 DBMET02451 0.242 0.071 DBMET02450 0.171 0.117 DBMET02444 0.241 0.072 DBMET02447 0.412 0.023 DBMET02446 0.319 0.043 DBMET02442 | DBMET02446 | |
| 0.055 | 0.056 | 0.093 | Ryanodine receptor antagonist | 0.072 0.015 DB00988 0.063 0.029 DBMET02439 0.085 0.006 DBMET02440 0.059 0.041 DBMET02443 0.062 0.033 DBMET02445 0.072 0.015 DBMET02441 0.066 0.024 DBMET02447 0.078 0.01 DBMET02446 0.093 0.005 DBMET02442 | DBMET02442 | |
| 0.2 | 0.201 | 0.695 | Toll-Like receptor 7 agonist | 0.208 0.191 DBMET02439 0.241 0.155 DBMET02451 0.241 0.155 DBMET02450 0.412 0.055 DBMET02443 0.695 0.009 DBMET02444 0.53 0.026 DBMET02446 0.476 0.037 DBMET02442 | DBMET02444 | |
| 0.02 | 0.022 | 0.037 | NMDA receptor glycine site antagonist | 0.037 0.009 DBMET02446 | DBMET02446 | |
| 0.004 | 0.007 | 0.007 | Insulin like growth factor 3 antagonist | 0.006 0.004 DBMET02445 0.006 0.004 DBMET02447 0.007 0.004 DBMET02446 0.006 0.005 DBMET02442 | DBMET02446 | |
| 0.049 | 0.052 | 0.082 | Dihydroorotate oxidase inhibitor | 0.061 0.027 DB00988 0.058 0.033 DBMET02443 0.078 0.012 DBMET02445 0.051 0.048 DBMET02444 0.079 0.011 DBMET02447 0.082 0.009 DBMET02446 0.053 0.042 DBMET02442 | DBMET02446 | |
| 0.079 | 0.082 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.084 0.07 DB00988 0.095 0.047 DBMET02439 0.128 0.015 DBMET02451 0.128 0.015 DBMET02450 0.101 0.038 DBMET02440 0.097 0.043 DBMET02443 0.096 0.046 DBMET02441 0.096 0.045 DBMET02444 0.1 0.04 DBMET02447 0.103 0.036 DBMET02446 0.114 0.024 DBMET02442 | DBMET02450 | |
| 0.017 | 0.02 | 0.019 | Caspase 8 inhibitor | 0.019 0.015 DBMET02446 | DBMET02446 | |
| 0.127 | 0.131 | 0.214 | Amyloid beta precursor protein antagonist | 0.14 0.113 DBMET02439 0.134 0.12 DBMET02440 0.212 0.05 DBMET02445 0.21 0.051 DBMET02441 0.214 0.049 DBMET02447 0.177 0.074 DBMET02446 0.182 0.07 DBMET02442 | DBMET02447 | |
| 0.053 | 0.057 | 0.066 | Lipocortins synthesis agonist | 0.066 0.026 DBMET02451 0.066 0.026 DBMET02450 0.059 0.037 DBMET02447 0.056 0.046 DBMET02446 | DBMET02450 | |
| 0.191 | 0.196 | 0.335 | Calpain 2 inhibitor | 0.227 0.166 DBMET02443 0.335 0.094 DBMET02445 0.279 0.129 DBMET02441 0.318 0.103 DBMET02444 | DBMET02445 | |
| 0.011 | 0.015 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 DB00988 0.014 0.009 DBMET02440 0.015 0.006 DBMET02445 0.012 0.011 DBMET02441 0.015 0.006 DBMET02447 0.018 0.005 DBMET02446 0.014 0.007 DBMET02442 | DBMET02446 | |
| 0.037 | 0.042 | 0.106 | Plasmin inhibitor | 0.066 0.026 DB00988 0.106 0.017 DBMET02448 0.106 0.017 DBMET02449 0.059 0.028 DBMET02445 | DBMET02449 | |
| 0.031 | 0.036 | 0.054 | Ceramide glucosyltransferase inhibitor | 0.046 0.01 DBMET02443 0.054 0.005 DBMET02444 0.043 0.013 DBMET02447 | DBMET02444 | |
| 0.029 | 0.034 | 0.052 | Somatostatin 5 agonist | 0.052 0.012 DB00988 0.036 0.022 DBMET02440 0.035 0.024 DBMET02443 | DB00988 | |
| 0.028 | 0.034 | 0.122 | Retinoid X alpha receptor agonist | 0.048 0.015 DBMET02447 0.122 0.004 DBMET02446 0.08 0.007 DBMET02442 | DBMET02446 | |
| 0.019 | 0.025 | 0.054 | Prostaglandin H2 antagonist | 0.027 0.016 DB00988 0.033 0.01 DBMET02447 0.054 0.003 DBMET02446 0.046 0.004 DBMET02442 | DBMET02446 | |
| 0.029 | 0.035 | 0.105 | Calpain 1 inhibitor | 0.105 0.004 DBMET02445 0.049 0.005 DBMET02441 | DBMET02445 | |
| 0.008 | 0.014 | 0.073 | Beta 3 adrenoreceptor agonist | 0.01 0.009 DB00988 0.06 0.003 DBMET02443 0.073 0.003 DBMET02444 0.011 0.009 DBMET02447 0.015 0.005 DBMET02446 | DBMET02444 | |
| 0.042 | 0.049 | 0.085 | Topoisomerase II beta inhibitor | 0.054 0.028 DB00988 0.049 0.034 DBMET02440 0.056 0.025 DBMET02443 0.046 0.039 DBMET02445 0.072 0.016 DBMET02444 0.062 0.021 DBMET02447 0.085 0.012 DBMET02446 0.075 0.015 DBMET02442 | DBMET02446 | |
| 0.047 | 0.054 | 0.098 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.057 0.038 DB00988 0.054 0.043 DBMET02451 0.054 0.043 DBMET02450 0.065 0.03 DBMET02443 0.098 0.015 DBMET02445 0.057 0.038 DBMET02441 0.097 0.015 DBMET02447 0.08 0.02 DBMET02446 | DBMET02445 | |
| 0.012 | 0.019 | 0.018 | Integrin beta6 antagonist | 0.018 0.005 DBMET02446 0.014 0.009 DBMET02442 | DBMET02446 | |
| 0.021 | 0.028 | 0.037 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.02 DBMET02443 0.028 0.013 DBMET02447 0.037 0.007 DBMET02446 0.029 0.012 DBMET02442 | DBMET02446 | |
| 0.093 | 0.1 | 0.153 | Beta amyloid protein antagonist | 0.135 0.053 DB00988 0.112 0.076 DBMET02439 0.143 0.045 DBMET02451 0.143 0.045 DBMET02450 0.153 0.039 DBMET02440 0.116 0.071 DBMET02447 0.101 0.088 DBMET02446 0.122 0.066 DBMET02442 | DBMET02440 | |
| 0.017 | 0.026 | 0.044 | Lysophosphatidic acid 1 receptor antagonist | 0.04 0.004 DBMET02446 0.044 0.004 DBMET02442 | DBMET02442 | |
| 0.161 | 0.169 | 0.294 | 5 Hydroxytryptamine 3E antagonist | 0.294 0.005 DB00988 0.195 0.072 DBMET02448 0.195 0.072 DBMET02449 0.233 0.025 DBMET02440 0.198 0.066 DBMET02443 0.196 0.069 DBMET02445 0.212 0.045 DBMET02444 0.208 0.051 DBMET02447 0.173 0.125 DBMET02446 | DB00988 | |
| 0.007 | 0.016 | 0.023 | Thromboxane agonist | 0.023 0.004 DBMET02447 0.018 0.004 DBMET02446 | DBMET02447 | |
| 0.024 | 0.034 | 0.054 | Estrogen-related receptor gamma antagonist | 0.037 0.006 DB00988 0.029 0.017 DBMET02440 0.033 0.011 DBMET02443 0.032 0.013 DBMET02445 0.042 0.005 DBMET02444 0.054 0.003 DBMET02447 0.035 0.009 DBMET02446 0.027 0.023 DBMET02442 | DBMET02447 | |
| 0.004 | 0.014 | 0.008 | Integrin alpha5beta6 antagonist | 0.008 0.004 DBMET02446 | DBMET02446 | |
| 0.028 | 0.038 | 0.061 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.043 0.014 DB00988 0.032 0.028 DBMET02440 0.042 0.014 DBMET02447 0.061 0.006 DBMET02446 0.045 0.012 DBMET02442 | DBMET02446 | |
| 0.105 | 0.116 | 0.122 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.122 0.1 DB00988 | DB00988 | |
| 0.075 | 0.088 | 0.085 | T cell inhibitor | 0.085 0.049 DBMET02451 0.085 0.049 DBMET02450 | DBMET02450 | |
| 0.118 | 0.13 | 0.188 | GABA C receptor rho-2 antagonist | 0.172 0.049 DB00988 0.165 0.056 DBMET02440 0.131 0.104 DBMET02443 0.155 0.067 DBMET02445 0.149 0.075 DBMET02441 0.167 0.054 DBMET02444 0.18 0.042 DBMET02447 0.188 0.036 DBMET02446 0.181 0.042 DBMET02442 | DBMET02446 | |
| 0.046 | 0.058 | 0.092 | Thromboxane synthase inhibitor | 0.052 0.044 DB00988 0.066 0.021 DBMET02447 0.092 0.008 DBMET02446 0.07 0.018 DBMET02442 | DBMET02446 | |
| 0.054 | 0.066 | 0.141 | Leukotriene synthesis inhibitor | 0.066 0.048 DBMET02445 0.059 0.056 DBMET02441 0.082 0.036 DBMET02447 0.141 0.011 DBMET02446 0.12 0.017 DBMET02442 | DBMET02446 | |
| 0.124 | 0.137 | 0.321 | Tumour necrosis factor antagonist | 0.217 0.044 DB00988 0.2 0.054 DBMET02439 0.321 0.014 DBMET02440 0.169 0.078 DBMET02445 0.261 0.027 DBMET02441 0.14 0.113 DBMET02447 0.13 0.128 DBMET02446 0.207 0.049 DBMET02442 | DBMET02440 | |
| 0.031 | 0.044 | 0.076 | GABA uptake inhibitor | 0.045 0.02 DB00988 0.053 0.014 DBMET02445 0.076 0.005 DBMET02447 0.055 0.013 DBMET02446 | DBMET02447 | |
| 0.011 | 0.024 | 0.022 | Thromboxane A2 agonist | 0.016 0.009 DBMET02447 0.022 0.005 DBMET02446 | DBMET02446 | |
| 0.052 | 0.066 | 0.075 | Nitric oxide donor | 0.075 0.027 DBMET02451 0.075 0.027 DBMET02450 0.058 0.053 DBMET02447 0.057 0.054 DBMET02446 | DBMET02450 | |
| 0.015 | 0.03 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.011 DBMET02445 0.017 0.016 DBMET02447 0.019 0.011 DBMET02446 | DBMET02446 | |
| 0.027 | 0.042 | 0.241 | Peroxisome proliferator-activated receptor delta antagonist | 0.241 0.004 DBMET02446 0.133 0.005 DBMET02442 | DBMET02446 | |
| 0.028 | 0.043 | 0.034 | Factor VIIa inhibitor | 0.034 0.032 DB00988 | DB00988 | |
| 0.016 | 0.032 | 0.024 | Somatostatin 4 antagonist | 0.024 0.016 DBMET02443 | DBMET02443 | |
| 0.022 | 0.037 | 0.026 | Thrombin receptor antagonist | 0.026 0.023 DBMET02443 | DBMET02443 | |
| 0.034 | 0.049 | 0.046 | Plasmepsin II inhibitor | 0.043 0.025 DB00988 0.046 0.021 DBMET02440 0.042 0.028 DBMET02447 0.04 0.031 DBMET02442 | DBMET02440 | |
| 0.049 | 0.066 | 0.084 | Heat shock protein 90 beta antagonist | 0.084 0.018 DB00988 0.082 0.019 DBMET02440 0.054 0.052 DBMET02443 0.059 0.041 DBMET02447 | DB00988 | |
| 0.01 | 0.028 | 0.015 | Carbonic anhydrase VIII inhibitor | 0.015 0.014 DBMET02446 | DBMET02446 | |
| 0.01 | 0.028 | 0.015 | Carbonic anhydrase X inhibitor | 0.015 0.014 DBMET02446 | DBMET02446 | |
| 0.12 | 0.138 | 0.435 | Dual specificity phosphatase inhibitor | 0.14 0.107 DB00988 0.435 0.011 DBMET02448 0.435 0.011 DBMET02449 0.138 0.108 DBMET02440 0.127 0.126 DBMET02441 0.174 0.072 DBMET02447 0.324 0.025 DBMET02446 0.272 0.033 DBMET02442 | DBMET02449 | |
| 0.022 | 0.041 | 0.102 | Retinoid X receptor agonist | 0.048 0.019 DBMET02447 0.102 0.004 DBMET02446 0.071 0.01 DBMET02442 | DBMET02446 | |
| 0.009 | 0.027 | 0.095 | Peroxisome proliferator-activated receptor alpha antagonist | 0.025 0.013 DBMET02447 0.095 0.005 DBMET02446 0.056 0.008 DBMET02442 | DBMET02446 | |
| 0.01 | 0.029 | 0.769 | Cholecystokinin agonist | 0.769 0.002 DBMET02448 0.769 0.002 DBMET02449 | DBMET02449 | |
| 0.04 | 0.059 | 0.198 | Beta tubulin antagonist | 0.065 0.037 DB00988 0.109 0.02 DBMET02439 0.15 0.012 DBMET02440 0.105 0.021 DBMET02445 0.198 0.008 DBMET02441 0.091 0.025 DBMET02447 0.088 0.026 DBMET02446 0.178 0.009 DBMET02442 | DBMET02441 | |
| 0.012 | 0.031 | 0.018 | Vitamin D receptor agonist | 0.018 0.009 DBMET02447 0.018 0.008 DBMET02446 | DBMET02446 | |
| 0.018 | 0.038 | 0.035 | Glucagon receptor antagonist | 0.035 0.016 DBMET02446 | DBMET02446 | |
| 0.032 | 0.052 | 0.09 | Leukocyte elastase inhibitor | 0.09 0.011 DBMET02448 0.09 0.011 DBMET02449 0.046 0.027 DBMET02446 0.04 0.033 DBMET02442 | DBMET02449 | |
| 0.076 | 0.097 | 0.246 | ABCA1 expression enhancer | 0.128 0.026 DBMET02445 0.105 0.045 DBMET02441 0.143 0.019 DBMET02447 0.246 0.006 DBMET02446 0.181 0.012 DBMET02442 | DBMET02446 | |
| 0.009 | 0.03 | 0.743 | Cholecystokinin A agonist | 0.743 0.001 DBMET02448 0.743 0.001 DBMET02449 | DBMET02449 | |
| 0.073 | 0.094 | 0.181 | 3C-Like protease (SARS coronavirus) inhibitor | 0.181 0.005 DBMET02445 0.141 0.012 DBMET02441 | DBMET02445 | |
| 0.022 | 0.043 | 0.056 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 DB00988 0.056 0.002 DBMET02448 0.056 0.002 DBMET02449 0.033 0.008 DBMET02451 0.033 0.008 DBMET02450 0.039 0.004 DBMET02443 0.034 0.008 DBMET02444 | DBMET02449 | |
| 0.033 | 0.054 | 0.113 | Thromboxane A2 antagonist | 0.074 0.019 DBMET02447 0.113 0.005 DBMET02446 0.083 0.013 DBMET02442 | DBMET02446 | |
| 0.013 | 0.034 | 0.025 | Somatostatin 2 antagonist | 0.025 0.022 DBMET02443 | DBMET02443 | |
| 0.014 | 0.037 | 0.05 | Leukotriene B4 receptor 2 antagonist | 0.023 0.014 DBMET02451 0.023 0.014 DBMET02450 0.021 0.017 DBMET02447 0.05 0.004 DBMET02446 0.037 0.006 DBMET02442 | DBMET02446 | |
| 0.032 | 0.055 | 0.144 | Peroxisome proliferator-activated receptor alpha agonist | 0.074 0.02 DBMET02447 0.144 0.007 DBMET02446 0.133 0.008 DBMET02442 | DBMET02446 | |
| 0.034 | 0.057 | 0.046 | GABA B receptor antagonist | 0.046 0.025 DB00988 0.046 0.024 DBMET02446 | DBMET02446 | |
| 0.006 | 0.029 | 0.111 | Prostaglandin EP4 agonist | 0.014 0.011 DBMET02447 0.111 0.003 DBMET02446 0.052 0.005 DBMET02442 | DBMET02446 | |
| 0.016 | 0.039 | 0.066 | Leukotriene B4 receptor 1 antagonist | 0.036 0.014 DBMET02447 0.066 0.005 DBMET02446 0.051 0.007 DBMET02442 | DBMET02446 | |
| 0.048 | 0.072 | 0.075 | Pregnane X receptor antagonist | 0.055 0.046 DB00988 0.054 0.048 DBMET02440 0.057 0.04 DBMET02443 0.07 0.014 DBMET02445 0.07 0.014 DBMET02441 0.074 0.01 DBMET02447 0.075 0.009 DBMET02446 0.074 0.01 DBMET02442 | DBMET02446 | |
| 0.04 | 0.067 | 0.123 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.071 0.021 DB00988 0.051 0.042 DBMET02440 0.053 0.038 DBMET02443 0.087 0.013 DBMET02445 0.062 0.028 DBMET02441 0.123 0.007 DBMET02447 0.083 0.015 DBMET02446 0.059 0.031 DBMET02442 | DBMET02447 | |
| 0.035 | 0.062 | 0.127 | Thromboxane antagonist | 0.082 0.019 DBMET02447 0.127 0.006 DBMET02446 0.09 0.015 DBMET02442 | DBMET02446 | |
| 0.025 | 0.052 | 0.142 | Diamine oxidase inhibitor | 0.127 0.004 DB00988 0.119 0.004 DBMET02440 0.142 0.003 DBMET02443 0.128 0.004 DBMET02444 0.047 0.016 DBMET02447 | DBMET02443 | |
| 0.042 | 0.069 | 0.096 | Cathepsin B inhibitor | 0.096 0.018 DBMET02445 0.06 0.035 DBMET02441 | DBMET02445 | |
| 0.019 | 0.046 | 0.136 | Prostaglandin agonist | 0.064 0.008 DBMET02447 0.136 0.004 DBMET02446 0.071 0.007 DBMET02442 | DBMET02446 | |
| 0.015 | 0.043 | 0.024 | Retinoid X beta receptor antagonist | 0.024 0.008 DBMET02446 | DBMET02446 | |
| 0.006 | 0.034 | 0.012 | Lysophosphatidic acid receptor 3 agonist | 0.012 0.011 DBMET02447 | DBMET02447 | |
| 0.163 | 0.191 | 0.417 | Thyroid hormone beta antagonist | 0.182 0.172 DBMET02439 0.389 0.057 DBMET02446 0.417 0.049 DBMET02442 | DBMET02442 | |
| 0.088 | 0.116 | 0.352 | Tubulin antagonist | 0.11 0.091 DB00988 0.225 0.03 DBMET02439 0.287 0.021 DBMET02440 0.129 0.072 DBMET02445 0.327 0.016 DBMET02441 0.129 0.072 DBMET02447 0.161 0.053 DBMET02446 0.352 0.014 DBMET02442 | DBMET02442 | |
| 0.044 | 0.072 | 0.213 | Dopamine agonist | 0.213 0.009 DB00988 0.203 0.01 DBMET02448 0.203 0.01 DBMET02449 0.146 0.015 DBMET02440 0.206 0.009 DBMET02443 0.1 0.028 DBMET02444 0.081 0.037 DBMET02447 | DB00988 | |
| 0.016 | 0.045 | 0.062 | Sphingosine 1-phosphate receptor 3 agonist | 0.062 0.011 DBMET02447 0.034 0.025 DBMET02446 | DBMET02447 | |
| 0.011 | 0.04 | 0.053 | Prostaglandin EP2 agonist | 0.046 0.007 DBMET02447 0.053 0.005 DBMET02446 0.028 0.013 DBMET02442 | DBMET02446 | |
| 0.026 | 0.055 | 0.083 | Antibiotic Aminoglycoside-like | 0.034 0.029 DB00988 0.083 0.004 DBMET02451 0.083 0.004 DBMET02450 0.037 0.024 DBMET02443 | DBMET02450 | |
| 0.014 | 0.043 | 0.038 | Kynurenine 3 monooxygenase inhibitor | 0.038 0.011 DBMET02446 0.037 0.011 DBMET02442 | DBMET02446 | |
| 0.057 | 0.086 | 0.076 | Phospholipase D inhibitor | 0.076 0.042 DBMET02444 0.066 0.061 DBMET02447 0.069 0.055 DBMET02446 | DBMET02444 | |
| 0.127 | 0.156 | 0.277 | P-glycoprotein inhibitor | 0.179 0.081 DBMET02439 0.165 0.096 DBMET02451 0.165 0.096 DBMET02450 0.196 0.067 DBMET02440 0.171 0.088 DBMET02441 0.163 0.098 DBMET02444 0.228 0.049 DBMET02447 0.204 0.061 DBMET02446 0.277 0.034 DBMET02442 | DBMET02442 | |
| 0.018 | 0.048 | 0.043 | Protocollagen prolyl hydroxylase inhibitor | 0.043 0.007 DBMET02446 0.029 0.017 DBMET02442 | DBMET02446 | |
| 0.028 | 0.058 | 0.033 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.029 DBMET02446 | DBMET02446 | |
| 0.063 | 0.093 | 0.12 | Estrogen receptor alpha antagonist | 0.103 0.025 DB00988 0.083 0.044 DBMET02440 0.073 0.061 DBMET02443 0.099 0.028 DBMET02445 0.08 0.048 DBMET02441 0.07 0.068 DBMET02444 0.12 0.019 DBMET02447 0.111 0.022 DBMET02446 0.088 0.038 DBMET02442 | DBMET02447 | |
| 0.066 | 0.098 | 0.166 | MAO A inhibitor | 0.143 0.043 DB00988 0.144 0.043 DBMET02440 0.087 0.074 DBMET02443 0.12 0.053 DBMET02444 0.166 0.037 DBMET02447 | DBMET02447 | |
| 0.027 | 0.059 | 0.062 | Retinoid X receptor antagonist | 0.037 0.027 DBMET02447 0.062 0.005 DBMET02446 0.048 0.014 DBMET02442 | DBMET02446 | |
| 0.006 | 0.039 | 0.036 | G-protein-coupled receptor 120 agonist | 0.023 0.008 DBMET02447 0.036 0.004 DBMET02446 0.028 0.005 DBMET02442 | DBMET02446 | |
| 0.015 | 0.048 | 0.066 | Protein 30S ribosomal subunit inhibitor | 0.066 0.005 DBMET02451 0.066 0.005 DBMET02450 | DBMET02450 | |
| 0.015 | 0.049 | 0.025 | Endothelin receptor antagonist | 0.025 0.023 DBMET02442 | DBMET02442 | |
| 0.028 | 0.062 | 0.057 | Guanylate cyclase inhibitor | 0.04 0.033 DBMET02451 0.04 0.033 DBMET02450 0.057 0.014 DBMET02447 0.057 0.014 DBMET02446 0.05 0.021 DBMET02442 | DBMET02446 | |
| 0.036 | 0.07 | 0.05 | Heme oxygenase inhibitor | 0.043 0.029 DB00988 0.046 0.02 DBMET02443 0.043 0.028 DBMET02445 0.041 0.038 DBMET02444 0.05 0.014 DBMET02447 0.048 0.016 DBMET02446 0.041 0.039 DBMET02442 | DBMET02447 | |
| 0.02 | 0.054 | 0.039 | Purinergic P2Y15 antagonist | 0.035 0.01 DB00988 0.029 0.019 DBMET02440 0.039 0.008 DBMET02443 0.032 0.014 DBMET02444 | DBMET02443 | |
| 0.085 | 0.12 | 0.325 | Cholinergic antagonist | 0.148 0.053 DB00988 0.115 0.078 DBMET02440 0.262 0.019 DBMET02443 0.325 0.012 DBMET02444 0.13 0.065 DBMET02447 | DBMET02444 | |
| 0.011 | 0.046 | 0.097 | Prostaglandin E2 agonist | 0.04 0.007 DBMET02447 0.097 0.004 DBMET02446 0.042 0.007 DBMET02442 | DBMET02446 | |
| 0.018 | 0.053 | 0.049 | Prostaglandin D2 agonist | 0.029 0.024 DBMET02443 0.049 0.008 DBMET02446 0.039 0.013 DBMET02442 | DBMET02446 | |
| 0.083 | 0.119 | 0.315 | Acetylcholine antagonist | 0.145 0.053 DB00988 0.113 0.077 DBMET02440 0.258 0.019 DBMET02443 0.315 0.013 DBMET02444 0.125 0.066 DBMET02447 | DBMET02444 | |
| 0.02 | 0.056 | 0.064 | Nicotinic acid receptor agonist | 0.054 0.013 DBMET02447 0.064 0.01 DBMET02446 | DBMET02446 | |
| 0.042 | 0.078 | 0.058 | Collagenase 3 inhibitor | 0.058 0.044 DBMET02446 0.056 0.048 DBMET02442 | DBMET02446 | |
| 0.021 | 0.058 | 0.03 | Hedgehog signaling activator | 0.027 0.02 DB00988 0.028 0.018 DBMET02440 0.026 0.024 DBMET02441 0.03 0.013 DBMET02447 0.027 0.02 DBMET02446 0.028 0.019 DBMET02442 | DBMET02447 | |
| 0.023 | 0.06 | 0.032 | Angiotensin II receptor antagonist | 0.032 0.028 DBMET02446 | DBMET02446 | |
| 0.034 | 0.072 | 0.211 | Alpha tubulin antagonist | 0.072 0.023 DB00988 0.068 0.025 DBMET02439 0.151 0.009 DBMET02440 0.124 0.012 DBMET02445 0.211 0.005 DBMET02441 0.095 0.016 DBMET02447 0.107 0.014 DBMET02446 0.193 0.006 DBMET02442 | DBMET02441 | |
| 0.05 | 0.089 | 0.159 | Potassium channel large-conductance Ca-activated activator | 0.159 0.01 DBMET02447 0.152 0.01 DBMET02446 0.103 0.022 DBMET02442 | DBMET02447 | |
| 0.024 | 0.062 | 0.052 | Retinoid X alpha receptor antagonist | 0.032 0.029 DBMET02447 0.052 0.005 DBMET02446 0.04 0.015 DBMET02442 | DBMET02446 | |
| 0.037 | 0.077 | 0.064 | CXC chemokine 1 receptor antagonist | 0.064 0.017 DBMET02446 0.047 0.043 DBMET02442 | DBMET02446 | |
| 0.013 | 0.053 | 0.055 | Leukotriene D4 antagonist | 0.055 0.009 DBMET02446 0.026 0.018 DBMET02442 | DBMET02446 | |
| 0.016 | 0.056 | 0.384 | Cholecystokinin A antagonist | 0.384 0.003 DBMET02448 0.384 0.003 DBMET02449 | DBMET02449 | |
| 0.064 | 0.105 | 0.089 | Falcipain inhibitor | 0.089 0.063 DBMET02451 0.089 0.063 DBMET02450 0.082 0.071 DBMET02445 | DBMET02450 | |
| 0.03 | 0.07 | 0.043 | Dihydroorotase inhibitor | 0.04 0.039 DBMET02447 0.043 0.034 DBMET02446 | DBMET02446 | |
| 0.038 | 0.079 | 0.271 | Acetylcholine M3 receptor antagonist | 0.094 0.02 DB00988 0.067 0.034 DBMET02440 0.155 0.01 DBMET02443 0.271 0.004 DBMET02444 0.066 0.035 DBMET02447 | DBMET02444 | |
| 0.025 | 0.067 | 0.089 | Carbonic anhydrase VII inhibitor | 0.089 0.011 DB00988 0.042 0.038 DBMET02448 0.042 0.038 DBMET02449 0.057 0.021 DBMET02451 0.057 0.021 DBMET02450 0.086 0.011 DBMET02440 0.049 0.029 DBMET02445 0.048 0.03 DBMET02441 0.066 0.016 DBMET02447 0.05 0.028 DBMET02446 0.049 0.029 DBMET02442 | DB00988 | |
| 0.006 | 0.048 | 0.034 | Egl nine homolog 1 inhibitor | 0.034 0.004 DBMET02446 0.017 0.007 DBMET02442 | DBMET02446 | |
| 0.035 | 0.078 | 0.051 | Cathepsin L inhibitor | 0.051 0.05 DB00988 | DB00988 | |
| 0.006 | 0.049 | 0.074 | Free fatty acid receptor 1 agonist | 0.074 0.004 DBMET02446 0.032 0.006 DBMET02442 | DBMET02446 | |
| 0.061 | 0.105 | 0.086 | Falcipain 2 inhibitor | 0.086 0.063 DBMET02451 0.086 0.063 DBMET02450 | DBMET02450 | |
| 0.01 | 0.055 | 0.047 | Retinoid X beta receptor agonist | 0.047 0.005 DBMET02446 0.025 0.011 DBMET02442 | DBMET02446 | |
| 0.048 | 0.093 | 0.079 | Protein kinase C beta inhibitor | 0.079 0.032 DB00988 0.071 0.046 DBMET02443 0.076 0.037 DBMET02444 0.078 0.032 DBMET02447 | DB00988 | |
| 0.07 | 0.115 | 0.091 | CC chemokine 5 receptor agonist | 0.091 0.035 DB00988 0.079 0.068 DBMET02448 0.079 0.068 DBMET02449 0.085 0.049 DBMET02445 0.086 0.046 DBMET02447 0.083 0.055 DBMET02446 | DB00988 | |
| 0.025 | 0.071 | 0.156 | Liver X receptor alpha agonist | 0.081 0.007 DBMET02447 0.156 0.004 DBMET02446 0.126 0.004 DBMET02442 | DBMET02446 | |
| 0.017 | 0.063 | 0.098 | Liver X receptor alpha antagonist | 0.039 0.01 DBMET02447 0.098 0.004 DBMET02446 0.059 0.005 DBMET02442 | DBMET02446 | |
| 0.011 | 0.057 | 0.3 | Cholecystokinin B antagonist | 0.3 0.004 DBMET02448 0.3 0.004 DBMET02449 | DBMET02449 | |
| 0.015 | 0.062 | 0.312 | Cholecystokinin antagonist | 0.312 0.004 DBMET02448 0.312 0.004 DBMET02449 | DBMET02449 | |
| 0.163 | 0.21 | 0.248 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.248 0.109 DB00988 0.242 0.114 DBMET02440 | DB00988 | |
| 0.03 | 0.077 | 0.042 | Microtubule stabilization | 0.042 0.038 DBMET02451 0.042 0.038 DBMET02450 | DBMET02450 | |
| 0.046 | 0.093 | 0.083 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.076 0.022 DB00988 0.06 0.044 DBMET02440 0.083 0.018 DBMET02445 0.064 0.036 DBMET02441 0.071 0.027 DBMET02447 0.075 0.023 DBMET02446 0.059 0.045 DBMET02442 | DBMET02445 | |
| 0.008 | 0.056 | 0.016 | Adenosine A2 receptor agonist | 0.015 0.014 DB00988 0.016 0.012 DBMET02447 | DBMET02447 | |
| 0.119 | 0.168 | 0.218 | 3C-like protease (Human coronavirus) inhibitor | 0.216 0.043 DBMET02445 0.218 0.042 DBMET02441 0.142 0.115 DBMET02447 0.137 0.126 DBMET02446 0.138 0.124 DBMET02442 | DBMET02441 | |
| 0.063 | 0.113 | 0.27 | Topoisomerase I inhibitor | 0.134 0.048 DB00988 0.087 0.083 DBMET02448 0.087 0.083 DBMET02449 0.27 0.014 DBMET02451 0.27 0.014 DBMET02450 0.146 0.043 DBMET02440 0.118 0.057 DBMET02447 0.099 0.071 DBMET02442 | DBMET02450 | |
| 0.049 | 0.099 | 0.192 | Topoisomerase II alpha inhibitor | 0.08 0.053 DB00988 0.192 0.016 DBMET02451 0.192 0.016 DBMET02450 0.099 0.04 DBMET02440 0.068 0.064 DBMET02443 0.094 0.043 DBMET02445 0.11 0.034 DBMET02441 0.158 0.022 DBMET02447 0.075 0.057 DBMET02446 0.096 0.042 DBMET02442 | DBMET02450 | |
| 0.035 | 0.085 | 0.071 | Protein kinase C eta inhibitor | 0.059 0.035 DBMET02443 0.071 0.028 DBMET02444 | DBMET02444 | |
| 0.016 | 0.067 | 0.076 | 5-Alpha-reductase inhibitor | 0.033 0.031 DBMET02447 0.076 0.013 DBMET02446 0.043 0.022 DBMET02442 | DBMET02446 | |
| 0.062 | 0.113 | 0.831 | Bronchodilator | 0.165 0.027 DB00988 0.116 0.047 DBMET02439 0.117 0.047 DBMET02451 0.117 0.047 DBMET02450 0.212 0.017 DBMET02440 0.709 0.004 DBMET02443 0.105 0.058 DBMET02445 0.169 0.025 DBMET02441 0.831 0.003 DBMET02444 0.211 0.017 DBMET02447 0.156 0.03 DBMET02446 0.205 0.017 DBMET02442 | DBMET02444 | |
| 0.035 | 0.087 | 0.088 | Squalene epoxidase inhibitor | 0.071 0.013 DB00988 0.051 0.032 DBMET02440 0.057 0.023 DBMET02443 0.058 0.022 DBMET02445 0.067 0.015 DBMET02444 0.088 0.007 DBMET02447 0.065 0.017 DBMET02446 0.047 0.04 DBMET02442 | DBMET02447 | |
| 0.009 | 0.061 | 0.028 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.02 0.018 DB00988 0.028 0.013 DBMET02445 0.021 0.017 DBMET02447 0.023 0.015 DBMET02446 | DBMET02445 | |
| 0.011 | 0.062 | 0.045 | Retinoid X gamma receptor agonist | 0.045 0.006 DBMET02446 0.025 0.014 DBMET02442 | DBMET02446 | |
| 0.024 | 0.076 | 0.042 | Angiotensin AT1 receptor antagonist | 0.042 0.029 DBMET02446 | DBMET02446 | |
| 0.029 | 0.082 | 0.096 | Adenylate cyclase 1 inhibitor | 0.096 0.005 DB00988 0.076 0.01 DBMET02440 0.045 0.033 DBMET02443 0.052 0.024 DBMET02445 0.073 0.011 DBMET02447 0.064 0.015 DBMET02446 0.044 0.036 DBMET02442 | DB00988 | |
| 0.013 | 0.066 | 0.088 | Liver X receptor beta antagonist | 0.058 0.006 DBMET02447 0.088 0.004 DBMET02446 0.063 0.005 DBMET02442 | DBMET02446 | |
| 0.044 | 0.097 | 0.065 | I kappa B kinase 2 inhibitor | 0.065 0.039 DB00988 | DB00988 | |
| 0.052 | 0.106 | 0.082 | Exportin-1 inhibitor | 0.073 0.037 DB00988 0.067 0.05 DBMET02440 0.082 0.023 DBMET02443 0.072 0.038 DBMET02445 0.067 0.051 DBMET02441 0.065 0.056 DBMET02447 0.075 0.034 DBMET02446 0.069 0.046 DBMET02442 | DBMET02443 | |
| 0.053 | 0.107 | 0.117 | Protein kinase A inhibitor | 0.117 0.035 DB00988 0.077 0.063 DBMET02440 0.071 0.07 DBMET02443 | DB00988 | |
| 0.015 | 0.069 | 0.083 | Sodium/glucose cotransporter inhibitor | 0.083 0.003 DBMET02451 0.083 0.003 DBMET02450 0.024 0.021 DBMET02445 0.064 0.004 DBMET02447 0.025 0.019 DBMET02446 | DBMET02450 | |
| 0.01 | 0.064 | 0.046 | Squalene synthetase inhibitor | 0.031 0.023 DBMET02451 0.031 0.023 DBMET02450 0.046 0.016 DBMET02446 0.035 0.02 DBMET02442 | DBMET02446 | |
| 0.05 | 0.104 | 0.196 | CYP2A6 inhibitor | 0.196 0.008 DB00988 0.138 0.02 DBMET02440 0.067 0.064 DBMET02443 | DB00988 | |
| 0.013 | 0.067 | 0.065 | Prostaglandin EP4 antagonist | 0.023 0.022 DBMET02447 0.065 0.006 DBMET02446 0.039 0.011 DBMET02442 | DBMET02446 | |
| 0.002 | 0.057 | 0.008 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.005 DBMET02447 | DBMET02447 | |
| 0.006 | 0.061 | 0.014 | Prostacyclin agonist | 0.014 0.013 DBMET02446 | DBMET02446 | |
| 0.007 | 0.062 | 0.067 | Estrogen receptor alpha agonist | 0.029 0.027 DB00988 0.045 0.019 DBMET02445 0.067 0.014 DBMET02447 0.045 0.019 DBMET02446 | DBMET02447 | |
| 0.046 | 0.101 | 0.078 | Histone deacetylase SIRT2 inhibitor | 0.078 0.047 DB00988 | DB00988 | |
| 0.03 | 0.086 | 0.236 | Prostaglandin EP2 antagonist | 0.058 0.043 DBMET02447 0.236 0.005 DBMET02446 0.173 0.008 DBMET02442 | DBMET02446 | |
| 0.008 | 0.064 | 0.114 | Estrogen receptor beta agonist | 0.114 0.01 DBMET02448 0.114 0.01 DBMET02449 0.048 0.02 DBMET02445 0.106 0.011 DBMET02447 0.04 0.021 DBMET02446 | DBMET02449 | |
| 0.017 | 0.073 | 0.025 | Retinoid X gamma receptor antagonist | 0.025 0.024 DBMET02446 | DBMET02446 | |
| 0.058 | 0.115 | 0.073 | Vanilloid 4 agonist | 0.07 0.065 DBMET02447 0.073 0.056 DBMET02446 | DBMET02446 | |
| 0.014 | 0.071 | 0.104 | Peroxisome proliferator-activated receptor delta agonist | 0.039 0.018 DBMET02447 0.104 0.005 DBMET02446 0.092 0.006 DBMET02442 | DBMET02446 | |
| 0.014 | 0.071 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.031 0.011 DBMET02447 0.034 0.008 DBMET02446 | DBMET02446 | |
| 0.086 | 0.143 | 0.156 | Nav1.2 sodium channel blocker | 0.156 0.054 DB00988 0.136 0.067 DBMET02448 0.136 0.067 DBMET02449 0.131 0.071 DBMET02440 | DB00988 | |
| 0.024 | 0.082 | 0.047 | Retinoic acid alpha receptor agonist | 0.047 0.017 DBMET02447 | DBMET02447 | |
| 0.04 | 0.098 | 0.201 | Antineoplastic antibiotic | 0.201 0.021 DBMET02451 0.201 0.021 DBMET02450 0.072 0.063 DBMET02445 0.072 0.064 DBMET02441 | DBMET02450 | |
| 0.048 | 0.106 | 0.06 | Heme oxygenase stimulant | 0.059 0.049 DBMET02444 0.06 0.046 DBMET02446 | DBMET02446 | |
| 0.019 | 0.078 | 0.199 | Estrogen agonist | 0.199 0.008 DBMET02448 0.199 0.008 DBMET02449 0.05 0.035 DBMET02451 0.05 0.035 DBMET02450 0.053 0.034 DBMET02445 0.113 0.015 DBMET02447 0.077 0.024 DBMET02446 0.046 0.038 DBMET02442 | DBMET02449 | |
| 0.014 | 0.073 | 0.037 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.037 0.023 DBMET02445 0.035 0.025 DBMET02447 0.035 0.024 DBMET02446 | DBMET02445 | |
| 0.019 | 0.078 | 0.08 | Estradiol 17 beta-dehydrogenase inhibitor | 0.038 0.033 DB00988 0.052 0.023 DBMET02445 0.045 0.028 DBMET02441 0.08 0.013 DBMET02447 0.058 0.02 DBMET02446 0.051 0.024 DBMET02442 | DBMET02447 | |
| 0.019 | 0.079 | 0.031 | HMG CoA reductase inhibitor | 0.031 0.03 DBMET02446 | DBMET02446 | |
| 0.028 | 0.089 | 0.24 | Protein 50S ribosomal subunit inhibitor | 0.103 0.012 DBMET02451 0.103 0.012 DBMET02450 0.24 0.004 DBMET02445 0.172 0.005 DBMET02441 | DBMET02445 | |
| 0.029 | 0.091 | 0.087 | 5 Hydroxytryptamine 2 agonist | 0.087 0.013 DB00988 0.082 0.014 DBMET02440 | DB00988 | |
| 0.03 | 0.093 | 0.073 | Diacylglycerol O-acyltransferase inhibitor | 0.073 0.018 DBMET02446 | DBMET02446 | |
| 0.009 | 0.075 | 0.026 | 5-Alpha-reductase 2 inhibitor | 0.026 0.01 DBMET02446 | DBMET02446 | |
| 0.066 | 0.132 | 0.271 | Topoisomerase II inhibitor | 0.113 0.073 DB00988 0.271 0.021 DBMET02451 0.271 0.021 DBMET02450 0.13 0.06 DBMET02440 0.102 0.084 DBMET02443 0.102 0.084 DBMET02441 0.097 0.089 DBMET02444 0.139 0.055 DBMET02447 0.095 0.091 DBMET02446 0.116 0.07 DBMET02442 | DBMET02450 | |
| 0.023 | 0.089 | 0.112 | Carbonic anhydrase I inhibitor | 0.057 0.037 DB00988 0.112 0.015 DBMET02448 0.112 0.015 DBMET02449 0.051 0.043 DBMET02447 | DBMET02449 | |
| 0.004 | 0.07 | 0.011 | Egl nine homolog 3 inhibitor | 0.011 0.01 DBMET02446 | DBMET02446 | |
| 0.018 | 0.084 | 0.099 | Urate transporter 1 inhibitor | 0.099 0.005 DBMET02446 0.076 0.009 DBMET02442 | DBMET02446 | |
| 0.026 | 0.092 | 0.048 | Thymidine kinase inhibitor | 0.048 0.02 DBMET02447 | DBMET02447 | |
| 0.064 | 0.131 | 0.117 | Protein kinase (CK2) alpha inhibitor | 0.117 0.064 DBMET02446 0.093 0.084 DBMET02442 | DBMET02446 | |
| 0.022 | 0.089 | 0.033 | Tubulin agonist | 0.033 0.027 DBMET02442 | DBMET02442 | |
| 0.015 | 0.083 | 0.063 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.031 0.023 DBMET02445 0.063 0.008 DBMET02447 0.034 0.02 DBMET02446 0.03 0.024 DBMET02442 | DBMET02447 | |
| 0.011 | 0.079 | 0.093 | Sodium/glucose cotransporter 2 inhibitor | 0.093 0.003 DBMET02451 0.093 0.003 DBMET02450 0.027 0.017 DBMET02445 0.08 0.004 DBMET02447 0.027 0.017 DBMET02446 0.024 0.023 DBMET02442 | DBMET02450 | |
| 0.046 | 0.114 | 0.062 | Bcl-xL inhibitor | 0.062 0.035 DBMET02447 | DBMET02447 | |
| 0.073 | 0.143 | 0.343 | Cyclooxygenase 1 inhibitor | 0.177 0.045 DBMET02447 0.343 0.01 DBMET02446 0.295 0.015 DBMET02442 | DBMET02446 | |
| 0.011 | 0.081 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.015 DBMET02447 | DBMET02447 | |
| 0.005 | 0.079 | 0.505 | Prostaglandin D2 antagonist | 0.505 0.003 DBMET02446 0.331 0.003 DBMET02442 | DBMET02446 | |
| 0.048 | 0.123 | 0.076 | Transcription factor RelA inhibitor | 0.067 0.035 DB00988 0.076 0.021 DBMET02440 0.06 0.054 DBMET02443 0.062 0.048 DBMET02445 0.071 0.029 DBMET02441 0.06 0.054 DBMET02447 0.062 0.049 DBMET02446 0.07 0.03 DBMET02442 | DBMET02440 | |
| 0.016 | 0.091 | 0.05 | Carnitine palmitoyltransferase inhibitor | 0.047 0.01 DBMET02446 0.05 0.008 DBMET02442 | DBMET02442 | |
| 0.016 | 0.092 | 0.029 | Thymidine phosphorylase inhibitor | 0.029 0.013 DBMET02447 | DBMET02447 | |
| 0.022 | 0.098 | 0.043 | Melanocortin antagonist | 0.043 0.038 DB00988 | DB00988 | |
| 0.069 | 0.146 | 0.303 | Beta glucuronidase inhibitor | 0.102 0.067 DB00988 0.303 0.006 DBMET02451 0.303 0.006 DBMET02450 0.104 0.064 DBMET02440 0.102 0.067 DBMET02443 0.145 0.027 DBMET02445 0.148 0.026 DBMET02441 0.137 0.032 DBMET02447 0.12 0.046 DBMET02446 0.123 0.043 DBMET02442 | DBMET02450 | |
| 0.02 | 0.098 | 0.101 | Carbonic anhydrase II inhibitor | 0.058 0.037 DB00988 0.101 0.018 DBMET02448 0.101 0.018 DBMET02449 0.059 0.036 DBMET02447 | DBMET02449 | |
| 0.016 | 0.096 | 0.049 | Carnitine palmitoyltransferase 1 inhibitor | 0.046 0.01 DBMET02446 0.049 0.008 DBMET02442 | DBMET02442 | |
| 0.022 | 0.102 | 0.073 | Histamine H2 receptor agonist | 0.073 0.009 DB00988 0.043 0.03 DBMET02440 0.04 0.034 DBMET02443 0.05 0.022 DBMET02444 | DB00988 | |
| 0.024 | 0.106 | 0.066 | Phenylethanolamine N methyltransferase inhibitor | 0.043 0.023 DB00988 0.066 0.005 DBMET02443 | DBMET02443 | |
| 0.025 | 0.108 | 0.215 | Carbonic anhydrase inhibitor | 0.062 0.044 DB00988 0.215 0.008 DBMET02448 0.215 0.008 DBMET02449 0.058 0.048 DBMET02451 0.058 0.048 DBMET02450 0.075 0.037 DBMET02447 | DBMET02449 | |
| 0.01 | 0.095 | 0.019 | Retinoic acid beta receptor agonist | 0.019 0.014 DBMET02447 | DBMET02447 | |
| 0.031 | 0.116 | 0.051 | Cytokine production stimulant | 0.048 0.033 DBMET02451 0.048 0.033 DBMET02450 0.046 0.042 DBMET02443 0.051 0.026 DBMET02447 | DBMET02447 | |
| 0.069 | 0.154 | 0.25 | Multidrug resistance-associated protein 1 inhibitor | 0.101 0.076 DBMET02439 0.25 0.005 DBMET02448 0.25 0.005 DBMET02449 0.124 0.044 DBMET02451 0.124 0.044 DBMET02450 0.123 0.045 DBMET02440 0.103 0.073 DBMET02441 0.105 0.07 DBMET02447 0.122 0.046 DBMET02446 0.149 0.025 DBMET02442 | DBMET02449 | |
| 0.017 | 0.102 | 0.037 | Tryptase inhibitor | 0.037 0.026 DB00988 | DB00988 | |
| 0.049 | 0.136 | 0.106 | Calcium channel P-type blocker | 0.078 0.017 DB00988 0.06 0.057 DBMET02439 0.106 0.005 DBMET02440 0.061 0.053 DBMET02445 0.078 0.017 DBMET02441 0.079 0.016 DBMET02447 0.066 0.037 DBMET02446 0.086 0.011 DBMET02442 | DBMET02440 | |
| 0.019 | 0.107 | 0.051 | Estrogen-related receptor beta antagonist | 0.051 0.005 DBMET02447 | DBMET02447 | |
| 0.012 | 0.1 | 0.098 | Liver X receptor antagonist | 0.036 0.016 DBMET02447 0.098 0.005 DBMET02446 0.059 0.008 DBMET02442 | DBMET02446 | |
| 0.131 | 0.219 | 0.349 | 5 Hydroxytryptamine 1E antagonist | 0.349 0.01 DB00988 0.222 0.106 DBMET02448 0.222 0.106 DBMET02449 0.348 0.01 DBMET02440 0.251 0.074 DBMET02443 0.225 0.102 DBMET02445 0.223 0.104 DBMET02441 0.28 0.045 DBMET02444 0.206 0.125 DBMET02447 0.198 0.133 DBMET02446 0.196 0.135 DBMET02442 | DB00988 | |
| 0.082 | 0.171 | 0.163 | Interleukin 1 antagonist | 0.15 0.057 DBMET02446 0.163 0.05 DBMET02442 | DBMET02442 | |
| 0.027 | 0.116 | 0.073 | Dopamine uptake inhibitor | 0.055 0.043 DB00988 0.073 0.028 DBMET02444 | DBMET02444 | |
| 0.014 | 0.105 | 0.03 | Estrogen-related receptor alpha antagonist | 0.03 0.026 DBMET02442 | DBMET02442 | |
| 0.025 | 0.117 | 0.057 | Histamine H1 receptor agonist | 0.057 0.01 DB00988 | DB00988 | |
| 0.006 | 0.097 | 0.041 | Calcium-sensing receptor antagonist | 0.014 0.012 DBMET02443 0.041 0.005 DBMET02444 | DBMET02444 | |
| 0.046 | 0.139 | 0.085 | I kappa B kinase inhibitor | 0.085 0.054 DB00988 | DB00988 | |
| 0.014 | 0.108 | 0.18 | Factor Xa inhibitor | 0.18 0.007 DBMET02448 0.18 0.007 DBMET02449 0.057 0.025 DBMET02451 0.057 0.025 DBMET02450 | DBMET02449 | |
| 0.004 | 0.099 | 0.017 | 3C-Like protease (MERS coronavirus) inhibitor | 0.017 0.004 DBMET02445 0.011 0.01 DBMET02441 | DBMET02445 | |
| 0.033 | 0.128 | 0.071 | Nicotinic alpha3beta2 receptor antagonist | 0.071 0.017 DBMET02447 | DBMET02447 | |
| 0.05 | 0.146 | 0.083 | Antineoplastic alkaloid | 0.076 0.071 DBMET02440 0.083 0.062 DBMET02442 | DBMET02442 | |
| 0.013 | 0.109 | 0.059 | TRPM8 blocker | 0.059 0.012 DB00988 0.045 0.02 DBMET02440 | DB00988 | |
| 0.116 | 0.212 | 0.227 | Death-associated protein kinase 2 inhibitor | 0.227 0.02 DB00988 0.19 0.043 DBMET02440 0.18 0.054 DBMET02443 0.145 0.118 DBMET02445 | DB00988 | |
| 0.088 | 0.185 | 0.423 | Dual specificity phosphatase 3 inhibitor | 0.127 0.12 DB00988 0.423 0.012 DBMET02448 0.423 0.012 DBMET02449 0.133 0.113 DBMET02440 0.126 0.121 DBMET02441 0.173 0.078 DBMET02447 0.338 0.023 DBMET02446 0.297 0.029 DBMET02442 | DBMET02449 | |
| 0.026 | 0.123 | 0.113 | Carnitine palmitoyltransferase 1B inhibitor | 0.113 0.004 DBMET02446 0.104 0.005 DBMET02442 | DBMET02446 | |
| 0.041 | 0.139 | 0.096 | Acetylcholine nicotinic antagonist | 0.089 0.047 DB00988 0.073 0.063 DBMET02440 0.094 0.043 DBMET02443 0.096 0.042 DBMET02444 0.073 0.064 DBMET02447 | DBMET02444 | |
| 0.011 | 0.109 | 0.023 | Melanocortin 5 antagonist | 0.023 0.022 DB00988 | DB00988 | |
| 0.028 | 0.127 | 0.053 | CF transmembrane conductance regulator antagonist | 0.038 0.035 DBMET02445 0.04 0.028 DBMET02444 0.053 0.006 DBMET02447 0.04 0.027 DBMET02446 | DBMET02447 | |
| 0.013 | 0.114 | 0.043 | Cholesterol ester transfer protein antagonist | 0.043 0.011 DBMET02447 0.036 0.016 DBMET02446 0.035 0.017 DBMET02442 | DBMET02447 | |
| 0.029 | 0.131 | 0.066 | Androgen agonist | 0.061 0.039 DBMET02447 0.066 0.034 DBMET02446 | DBMET02446 | |
| 0.005 | 0.109 | 0.262 | Alpha 2a adrenoreceptor agonist | 0.025 0.006 DB00988 0.22 0.002 DBMET02443 0.262 0.002 DBMET02444 | DBMET02444 | |
| 0.025 | 0.13 | 0.113 | Purinergic P2X2 antagonist | 0.073 0.044 DB00988 0.113 0.024 DBMET02440 0.058 0.053 DBMET02443 0.082 0.039 DBMET02441 0.057 0.054 DBMET02447 0.075 0.043 DBMET02442 | DBMET02440 | |
| 0.053 | 0.158 | 0.085 | Caspase 7 inhibitor | 0.085 0.05 DBMET02445 0.082 0.057 DBMET02441 0.08 0.06 DBMET02447 0.083 0.054 DBMET02446 0.08 0.061 DBMET02442 | DBMET02445 | |
| 0.015 | 0.12 | 0.147 | Alpha 1d adrenoreceptor agonist | 0.069 0.007 DB00988 0.045 0.021 DBMET02440 0.146 0.002 DBMET02443 0.042 0.024 DBMET02445 0.147 0.002 DBMET02444 0.036 0.031 DBMET02447 | DBMET02444 | |
| 0.019 | 0.124 | 0.051 | Fructose-1,6-bisphosphatase inhibitor | 0.051 0.024 DBMET02447 0.046 0.03 DBMET02446 0.044 0.032 DBMET02442 | DBMET02447 | |
| 0.072 | 0.18 | 0.144 | Acetylcholine release stimulant | 0.122 0.046 DB00988 0.144 0.02 DBMET02448 0.144 0.02 DBMET02449 0.106 0.074 DBMET02451 0.106 0.074 DBMET02450 0.131 0.033 DBMET02440 0.097 0.095 DBMET02445 0.106 0.074 DBMET02441 0.11 0.065 DBMET02444 0.122 0.045 DBMET02447 0.109 0.068 DBMET02446 0.118 0.051 DBMET02442 | DBMET02449 | |
| 0.089 | 0.2 | 0.146 | Heat shock protein 90 alpha antagonist | 0.146 0.091 DB00988 0.138 0.1 DBMET02440 0.134 0.105 DBMET02445 0.127 0.115 DBMET02441 0.141 0.096 DBMET02447 | DB00988 | |
| 0.029 | 0.14 | 0.067 | Neuronal nicotinic receptor antagonist | 0.067 0.047 DB00988 0.058 0.057 DBMET02443 | DB00988 | |
| 0.002 | 0.114 | 0.029 | Antibiotic Macrolide-like | 0.029 0.004 DBMET02445 0.022 0.006 DBMET02441 | DBMET02445 | |
| 0.058 | 0.172 | 0.099 | Thioredoxin reductase inhibitor | 0.098 0.031 DBMET02445 0.099 0.029 DBMET02441 0.085 0.05 DBMET02447 0.076 0.075 DBMET02446 0.081 0.058 DBMET02442 | DBMET02441 | |
| 0.101 | 0.215 | 0.353 | Platelet aggregation inhibitor | 0.187 0.091 DBMET02439 0.238 0.057 DBMET02446 0.353 0.025 DBMET02442 | DBMET02442 | |
| 0.005 | 0.12 | 0.045 | Prostaglandin EP3 antagonist | 0.045 0.012 DBMET02446 0.03 0.022 DBMET02442 | DBMET02446 | |
| 0.118 | 0.233 | 0.2 | Histone acetyltransferase inhibitor | 0.199 0.07 DB00988 0.2 0.069 DBMET02440 0.175 0.107 DBMET02447 0.173 0.109 DBMET02446 0.175 0.107 DBMET02442 | DBMET02440 | |
| 0.01 | 0.126 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.009 DBMET02447 | DBMET02447 | |
| 0.018 | 0.134 | 0.046 | Melatonin receptor 1A agonist | 0.035 0.02 DB00988 0.043 0.011 DBMET02440 0.033 0.023 DBMET02447 0.038 0.016 DBMET02446 0.046 0.009 DBMET02442 | DBMET02442 | |
| 0.032 | 0.148 | 0.06 | Transcription factor AP-1 inhibitor | 0.057 0.051 DBMET02446 0.06 0.045 DBMET02442 | DBMET02442 | |
| 0.033 | 0.151 | 0.214 | MAO B inhibitor | 0.214 0.022 DB00988 0.208 0.023 DBMET02440 0.147 0.038 DBMET02447 | DB00988 | |
| 0.01 | 0.13 | 0.105 | Carbonic anhydrase XII inhibitor | 0.051 0.038 DB00988 0.095 0.021 DBMET02448 0.095 0.021 DBMET02449 0.105 0.019 DBMET02451 0.105 0.019 DBMET02450 | DBMET02450 | |
| 0.096 | 0.217 | 0.337 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.198 0.101 DB00988 0.247 0.079 DBMET02440 0.169 0.122 DBMET02445 0.206 0.097 DBMET02441 0.337 0.054 DBMET02447 0.24 0.081 DBMET02446 0.308 0.062 DBMET02442 | DBMET02447 | |
| 0.03 | 0.15 | 0.058 | Fatty acid synthase inhibitor | 0.058 0.038 DBMET02447 | DBMET02447 | |
| 0.05 | 0.17 | 0.163 | Gastric antisecretory | 0.087 0.082 DBMET02448 0.087 0.082 DBMET02449 0.094 0.074 DBMET02443 0.163 0.021 DBMET02444 0.124 0.04 DBMET02447 0.103 0.062 DBMET02446 0.104 0.061 DBMET02442 | DBMET02444 | |
| 0.039 | 0.165 | 0.085 | Protein kinase (CK2) inhibitor | 0.085 0.078 DBMET02446 | DBMET02446 | |
| 0.09 | 0.216 | 0.366 | Antimitotic | 0.182 0.095 DB00988 0.237 0.065 DBMET02439 0.232 0.067 DBMET02448 0.232 0.067 DBMET02449 0.366 0.029 DBMET02440 0.169 0.104 DBMET02441 0.266 0.054 DBMET02442 | DBMET02440 | |
| 0.035 | 0.162 | 0.145 | Calcium antagonist | 0.1 0.048 DB00988 0.145 0.024 DBMET02440 0.073 0.07 DBMET02441 0.109 0.042 DBMET02447 0.102 0.046 DBMET02442 | DBMET02440 | |
| 0.017 | 0.147 | 0.058 | p53 inhibitor | 0.058 0.01 DBMET02446 0.042 0.019 DBMET02442 | DBMET02446 | |
| 0.055 | 0.185 | 0.145 | Interleukin 5 antagonist | 0.103 0.038 DBMET02443 0.145 0.013 DBMET02445 0.127 0.02 DBMET02441 0.11 0.032 DBMET02446 0.098 0.044 DBMET02442 | DBMET02445 | |
| 0.01 | 0.142 | 0.043 | Dopamine D5 antagonist | 0.038 0.034 DB00988 0.043 0.03 DBMET02447 | DBMET02447 | |
| 0.062 | 0.197 | 0.147 | Phosphodiesterase 6D inhibitor | 0.096 0.06 DB00988 0.147 0.01 DBMET02451 0.147 0.01 DBMET02450 0.111 0.035 DBMET02443 0.091 0.074 DBMET02445 0.125 0.021 DBMET02444 0.135 0.015 DBMET02447 0.101 0.05 DBMET02446 0.09 0.075 DBMET02442 | DBMET02450 | |
| 0.011 | 0.147 | 0.081 | Liver X receptor beta agonist | 0.044 0.013 DBMET02447 0.081 0.006 DBMET02446 0.052 0.01 DBMET02442 | DBMET02446 | |
| 0.016 | 0.153 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.011 DBMET02447 | DBMET02447 | |
| 0.065 | 0.204 | 0.159 | Electron transport complex I inhibitor | 0.102 0.079 DB00988 0.112 0.059 DBMET02439 0.146 0.023 DBMET02440 0.155 0.018 DBMET02443 0.099 0.084 DBMET02445 0.147 0.022 DBMET02441 0.159 0.016 DBMET02444 0.138 0.028 DBMET02447 0.11 0.062 DBMET02446 0.154 0.019 DBMET02442 | DBMET02444 | |
| 0.004 | 0.143 | 0.025 | Sigma 2 receptor antagonist | 0.025 0.02 DBMET02440 0.024 0.021 DBMET02441 0.024 0.021 DBMET02447 | DBMET02440 | |
| 0.027 | 0.167 | 0.097 | Dopamine D1 antagonist | 0.088 0.029 DB00988 0.097 0.026 DBMET02440 0.077 0.034 DBMET02447 | DBMET02440 | |
| 0.011 | 0.152 | 0.288 | Dopamine D2 agonist | 0.112 0.009 DB00988 0.288 0.004 DBMET02448 0.288 0.004 DBMET02449 0.06 0.021 DBMET02451 0.06 0.021 DBMET02450 0.071 0.017 DBMET02440 0.126 0.008 DBMET02443 0.059 0.022 DBMET02444 0.055 0.024 DBMET02447 | DBMET02449 | |
| 0.016 | 0.158 | 0.038 | Purinergic P2Y2 antagonist | 0.038 0.017 DBMET02448 0.038 0.017 DBMET02449 | DBMET02449 | |
| 0.008 | 0.152 | 0.032 | Alpha 2b adrenoreceptor agonist | 0.032 0.004 DBMET02443 0.02 0.011 DBMET02444 | DBMET02443 | |
| 0.017 | 0.164 | 0.029 | Elastase 3B inhibitor | 0.029 0.025 DBMET02446 | DBMET02446 | |
| 0.017 | 0.164 | 0.029 | Elastase 3A inhibitor | 0.029 0.025 DBMET02446 | DBMET02446 | |
| 0.017 | 0.164 | 0.029 | Elastase 2B inhibitor | 0.029 0.025 DBMET02446 | DBMET02446 | |
| 0.015 | 0.164 | 0.601 | Prostaglandin antagonist | 0.601 0.004 DBMET02446 0.425 0.004 DBMET02442 | DBMET02446 | |
| 0.045 | 0.195 | 0.127 | DNA intercalator | 0.127 0.054 DBMET02451 0.127 0.054 DBMET02450 0.11 0.064 DBMET02445 0.111 0.064 DBMET02441 | DBMET02450 | |
| 0.014 | 0.164 | 0.048 | Factor XIa inhibitor | 0.048 0.02 DBMET02448 0.048 0.02 DBMET02449 | DBMET02449 | |
| 0.21 | 0.36 | 0.342 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.319 0.188 DB00988 0.286 0.232 DBMET02443 0.335 0.168 DBMET02445 0.342 0.16 DBMET02444 0.309 0.2 DBMET02447 0.305 0.206 DBMET02446 | DBMET02444 | |
| 0.022 | 0.172 | 0.054 | Vanilloid 3 antagonist | 0.038 0.027 DBMET02441 0.04 0.022 DBMET02447 0.042 0.018 DBMET02446 0.054 0.006 DBMET02442 | DBMET02442 | |
| 0.06 | 0.211 | 0.296 | Cyclooxygenase inhibitor | 0.14 0.079 DBMET02447 0.296 0.018 DBMET02446 0.262 0.024 DBMET02442 | DBMET02446 | |
| 0.007 | 0.158 | 0.081 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.081 0.005 DBMET02446 0.028 0.021 DBMET02442 | DBMET02446 | |
| 0.027 | 0.18 | 0.088 | Nicotinic alpha4beta2 receptor antagonist | 0.075 0.055 DB00988 0.086 0.044 DBMET02443 0.069 0.063 DBMET02445 0.088 0.042 DBMET02447 | DBMET02447 | |
| 0.022 | 0.177 | 0.217 | Alpha 2 adrenoreceptor agonist | 0.096 0.016 DB00988 0.077 0.026 DBMET02440 0.19 0.005 DBMET02443 0.217 0.004 DBMET02444 | DBMET02444 | |
| 0.138 | 0.293 | 0.671 | Antiobesity | 0.251 0.155 DBMET02448 0.251 0.155 DBMET02449 0.519 0.033 DBMET02443 0.671 0.013 DBMET02444 0.294 0.121 DBMET02446 | DBMET02444 | |
| 0.018 | 0.173 | 0.053 | Dopamine transporter inhibitor | 0.053 0.03 DBMET02444 | DBMET02444 | |
| 0.007 | 0.163 | 0.031 | Factor IX inhibitor | 0.031 0.006 DBMET02443 | DBMET02443 | |
| 0.028 | 0.185 | 0.103 | 5 Hydroxytryptamine 7 agonist | 0.081 0.012 DB00988 0.103 0.006 DBMET02440 | DBMET02440 | |
| 0.004 | 0.162 | 0.12 | Estrone sulfatase inhibitor | 0.12 0.004 DBMET02448 0.12 0.004 DBMET02449 | DBMET02449 | |
| 0.016 | 0.176 | 0.03 | Toll-Like receptor 4 agonist | 0.029 0.013 DBMET02448 0.029 0.013 DBMET02449 0.03 0.012 DBMET02451 0.03 0.012 DBMET02450 | DBMET02450 | |
| 0.013 | 0.175 | 0.089 | Aromatase inhibitor | 0.05 0.048 DB00988 0.089 0.024 DBMET02445 0.074 0.031 DBMET02441 0.064 0.039 DBMET02447 0.062 0.04 DBMET02446 | DBMET02445 | |
| 0.03 | 0.192 | 0.065 | Potassium channel (ATP-sensitive) blocker | 0.065 0.051 DB00988 0.064 0.051 DBMET02440 0.063 0.055 DBMET02447 | DB00988 | |
| 0.051 | 0.213 | 0.083 | mTOR complex 2 inhibitor | 0.081 0.066 DBMET02443 0.082 0.065 DBMET02444 0.083 0.061 DBMET02447 | DBMET02447 | |
| 0.006 | 0.169 | 0.071 | Carbonic anhydrase IX inhibitor | 0.071 0.032 DBMET02448 0.071 0.032 DBMET02449 0.05 0.042 DBMET02451 0.05 0.042 DBMET02450 | DBMET02449 | |
| 0.046 | 0.209 | 0.242 | 5 Hydroxytryptamine 3A agonist | 0.242 0.006 DB00988 0.188 0.019 DBMET02440 | DB00988 | |
| 0.149 | 0.314 | 0.22 | Analgesic | 0.22 0.213 DBMET02444 | DBMET02444 | |
| 0.05 | 0.216 | 0.132 | Nav1.6 sodium channel blocker | 0.132 0.077 DB00988 0.117 0.1 DBMET02440 0.117 0.1 DBMET02447 | DB00988 | |
| 0.053 | 0.22 | 0.154 | Interleukin 1b antagonist | 0.109 0.071 DBMET02441 0.118 0.064 DBMET02446 0.154 0.037 DBMET02442 | DBMET02442 | |
| 0.072 | 0.24 | 0.158 | Heat shock protein 90 antagonist | 0.147 0.077 DB00988 0.154 0.071 DBMET02440 0.158 0.067 DBMET02447 | DBMET02447 | |
| 0.023 | 0.191 | 0.106 | Amidase inhibitor | 0.073 0.045 DB00988 0.083 0.035 DBMET02443 0.093 0.028 DBMET02445 0.073 0.045 DBMET02441 0.104 0.022 DBMET02444 0.077 0.04 DBMET02447 0.106 0.021 DBMET02446 0.084 0.035 DBMET02442 | DBMET02446 | |
| 0.013 | 0.182 | 0.054 | Potassium channel Kv1.3 blocker | 0.046 0.034 DBMET02441 0.054 0.026 DBMET02447 0.045 0.035 DBMET02442 | DBMET02447 | |
| 0.018 | 0.188 | 0.107 | Elastase inhibitor | 0.107 0.009 DBMET02448 0.107 0.009 DBMET02449 | DBMET02449 | |
| 0.017 | 0.187 | 0.036 | Thiazolidinedione | 0.036 0.011 DBMET02447 | DBMET02447 | |
| 0.101 | 0.272 | 0.142 | CC chemokine 6 receptor antagonist | 0.142 0.035 DBMET02451 0.142 0.035 DBMET02450 | DBMET02450 | |
| 0.022 | 0.193 | 0.07 | CXC chemokine 4 receptor antagonist | 0.07 0.036 DB00988 | DB00988 | |
| 0.033 | 0.206 | 0.193 | Protein kinase B gamma inhibitor | 0.072 0.055 DB00988 0.193 0.008 DBMET02443 | DBMET02443 | |
| 0.022 | 0.194 | 0.05 | Purinergic P2X4 antagonist | 0.05 0.024 DBMET02447 | DBMET02447 | |
| 0.033 | 0.206 | 0.079 | Calcium channel L-type blocker | 0.079 0.041 DBMET02447 | DBMET02447 | |
| 0.041 | 0.216 | 0.085 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.085 0.055 DB00988 0.081 0.061 DBMET02440 | DB00988 | |
| 0.008 | 0.184 | 0.044 | Farnesoid X receptor agonist | 0.044 0.019 DBMET02446 | DBMET02446 | |
| 0.022 | 0.199 | 0.045 | Aldosterone antagonist | 0.045 0.038 DBMET02447 | DBMET02447 | |
| 0.031 | 0.211 | 0.083 | Histone deacetylase stimulant | 0.083 0.041 DBMET02451 0.083 0.041 DBMET02450 | DBMET02450 | |
| 0.031 | 0.211 | 0.083 | Histone deacetylase SIRT1 stimulant | 0.083 0.041 DBMET02451 0.083 0.041 DBMET02450 | DBMET02450 | |
| 0.021 | 0.204 | 0.359 | NMDA 2B receptor antagonist | 0.359 0.004 DBMET02448 0.359 0.004 DBMET02449 0.058 0.033 DBMET02443 0.05 0.044 DBMET02447 | DBMET02449 | |
| 0.008 | 0.194 | 0.046 | 5 Hydroxytryptamine 2C agonist | 0.046 0.031 DB00988 | DB00988 | |
| 0.022 | 0.209 | 0.349 | Alpha adrenoreceptor agonist | 0.129 0.02 DB00988 0.125 0.021 DBMET02440 0.265 0.005 DBMET02443 0.349 0.004 DBMET02444 | DBMET02444 | |
| 0.042 | 0.232 | 0.244 | Breast cancer-resistant protein inhibitor | 0.088 0.068 DBMET02439 0.135 0.03 DBMET02448 0.135 0.03 DBMET02449 0.152 0.023 DBMET02440 0.146 0.025 DBMET02441 0.244 0.01 DBMET02447 0.084 0.073 DBMET02446 0.16 0.021 DBMET02442 | DBMET02447 | |
| 0.019 | 0.212 | 0.06 | Histamine agonist | 0.06 0.028 DB00988 | DB00988 | |
| 0.019 | 0.213 | 0.065 | Cholesterol esterase inhibitor | 0.065 0.014 DBMET02447 0.056 0.022 DBMET02446 | DBMET02447 | |
| 0.022 | 0.217 | 0.079 | Cyclin D1 inhibitor | 0.059 0.045 DBMET02440 0.061 0.041 DBMET02445 0.066 0.033 DBMET02441 0.079 0.019 DBMET02447 | DBMET02447 | |
| 0.083 | 0.278 | 0.15 | Pregnane X receptor agonist | 0.15 0.052 DBMET02443 0.124 0.118 DBMET02445 0.149 0.056 DBMET02444 0.136 0.084 DBMET02447 0.132 0.095 DBMET02446 | DBMET02443 | |
| 0.037 | 0.235 | 0.128 | Histamine H2 receptor antagonist | 0.128 0.017 DB00988 0.103 0.032 DBMET02440 0.08 0.064 DBMET02443 0.115 0.024 DBMET02444 0.086 0.053 DBMET02447 | DB00988 | |
| 0.017 | 0.215 | 0.051 | Protein kinase C epsilon inhibitor | 0.051 0.04 DB00988 | DB00988 | |
| 0.004 | 0.202 | 0.037 | Sigma 1 receptor antagonist | 0.037 0.014 DBMET02447 | DBMET02447 | |
| 0.008 | 0.207 | 0.025 | Myristoyl transferase inhibitor | 0.025 0.024 DBMET02447 | DBMET02447 | |
| 0.015 | 0.214 | 0.176 | Acetylcholine M5 receptor antagonist | 0.057 0.046 DB00988 0.103 0.017 DBMET02443 0.176 0.005 DBMET02444 0.056 0.048 DBMET02447 | DBMET02444 | |
| 0.028 | 0.228 | 0.079 | Glucosylceramidase inhibitor | 0.053 0.041 DBMET02443 0.053 0.042 DBMET02445 0.079 0.016 DBMET02447 | DBMET02447 | |
| 0.014 | 0.213 | 0.131 | Acetylcholine M2 receptor antagonist | 0.073 0.034 DBMET02443 0.131 0.014 DBMET02444 | DBMET02444 | |
| 0.035 | 0.237 | 0.139 | Protein kinase C delta inhibitor | 0.082 0.074 DB00988 0.139 0.026 DBMET02443 | DBMET02443 | |
| 0.045 | 0.247 | 0.123 | MAP kinase kinase 1 inhibitor | 0.123 0.033 DBMET02447 | DBMET02447 | |
| 0.016 | 0.225 | 0.086 | Prostaglandin-E synthase inhibitor | 0.086 0.035 DBMET02446 | DBMET02446 | |
| 0.054 | 0.265 | 0.187 | Aryl hydrocarbon receptor agonist | 0.155 0.132 DBMET02446 0.187 0.109 DBMET02442 | DBMET02442 | |
| 0.006 | 0.217 | 0.056 | Factor XI inhibitor | 0.056 0.008 DBMET02448 0.056 0.008 DBMET02449 | DBMET02449 | |
| 0.005 | 0.217 | 0.055 | Sigma receptor antagonist | 0.055 0.031 DBMET02447 | DBMET02447 | |
| 0.04 | 0.253 | 0.199 | Cyclooxygenase 2 inhibitor | 0.109 0.092 DBMET02447 0.199 0.031 DBMET02446 0.178 0.038 DBMET02442 | DBMET02446 | |
| 0.02 | 0.234 | 0.116 | Lipase inhibitor | 0.116 0.02 DBMET02445 0.093 0.032 DBMET02441 0.076 0.048 DBMET02447 0.082 0.041 DBMET02446 0.064 0.06 DBMET02442 | DBMET02445 | |
| 0.008 | 0.234 | 0.031 | 5 Hydroxytryptamine 6 agonist | 0.031 0.016 DB00988 | DB00988 | |
| 0.06 | 0.287 | 0.147 | Protein kinase (CK1) gamma 3 inhibitor | 0.147 0.093 DB00988 | DB00988 | |
| 0.027 | 0.257 | 0.122 | 5 Hydroxytryptamine 5A antagonist | 0.122 0.011 DB00988 0.111 0.013 DBMET02440 | DB00988 | |
| 0.007 | 0.238 | 0.041 | Oleamide hydrolase inhibitor | 0.041 0.036 DBMET02446 | DBMET02446 | |
| 0.005 | 0.237 | 0.024 | Imidazoline I1 receptor antagonist | 0.024 0.011 DB00988 | DB00988 | |
| 0.036 | 0.269 | 0.134 | 5 Hydroxytryptamine 2B antagonist | 0.121 0.059 DB00988 0.134 0.049 DBMET02440 | DBMET02440 | |
| 0.026 | 0.26 | 0.07 | Aryl hydrocarbon receptor antagonist | 0.07 0.037 DBMET02447 | DBMET02447 | |
| 0.051 | 0.286 | 0.187 | Toll-Like receptor antagonist | 0.165 0.046 DB00988 0.187 0.035 DBMET02440 0.111 0.1 DBMET02447 | DBMET02440 | |
| 0.021 | 0.259 | 0.103 | Androgen antagonist | 0.089 0.056 DBMET02445 0.103 0.044 DBMET02447 | DBMET02447 | |
| 0.022 | 0.266 | 0.049 | Autotaxin inhibitor | 0.049 0.043 DBMET02446 | DBMET02446 | |
| 0.011 | 0.258 | 0.033 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.033 0.032 DBMET02447 | DBMET02447 | |
| 0.022 | 0.278 | 0.093 | 5 Hydroxytryptamine 3 agonist | 0.093 0.019 DB00988 0.058 0.052 DBMET02440 | DB00988 | |
| 0.063 | 0.319 | 0.162 | Sigma receptor agonist | 0.162 0.078 DBMET02440 0.118 0.117 DBMET02442 | DBMET02440 | |
| 0.023 | 0.281 | 0.115 | 5 Hydroxytryptamine 5 antagonist | 0.115 0.012 DB00988 0.11 0.013 DBMET02440 | DB00988 | |
| 0.07 | 0.331 | 0.127 | MAP kinase 3 inhibitor | 0.127 0.115 DBMET02447 | DBMET02447 | |
| 0.005 | 0.269 | 0.033 | Carnitine palmitoyltransferase 1A inhibitor | 0.033 0.014 DBMET02446 0.032 0.016 DBMET02442 | DBMET02446 | |
| 0.038 | 0.302 | 0.167 | Nav1.3 sodium channel blocker | 0.167 0.038 DBMET02444 | DBMET02444 | |
| 0.003 | 0.271 | 0.034 | Alpha 2c adrenoreceptor agonist | 0.028 0.005 DBMET02443 0.034 0.004 DBMET02444 | DBMET02444 | |
| 0.01 | 0.278 | 0.08 | Liver X receptor agonist | 0.042 0.033 DBMET02447 0.08 0.01 DBMET02446 0.055 0.019 DBMET02442 | DBMET02446 | |
| 0.044 | 0.316 | 0.102 | Nav1.5 sodium channel blocker | 0.096 0.093 DB00988 0.098 0.089 DBMET02444 0.102 0.081 DBMET02447 | DBMET02447 | |
| 0.012 | 0.285 | 0.078 | TRPA1 antagonist | 0.078 0.026 DBMET02445 | DBMET02445 | |
| 0.087 | 0.367 | 0.298 | DNA directed DNA polymerase inhibitor | 0.298 0.162 DBMET02447 0.226 0.208 DBMET02446 0.256 0.188 DBMET02442 | DBMET02447 | |
| 0.015 | 0.299 | 0.109 | 5 Hydroxytryptamine 2C antagonist | 0.094 0.05 DB00988 0.109 0.041 DBMET02440 | DBMET02440 | |
| 0.01 | 0.296 | 0.069 | Stearoyl-CoA desaturase inhibitor | 0.069 0.014 DBMET02444 | DBMET02444 | |
| 0.082 | 0.372 | 0.148 | Growth factor agonist | 0.148 0.147 DBMET02444 | DBMET02444 | |
| 0.074 | 0.375 | 0.562 | Alpha-glucosidase inhibitor | 0.562 0.063 DBMET02451 0.562 0.063 DBMET02450 0.262 0.18 DBMET02440 0.259 0.182 DBMET02441 0.393 0.118 DBMET02447 0.246 0.19 DBMET02446 0.3 0.16 DBMET02442 | DBMET02450 | |
| 0.003 | 0.304 | 0.042 | 5 Hydroxytryptamine 1D agonist | 0.042 0.013 DB00988 | DB00988 | |
| 0.044 | 0.348 | 0.151 | I kappa B kinase epsilon inhibitor | 0.151 0.118 DBMET02440 | DBMET02440 | |
| 0.011 | 0.315 | 0.214 | Alpha 1 adrenoreceptor agonist | 0.062 0.034 DB00988 0.072 0.027 DBMET02440 0.15 0.009 DBMET02443 0.214 0.006 DBMET02444 | DBMET02444 | |
| 0.032 | 0.339 | 0.237 | Alpha 2b adrenoreceptor antagonist | 0.137 0.045 DB00988 0.168 0.032 DBMET02440 0.183 0.028 DBMET02443 0.237 0.017 DBMET02444 | DBMET02444 | |
| 0.043 | 0.362 | 0.163 | MAP kinase kinase 2 inhibitor | 0.163 0.109 DBMET02447 | DBMET02447 | |
| 0.018 | 0.342 | 0.16 | Alpha 2a adrenoreceptor antagonist | 0.114 0.031 DB00988 0.149 0.023 DBMET02440 0.147 0.023 DBMET02443 0.16 0.02 DBMET02444 | DBMET02444 | |
| 0.069 | 0.393 | 0.264 | DNA polymerase beta inhibitor | 0.242 0.197 DBMET02447 0.217 0.212 DBMET02446 0.264 0.184 DBMET02442 | DBMET02442 | |
| 0.056 | 0.381 | 0.237 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.237 0.061 DB00988 0.155 0.107 DBMET02440 | DB00988 | |
| 0.074 | 0.401 | 0.149 | MAP kinase kinase 4 inhibitor | 0.149 0.063 DBMET02447 | DBMET02447 | |
| 0.004 | 0.332 | 0.056 | Vascular adhesion protein 1 inhibitor | 0.037 0.029 DB00988 0.056 0.011 DBMET02443 | DBMET02443 | |
| 0.007 | 0.335 | 0.052 | Melatonin 2 agonist | 0.034 0.022 DB00988 0.052 0.01 DBMET02440 | DBMET02440 | |
| 0.073 | 0.406 | 0.429 | Angiogenesis inhibitor | 0.429 0.045 DBMET02448 0.429 0.045 DBMET02449 | DBMET02449 | |
| 0.011 | 0.36 | 0.065 | Potassium channel (Inward rectifier) blocker | 0.065 0.02 DBMET02444 | DBMET02444 | |
| 0.014 | 0.364 | 0.072 | Protein kinase C alpha inhibitor | 0.072 0.042 DBMET02443 | DBMET02443 | |
| 0.026 | 0.379 | 0.171 | Alpha 2c adrenoreceptor antagonist | 0.12 0.05 DB00988 0.145 0.034 DBMET02440 0.142 0.036 DBMET02443 0.171 0.024 DBMET02444 | DBMET02444 | |
| 0.018 | 0.372 | 0.17 | Alpha 2 adrenoreceptor antagonist | 0.126 0.035 DB00988 0.161 0.024 DBMET02440 0.14 0.03 DBMET02443 0.17 0.023 DBMET02444 | DBMET02444 | |
| 0.027 | 0.385 | 0.106 | Phosphodiesterase VI inhibitor | 0.106 0.017 DBMET02447 | DBMET02447 | |
| 0.008 | 0.376 | 0.082 | 5 Hydroxytryptamine 1F antagonist | 0.082 0.041 DB00988 | DB00988 | |
| 0.041 | 0.418 | 0.219 | Prostaglandin dehydrogenase inhibitor | 0.219 0.145 DBMET02447 | DBMET02447 | |
| 0.005 | 0.384 | 0.086 | Dopamine D3 agonist | 0.086 0.008 DBMET02443 | DBMET02443 | |
| 0.012 | 0.395 | 0.086 | Insulin growth factor antagonist | 0.086 0.06 DBMET02444 | DBMET02444 | |
| 0.021 | 0.41 | 0.236 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.236 0.035 DB00988 0.132 0.076 DBMET02440 | DB00988 | |
| 0.008 | 0.397 | 0.043 | Melatonin 1 agonist | 0.043 0.013 DBMET02440 | DBMET02440 | |
| 0.005 | 0.397 | 0.045 | Prostaglandin E2 antagonist | 0.045 0.04 DBMET02446 | DBMET02446 | |
| 0.013 | 0.412 | 0.093 | 5 Hydroxytryptamine 2 antagonist | 0.089 0.081 DB00988 0.093 0.078 DBMET02440 | DBMET02440 | |
| 0.018 | 0.42 | 0.119 | MAP kinase kinase inhibitor | 0.119 0.075 DBMET02447 | DBMET02447 | |
| 0.006 | 0.41 | 0.043 | Melatonin agonist | 0.029 0.028 DB00988 0.043 0.013 DBMET02440 | DBMET02440 | |
| 0.005 | 0.409 | 0.077 | Alpha 1b adrenoreceptor antagonist | 0.067 0.055 DBMET02443 0.077 0.048 DBMET02444 | DBMET02444 | |
| 0.008 | 0.417 | 0.111 | Phosphodiesterase 4B inhibitor | 0.111 0.021 DBMET02442 | DBMET02442 | |
| 0.008 | 0.422 | 0.06 | 5 Hydroxytryptamine 1D antagonist | 0.06 0.049 DB00988 0.06 0.049 DBMET02440 | DBMET02440 | |
| 0.01 | 0.424 | 0.075 | Insulin like growth factor 1 antagonist | 0.075 0.068 DBMET02444 | DBMET02444 | |
| 0.012 | 0.442 | 0.113 | Alpha adrenoreceptor antagonist | 0.101 0.056 DBMET02440 0.096 0.06 DBMET02443 0.113 0.05 DBMET02444 | DBMET02444 | |
| 0.004 | 0.435 | 0.052 | Alpha 1d adrenoreceptor antagonist | 0.052 0.048 DBMET02444 | DBMET02444 | |
| 0.007 | 0.446 | 0.191 | Phosphodiesterase IV inhibitor | 0.075 0.067 DBMET02447 0.074 0.068 DBMET02446 0.191 0.014 DBMET02442 | DBMET02442 | |
| 0.022 | 0.467 | 0.111 | Alpha 1b adrenoreceptor agonist | 0.059 0.02 DBMET02443 0.111 0.004 DBMET02444 | DBMET02444 | |
| 0.014 | 0.461 | 0.66 | Antiadrenergic | 0.113 0.048 DB00988 0.137 0.04 DBMET02440 0.644 0.005 DBMET02443 0.66 0.005 DBMET02444 0.085 0.066 DBMET02447 | DBMET02444 | |
| 0.014 | 0.462 | 0.655 | Adrenaline antagonist | 0.106 0.05 DB00988 0.129 0.041 DBMET02440 0.64 0.005 DBMET02443 0.655 0.005 DBMET02444 0.083 0.066 DBMET02447 | DBMET02444 | |
| 0.011 | 0.464 | 0.189 | Adrenaline uptake inhibitor | 0.189 0.006 DBMET02444 | DBMET02444 | |
| 0.005 | 0.475 | 0.184 | 5 Hydroxytryptamine agonist | 0.184 0.016 DB00988 0.122 0.027 DBMET02440 | DB00988 | |
| 0.004 | 0.476 | 0.036 | Melatonin antagonist | 0.029 0.019 DB00988 0.036 0.012 DBMET02440 | DBMET02440 | |
| 0.016 | 0.52 | 0.136 | Acetylcholinesterase inhibitor | 0.136 0.065 DBMET02440 | DBMET02440 | |
| 0.031 | 0.566 | 0.293 | Toll-Like receptor 3 antagonist | 0.091 0.066 DB00988 0.111 0.037 DBMET02440 0.194 0.007 DBMET02443 0.293 0.004 DBMET02444 | DBMET02444 | |
| 0.005 | 0.555 | 0.135 | Alpha 1a adrenoreceptor agonist | 0.135 0.003 DBMET02443 0.078 0.004 DBMET02444 | DBMET02443 | |
| 0.004 | 0.554 | 0.021 | Melatonin 1 antagonist | 0.021 0.011 DBMET02440 | DBMET02440 | |
| 0.008 | 0.573 | 0.114 | DNA gyrase inhibitor | 0.114 0.014 DBMET02443 | DBMET02443 | |
| 0.011 | 0.589 | 0.189 | 5 Hydroxytryptamine 1B agonist | 0.189 0.004 DB00988 0.066 0.021 DBMET02448 0.066 0.021 DBMET02449 0.107 0.005 DBMET02440 | DB00988 | |
| 0.005 | 0.635 | 0.205 | Phosphodiesterase 4D inhibitor | 0.101 0.036 DBMET02446 0.205 0.01 DBMET02442 | DBMET02442 | |
| 0.004 | 0.646 | 0.158 | 5 Hydroxytryptamine uptake inhibitor | 0.158 0.015 DBMET02444 | DBMET02444 | |
| 0.004 | 0.787 | 0.128 | 5 Hydroxytryptamine 1 agonist | 0.128 0.016 DB00988 0.072 0.027 DBMET02440 | DB00988 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |